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Abstract 
 
Chapter 1. We reported the first synthesis of all-carbon quaternary centers via 
hydroformylations using a catalytic directing group. With the ability of reversibly and 
covalently binding to a substrate, and coordinating to a metal center, scaffolding catalyst 
1.1 is able to direct the branch-selective hydroformylation of 1,1-disubstituted olefins 
under mild temperature. 
 
Chapter 2. We have designed and synthesized a chiral organocatalyst 2.11. This catalyst 
is able to covalently bind to one hydroxyl, and utilize the induced intramolecularity to 
stereoselectively functionalize the other hydroxyl within a cis-1,2-diol via electrophile 
transfer. Catalyst 2.11 was used in the desymmetrization of meso-1,2-diols under mild 
conditions (4 °C to room temperature), leading to high yields and selectivities for a broad 
substrate scope.  
 
Chapter 3. Catalyst 3.1 and 3.6 were demonstrated to selectively bind to primary 
hydroxyls over secondary hydroxyls. By combining the binding selectivity with 
asymmetric catalysis, these scaffolding catalysts were shown to promote the selective 
silylation of secondary hydroxyls within terminal (S)-1,2-diols. The reversal of substrate 
bias was further applied to a regiodivergent kinetic resolution of racemic terminal 
1,2-diols, producing secondary protected products in synthetically practical levels of 
enantioselectivity (>95:5 er) and yields (≥40%). Time course studies of this reaction 
further revealed the optimal condition to form the primary silylated product in high 
s-factor. 
 
Chapter 4. Based on the previous understanding of catalyst 4.5 and 4.6, the exclusive 
catalyst recognition of cis-1,2-diols within polyhydroxylated molecules was further 
discovered. This unique functional group display recognition was further allied with the 
catalyst’s ability to stereoselectively differentiate hydroxyls within cis-1,2-diols, enabling 
the site-selective protection, functionalization, and activation of the inherently less 
reactive axial hydroxyl groups within carbohydrates. This methodology also enables the 
selective functionalization of multiple complex molecules, including digoxin, mupirocin, 
and ribonucleosides, demonstrating the potential power of scaffolding catalysis in the 
rapid access to valuable synthetic derivatives of polyhydroxylated compounds. 
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Chapter 1. Hydroformylation of 1,1-Disubstituted Alkenes 
 
1.1 Hydroformylation 
First discovered in 1938 by Roelen,1 hydroformylation has become one of the 
largest industrial processes today, with approximately 9 million tons of products 
manufactured every year.2 Besides its industrial importance, this atom-economical 
addition of CO and H2 to an alkene provides an opportunity to add a versatile aldehyde 
functional group through the formation of a carbon-carbon bond,3 and therefore is 
recognized as a valuable synthetic tool in organic chemistry (Scheme 1.1). 
 
 
 
1.2 Challenges in Regioselective Hydroformylation 
Despite its great value in industry and appealing synthetic advantages, the use of 
hydroformylation in organic synthesis is still limited due to the difficulty in controlling 
all aspects of reaction selectivities. 
One field that has been the focus of intensive research efforts is controlling 
regioselectivity of hydroformylation. Traditionally, the regioselectivity is determined by 
intrinsic substrate preferences. In the hydroformylation of terminal alkenes, the linear 
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product is favored, where the aldehyde is formed on the less hindered terminal carbon. 
This bias results from the metal-carbon bond formation on the less hindered terminal 
carbon atom following hydride insertion, due to the steric effect between the substrate 
and the metal catalyst (Figure 1.1). 
 
 
 
One of the most significant challenges in regioselective hydroformylation is the use 
of 1,1-disubstituted alkenes to yield products containing all-carbon quaternary centers. 
Due to the substrate’s strong favorability to bond metal with a primary carbon over a 
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tertiary carbon, the formation of linear product is dominant (Scheme 1.2). This 
observation was summarized as Keulemans’ rule,4 which stated that “addition of the 
formyl group to a tertiary C atom does not occur, so that no quaternary C atoms are 
formed”.  
 
 
 
The challenges of regioselective hydroformylation limit its potential applications in 
organic synthesis. Thus general and efficient methods to enrich, and more importantly, to 
reverse the inherent regioselectivities of substrates are highly desired. 
 
1.3 Directing Groups in Hydroformylation. 
     The use of directing group has been widely recognized as a powerful method to 
control selectivities in a variety of reactions.5 By incorporating the directing group into 
the substrate, an attractive substrate-reagent interaction can be achieved through covalent 
or noncovalent interactions. The resulting cyclic transition state can then accelerate the 
directed reaction by reducing the activation entropy. As a consequence, the directed 
reaction is able to out compete other non-directed reaction pathways (Figure 1.2). 
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     In the area of regioselective hydroformylation, the use of directing groups is a 
proven strategy.6 While linear products can be obtained via hydroformylations controlled 
by various methods, the access to branched aldehyde products generally relies on the use 
of phosphorus-based directing groups. 
 
 
 
In 1990, Jackson reported the first use of phosphites to direct the branch-selective 
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hydroformylation of cyclic and acyclic homoallylic olefins (Scheme 1.3).7 Burke also 
employed a triphenylphosphine group to remotely induce a regio- and diastereoselective 
hydroformylation on a 1,2-disubstituted alkene, leading to the synthesis of 
(+)-phyllanthocin (Scheme 1.4).8 Subsequently, Leighton9 and Breit10 demonstrated that 
similar directing groups can be used in the regio- and diastereoselective 
hydroformylations of terminal alkenes. 
 
 
 
In the hydroformylation of 1,1-disubstituted alkene, successful application of 
directing groups has been rare. In 2001, Leighton reported a single example of a directed 
hydroformylation of a 1,1-disubstituted allylic olefin to form the branched aldehyde 
product (Scheme 1.5, equation 1).9 Esters were also shown to direct hydroformylation 
giving aldehydes containing all-carbon quaternary center by Clarke (Scheme 1.5, 
equation 2).11 
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1.4 Catalytic Directing Groups in Hydroformylation. 
One critical disadvantage of directing groups is their use in stoichiometric 
quantities.  Additionally, synthetic steps are required to install and remove directing 
groups. Development of a catalytic directing group would largely expand the practical 
scope of this concept. To achieve this goal, directing groups utilizing reversible covalent 
bonds with substrates have been developed (Figure 1.3).6 
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In 2008, Tan reported scaffolding catalyst 1.1 as the first catalytic directing group 
in hydroformylation.12 In the design of this catalyst, a 1,3-azaphospholidine is employed 
to enable the formation of a reversible covalent bond between the catalyst and alcohol 
substrates. Simultaneously, the phosphine center in catalyst 1.1 is able to coordinate to 
the metal catalyst. As a result, a transient tether between substrate and metal catalyst is 
created, allowing a directed hydroformylation of the olefin with high selectivity (Figure 
1.4).  
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Catalytic amounts (20-25 mol %) of 1.1 were demonstrated to efficiently direct 
branch-selective hydroformylation of homoallylic alcohols. After hydroformylation and 
oxidation, products were isolated in the form of -lactones in high regio- and 
diastereoselectivities (Scheme 1.6, equation 1).12 The substrate scope was further 
expanded to allylic sulfonamides (Scheme 1.6, equation 2),13 as well as allylic alcohols 
(Scheme 1.6, equation 3),14 in which case the loading of 1.1 can be dropped to as low as 5 
mol %. Trisubstituted olefins, which are generally considered difficult substrates due to 
their higher activation barriers, also underwent scaffolding catalysed hydroformylation in 
high yields and regioselectivities (Scheme 1.6, equation 3). 
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     Similar to 1.1, a chiral scaffolding catalyst 1.2 was also developed by Tan, 
facilitating the control of both regio- and enantioselectivity in the hydroformylation of 
allylic anilines.15 Modifications of the aniline revealed that electron-donating groups 
promote the reaction in high yields and selectivities.16 Through hydroformylation and 
reduction, a variety of chiral -amino alcohols were synthesized with high 
Chapter 1, page 10 
 
enantioselectivities (Scheme 1.7). 
 
 
 
      Breit also introduced a phosphinite 1.3 as a catalytic directing group in 
hydroformylation (Scheme 1.8).17 Under a similar principle as the scaffolding catalysis, 
phosphinite 1.3 reversibly bonds to homoallylic alcohols, and directs hydroformylation to 
form branched aldehydes. A remote control of regioselectivity by 1.3 was also 
demonstrated in the hydroformylation and oxidation of bishomoaalylic alcohols to form 
-lactones.18 Later, the same catalyst was also applied to hydroformylation towards 
aldehydes containing quaternary centers.19 
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     The developments of supramolecular catalysts to direct regioselective 
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hydroformylations were also reported by Breit20a-b and Reek20c. Mimicking the enzymes, 
the functionalized supramolecular catalysts are able to recognize and coordinate to the 
substrate via multiple non-covalent bonds, and direct the regioselective 
hydroformylations. Even though attempts to form quaternary centers were not successful, 
these methods opened an important pathway to achieve regioselectivity in 
hydroformylations through supramolecular chemistry. 
 
1.5 Synthesis of Quaternary Carbon Centers via Hydroformylations 
Encouraged by previous successes with scaffolding catalyst 1.1, we attempted 
synthesis of quaternary carbon centers via hydroformylation of 1,1-disubstituted olefins. 
We began by investigating the hydroformylation of allylic alcohol 1.4a. Though styrenes 
are known to electronically promote branch-selective hydroformylation21, previous 
attempts to hydroformylate -substituted styrenes afforded only linear aldehyde 
products22. Applying Ph3P as ligand, hydroformylation of 1.4a at 75 °C  was found to only 
yield the linear product (Table 1.1, entry 1). In contrast to the background reaction, using 
20 mol % of catalyst 1.1, the branched aldehyde containing a quaternary carbon center 
was obtained as the major product (Table 1.1, entry 2), indicating a reversal of the 
substrate inherent selectivity. Due to the unstable nature of the branched aldehyde and its 
tendency to dimerize to a cyclic acetal, we oxidized the crude mixture to isolate the 
carboxylic acid. Further optimization revealed that when performed at 45 °C , the reaction 
forms the branched product in 64% yield and b:l = 95:5 regioselectivity (Table 1.1, entry 
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3). Interestingly, increasing the pressure of CO/H2 to 400 psi further elevates the 
regioselectivity to b:l = 97:3, suggesting that higher pressure may change the 
selectivity-determining step, or mitigate the competing pathways (Table 1.1, entry 7). In 
addition, a control reaction with Ph3P performed at the same temperature (45 °C ) resulted 
in no product formation, indicating that the directed reaction is accelerated dramatically 
compared to the background (Table 1.1, entry 8). 
 
 
 
In our exploration of the substrate scope, both electron-deficient and electron-rich 
modifications on the substrate provided the branched product in good yields and high 
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regioselectivities (Table 1.2, 1.5b-c). Bromo- or chloro-substituted aromatic rings also 
formed the quaternary aldehydes (Table 1.2, 1.5d-f). Further examination revealed that 
incorporation of -electron-withdrawing groups (Table 1.2, 1.5g-h), naphthalene (Table 
1.2, 1.5i), and heterocyles (Table 1.2, 1.5j-k) in the substrates were well tolerated. 
Hydroformylation of 2-methyl-propen-1-ol produced the branched product with 
promising regioselectivity (Table 1.2, 1.5l). To improve regioselectivities of aliphatic 
substituted substrates, modifications of the catalyst will be needed. 
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Since the required oxidation after hydroformylation limits the potential 
applications of this methodology, we also performed an acetal protection of the crude 
reaction mixture. The branched product was successfully isolated in the aldehyde 
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oxidation state with comparable yields (72%, Scheme 1.9). 
 
 
 
     Next, we studied a binding experiment of the scaffolding catalyst 1.1. By adding 
2.5 equivalents of substrate and 2.5 equivalents of the aldehyde product to catalyst 1.1 
under acidic condition, the substrate was found to form a favored binding to 1.1 over the 
product (1.8:1.9 = 61:39, Scheme 10). Therefore, the product inhibition can be mitigated 
during the reaction due to the catalyst’s preference for binding to the starting material 
over the product. 
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1.6 Conclusions 
     In summary, we have achieved the first synthesis of quaternary carbon centers via 
branch-selective hydroformylation with a catalytic directing group. The induced 
temporary intramolecularity allows this challenging reaction to be carried out under 
modest temperatures. We are currently developing catalysts to further expand the 
substrate scope of this method towards other disubstituted and trisubstituted olefins, as 
well as to achieve challenging selectivities in other organic transformations. 
 
1.7 Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and 
used without further purification. Flash column chromatography was performed using 
EMD Silica Gel 60 (230-400 mesh) and ACS grade solvents as received from Fisher 
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Scientific. All experiments were performed in oven or flame dried glassware under an 
atmosphere of nitrogen or argon using standard syringes, except where otherwise noted. 
All reactions were run with dry, degassed solvents dispensed from a Glass Contour 
Solvent Purification System (SG Water, USA LLC). 1H and 13C NMR’s were performed 
on either a Varian Unity INOVA 400 MHz or a Varian 500 MHz instrument. Deuterated 
solvents were purchased from Cambridge Isotope Labs and stored over 3Å molecular 
sieves. All NMR chemical shifts are reported in ppm relative to residual solvent for 1H 
and 13C. Coupling constants are reported in Hz. Abbreviations are as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), dd (doublet of doublet), m (multiplet), br s (broad 
singlet). All IR spectra were gathered on a Bruker Alpha FT-IR equipped with a single 
crystal diamond ATR module and values are reported in cm-1. HRMS data were generated 
in Boston College facilities. Hydroformylation was performed in an Argonaut 
Technologies Endeavor Catalyst Screening System using 1:1 H2/CO supplied by Airgas, 
Inc. 
Scaffolding catalyst 1.1 was synthesized following the previously reported 
procedures.12 
 
Optimization of Branch Selective Hydroformylation 
General Hydroformylation Procedure A.  The oven dried glass reaction vial was 
placed in the Endeavor, and 2-phenylprop-2-en-1-ol (20 mg, 0.15 mmol) was added.  
The Endeavor was sealed and purged with nitrogen (4 × 100 psi).  A solution of 
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dicarbonylacetylacetonato rhodium (I) (1.6 mg, 6.0 × 10-3 mmol, 4.0 mol %), 1.1 (8.6 mg, 
3.0 × 10-2 mmol, 20 mol %), p-toluenesulfonic acid (500 L of 6.0 × 10-4 M in benzene, 
3.0 × 10-4 mmol, 0.20 mol %) and benzene (to total volume of 1 mL) was injected, 
followed by injection of additional benzene (0.5 mL) to wash the injection port. The 
Endeavor was purged with nitrogen (1 × 100 psi), stirring was started at 250 rpm, and the 
Endeavor was heated to and held at the corresponding temperature (see below) for 10 
minutes.  Stirring was stopped, the Endeavor was charged with corresponding pressure 
(see below) of H2/CO, stirring was re-initiated at 700 rpm., and the Endeavor was 
maintained at a constant temperature (see below) and pressure (see below) of H2/CO for 
12 h. The Endeavor was vented to ambient pressure and cooled to ambient temperature. 
The reaction mixture was removed from the Endeavor and concentrated. The residue was 
redissolved in t-butanol (0.75 mL) and 2-methyl-2-butene (0.16 mL, 1.5 mmol, 10.0 eq.) 
followed by addition of a solution of NaClO2 (80%, 68 mg, 0.60 mmol, 4.0 eq.) and 
NaH2PO4 (72 mg, 0.60 mmol, 4.0 eq.) in H2O (0.4 mL). The solution was stirred at room 
temperature overnight. The resulting mixture was concentrated and redissolved in EtOAc 
(0.75 mL), followed by addition of 10% HCl (0.18 mL) and brine (0.18 mL). The 
solution was extracted with EtOAc (3 × 5 mL). Combined organic layers were dried over 
MgSO4, filtered and solvent was removed. 1,3,5-Trimethoxybenzene (100 L of 0.15 M 
in CDCl3, 0.015 mmol) was added as standard and 
1H NMR was measured to analyze 
yields and selectivities. 
General Hydroformylation Procedure B.  The oven dried glass reaction vial was 
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placed in the Endeavor, and 2-phenylprop-2-en-1-ol (80 mg, 0.60 mmol) was added.  
The Endeavor was sealed and purged with nitrogen (4 × 100 psi).  A solution of 
dicarbonylacetylacetonato rhodium (I) (6.2 mg, 2.4 × 10-2 mmol, 4.0 mol %), 
triphenylphosphine (13 mg, 4.8 × 10-2 mmol, 8.0 mol %) and benzene (to a total volume 
of 4 mL) was injected, followed by injection of additional benzene (2 mL) to wash the 
injection port. The Endeavor was purged with nitrogen (1 × 100 psi), stirring was started 
at 250 rpm, and the Endeavor was heated to and held at 45 °C  for 10 minutes.  Stirring 
was stopped, the Endeavor was charged with 400 psi H2/CO, stirring was re-initiated at 
700 rpm, and the Endeavor was maintained at a constant temperature and pressure of 
45 °C  and 400 psi H2/CO for 12 h. The Endeavor was vented to ambient pressure and 
cooled to ambient temperature. The reaction was removed from the Endeavor and 
concentrated. 1,3,5-Trimethoxybenzene (400 L of 0.15 M in CDCl3, 0.060 mmol) was 
added as standard and 1H NMR was measured to analyze conversion. 
General Hydroformylation Procedure C.  The oven dried glass reaction vial was 
placed in the Endeavor, and 2-phenylprop-2-en-1-ol (80 mg, 0.60 mmol) was added.  
The Endeavor was sealed and purged with nitrogen (4 × 100 psi).  A solution of 
dicarbonylacetylacetonato rhodium (I) (6.2 mg, 2.4 × 10-2 mmol, 4.0 mol %), 
triphenylphosphine (13 mg, 4.8 × 10-2 mmol, 8.0 mol %) and benzene (to a total volume 
of 4 mL) was injected, followed by injection of additional benzene (2 mL) to wash the 
injection port. The Endeavor was purged with nitrogen (1 × 100 psi), stirring was started 
at 250 rpm, and the Endeavor was heated to and held at 75°C  for 10 minutes.  Stirring 
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was stopped, the Endeavor was charged with 400 psi H2/CO, stirring was re-initiated at 
700 rpm, and the Endeavor was maintained at a constant temperature and pressure of 
75°C  and 400 psi H2/CO for 12 h. The Endeavor was vented to ambient pressure and 
cooled to ambient temperature. The reaction was removed from the Endeavor and 
concentrated. The residue was redissolved in t-butanol (3 mL) and 2-methyl-2-butene 
(0.64 mL, 6.0 mmol, 10.0 eq.) followed by addition of a solution of NaClO2 (80%, 270 
mg, 2.4 mmol, 4.0 eq.) and NaH2PO4 (290 mg, 2.4 mmol, 4.0 eq.) in H2O. The solution 
was stirred at room temperature overnight. The resulting mixture was concentrated and 
redissolved in EtOAc (3 mL), followed by addition of 10% HCl (0.75 mL) and brine 
(0.75 mL). The solution was extracted with EtOAc (3 × 20 mL). Combined organic layers 
were dried over MgSO4, filtered, and concentrated in vacuo. 
1H NMR was measured to 
analyze selectivity. Flash column chromatography (Hex/EtOAc = 8/1) was performed to 
determine isolated yields. 
Table 1.1, Entry 1. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure C. Analysis of crude mixture after oxidation by 1H NMR showed a b:l 
selectivity of  < 2:98. Linear product was isolated as a white solid (64.0 mg, 66%). 
Table 1.1, Entry 2. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure A with 200 psi CO/H2 at 35 °C . Analysis of crude mixture after oxidation by 
1H NMR showed a b:l selectivity of 96:4 and yield of 54%. 
Table 1.1, Entry 3. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure A with 200 psi CO/H2 at 45 °C . Analysis of crude mixture after oxidation by 
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1H NMR showed a b:l selectivity of 95:5 and yield of 64%. 
Table 1.1, Entry 4. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure A with 200 psi CO/H2 at 55 °C . Analysis of crude mixture after oxidation by 
1H NMR showed a b:l selectivity of 95:5 and yield of 50%. 
Table 1.1, Entry 5. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure A with 50 psi CO/H2 at 45 °C . Analysis of crude mixture after oxidation by 
1H 
NMR showed a b:l selectivity of 89:11 and yield of 38%. 
Table 1.1, Entry 6. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure A with 100 psi CO/H2 at 45 °C . Analysis of crude mixture after oxidation by 
1H NMR showed a b:l selectivity of 94:6 and yield of 53%. 
Table 1, Entry 7. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure A with 400 psi CO/H2 at 45 °C . Analysis of crude mixture after oxidation by 
1H NMR showed a b:l selectivity of 97:3 and yield of 70%. 
Table 1, Entry 8. 2-Phenylprop-2-en-1-ol was hydroformylated using General 
Procedure B. Analysis of crude mixture after hydroformylation by 1H NMR showed 0% 
conversion. 
 
Hydroformylation Using Catalyst 1.1 and Product Characterizations 
General Hydroformylation Procedure.  The oven dried glass reaction vial was 
placed in the Endeavor, and corresponding alcohol substrate (0.60 mmol, see below) was 
added.  The Endeavor was sealed and purged with nitrogen (4 × 100 psi). A solution of 
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dicarbonylacetylacetonato rhodium (I) (6.2 mg, 2.4 × 10-2 mmol, 4.0 mol %), 1.1 (34 mg, 
0.12 mmol, 20 mol %), p-toluenesulfonic acid (see below) and benzene (to total volume 
of 4 mL) was injected, followed by injection of additional benzene (2 mL) to wash the 
injection port. The Endeavor was purged with nitrogen (1 × 100 psi), stirring was started 
at 250 rpm, and the Endeavor was heated to and held at 35 °C (or 45 °C , see below) for 
10 minutes.  Stirring was stopped, the Endeavor was charged with 400 psi H2/CO, 
stirring was re-initiated at 700 rpm, and the Endeavor was maintained at a constant 
temperature (see below) and pressure (see below) of H2/CO for 12 h (or 16 h, see below). 
The Endeavor was vented to ambient pressure and cooled to ambient temperature. The 
reaction was removed from the Endeavor and concentrated. The residue was redissolved 
in t-butanol (3 mL) and 2-methyl-2-butene (0.64 mL, 6.0 mmol, 10.0 eq.) followed by 
addition of a solution of NaClO2 (80 %, 270 mg, 2.4 mmol, 4.0 eq.) and NaH2PO4 (290 
mg, 2.4 mmol, 4.0 eq.) in H2O. The solution was stirred at room temperature overnight. 
The resulting mixture was concentrated and redissolved in EtOAc (3 mL), followed by 
addition of 10 % HCl (0.75 ml) and brine (0.75 mL). The solution was extracted with 
EtOAc (3 × 20 mL). Combined organic layers were dried over MgSO4, filtered and 
concentrated. 1H NMR was measured to analyze selectivities. Flash column 
chromatography (Hex/EtOAc = 4/1) afforded pure branched products. 
3-Hydroxy-2-methyl-2-phenylpropanoic acid (1.5a). 2-Phenylprop-2-en-1-ol (80 
mg, 0.60 mmol) was hydroformylated with 0.20 mol % p-toluenesulfonic acid (2.0 mL of 
6.0 × 10-4 M in benzene, 1.2 × 10-3 mmol) at 45 °C  for 12 h. Analysis of crude mixture 
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after oxidation by 1H NMR showed selectivity (b:l = 97:3). Branched 
product was isolated as a white solid (79 mg, 73%). 1H NMR (CDCl3, 
400 MHz)  7.36-7.24 (m, 5H), 6.98 (br s, 1H), 4.09 (d, 1H, J = 11.6), 
3.66 (d, 1H, J = 11.2), 1.67 (s, 3H); 13C NMR (CDCl3, 100 MHz)  181.2, 139.5, 128.7, 
127.6, 126.3, 69.1, 52.4, 20.0; IR: 2982, 1701, 1239, 1026, 698 cm–1; HRMS 
(DART-TOF) calcd. for C10H16NO3 [M+NH4]
+: 198.11302, found: 198.11247. 
2-(3,5-Bis(trifluoromethyl)phenyl)-3-hydroxy-2-methylpropanoic acid (1.5b). 
2-(3,5-Bis(trifluoromethyl)phenyl)prop-2-en-1-ol (160 mg, 0.60 
mmol) was hydroformylated with 0.05 mol % p-toluenesulfonic 
acid (500 L of 6.0 × 10-4 M in benzene, 3.0 × 10-4 mmol) at 
45 °C  for 12 h. Analysis of crude mixture after oxidation by 1H 
NMR showed a b:l selectivity of > 98:2. Branched product was isolated as a white solid 
(152 mg, 80%). 1H NMR (CDCl3, 500 MHz)  7.86 (s, 3H), 4.06 (d, 1H, J = 11.5), 3.89 
(d, 1H, J = 11.5), 1.75 (s, 3H); 13C NMR (Acetone d-6, 125 MHz)  174.6, 145.3, 130.9 
(q, J = 32.9), 127.9, 123.7 (q, J = 270.1), 120.6, 67.6, 52.5, 20.1; IR: 2924, 1711, 1373, 
1287, 1187, 1132 cm–1; HRMS (DART-TOF) calcd. For C12H14F6NO3 [M+NH4]
+: 
334.08779, found: 334.08865. 
3-Hydroxy-2-(4-methoxyphenyl)-2-methylpropanoic acid (1.5c). 
2-(4-Methoxyphenyl)-prop-2-en-1-ol (98 mg, 0.60 mmol) was hydroformylated with 0.20 
mol % p-toluenesulfonic acid (2.0 mL of 6.0 × 10-4 M in benzene, 1.2 × 10-3 mmol) at 
35 °C  for 16 h. Analysis of crude mixture after oxidation by 1H NMR showed a b:l 
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selectivity of > 98:2. Branched product was isolated as a white 
solid (83 mg, 66%). 1H NMR (CDCl3, 500 MHz)  7.21 (d, 2H, J 
= 8.5), 6.99 (br s, 1H), 6.81 (d, 2H, J = 8.5), 4.00 (d, 1H, J = 11.5), 
3.72 (s, 3H), 3.56 (d, 1H, J = 11.5), 1.58 (s, 3H); 13C NMR (CDCl3, 
125 MHz)  181.3, 158.9, 131.5, 127.4, 114.1, 69.1, 55.2, 51.6, 20.1; IR: 2937, 1703, 
1514, 1253, 1187, 1029, 829 cm–1; HRMS (DART-TOF) calcd. for C11H18NO4 
[M+NH4]
+: 228.12358, found: 228.12384. 
2-(4-Chlorophenyl)-3-hydroxy-2-methylpropanoic acid (1.5d). 2-(4-Chlorophenyl)- 
prop-2-en-1-ol (100 mg, 0.60 mmol) was hydroformylated with 0.05 
mol % p-toluenesulfonic acid (500 L of 6.0 × 10-4 M in benzene, 3.0 
× 10-4 mmol) at 35 °C  for 12 h. Analysis of crude mixture after 
oxidation by 1H NMR showed a b:l selectivity of 97:3. Branched 
product was isolated as a white solid (78 mg, 60%). 1H NMR (CDCl3, 400 MHz)  
7.33-7.24 (m, 4H), 6.54 (br s, 1H), 4.04 (d, 1H, J = 11.2), 3.66 (d, 1H, J = 11.6), 1.64 (s, 
3H); 13C NMR (CDCl3, 100 MHz)  180.6, 138.1, 133.6, 128.8, 127.8, 68.9, 52.0, 20.1; 
IR: 2941, 1702, 1494, 1260, 1098, 1034, 1013, 824 cm–1; HRMS (DART-TOF) calcd. 
for C10H15Cl1NO3 [M+NH4]
+: 232.07405, found: 232.07432. 
2-(4-Bromophenyl)-3-hydroxy-2-methylpropanoic acid (1.5e). 2-(4-Bromophenyl)- 
prop-2-en-1-ol (130 mg, 0.60 mmol) was hydroformylated with 0.05 mol % 
p-toluenesulfonic acid (500 L of 6.0 × 10-4 M in benzene, 3.0 × 10-4 mmol) at 35 °C  for 
12 h. Analysis of crude mixture after oxidation by 1H NMR showed a b:l selectivity of 
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94:6. Branched product was isolated as a white solid (110 mg, 71%). 
1H NMR (CDCl3, 400 MHz)  7.48 (d, 1H, J = 8.8), 7.22 (d, 1H, J = 
8.8), 7.05 (br s, 1H), 4.03 (d, 1H, J = 11.6), 3.66 (d, 1H, J = 11.6), 
1.64 (s, 3H); 13C NMR (CDCl3, 100 MHz)  180.7, 138.5, 131.8, 
128.1, 121.8, 68.8, 52.0, 20.0; IR: 2938, 1703, 1491, 1398, 1241, 1034, 1009, 820 cm–1; 
HRMS (DART-TOF) calcd. for C10H15Br1NO3 [M+NH4]
+: 276.02353, found: 276.02357. 
2-(3-Chlorophenyl)-3-hydroxy-2-methylpropanoic acid (1.5f). 
2-(3-Chlorophenyl)prop-2-en-1-ol (100 mg, 0.60 mmol) was 
hydroformylated with 0.20 mol % p-toluenesulfonic acid (2.0 mL 
of 6.0 × 10-4 M in benzene, 1.2 × 10-3 mmol) at 35 °C  for 12 h. 
Analysis of crude mixture after oxidation by 1H NMR showed a b:l selectivity of > 98:2. 
Branched product was isolated as a white solid (99 mg, 77%). 1H NMR (CDCl3, 400 
MHz)  7.33 (s, 1H), 7.27-7.20 (m, 3H), 7.25 (br s, 1H),  4.04 (d, 1H, J = 11.2), 3.66 (d, 
1H, J = 11.6), 1.63 (s, 3H); 13C NMR (CDCl3, 100 MHz)  180.3, 141.6, 134.6, 129.9, 
127.8, 126.7, 124.6, 68.7, 52.2, 20.0; IR: 2982, 1703, 1244, 1035, 698 cm–1; HRMS 
(DART-TOF) calcd. for C10H12Cl1O3 [M+H]
+: 215.04750, found: 215.04853. 
3-Hydroxy-2-(4-(methoxycarbonyl)phenyl)-2-methylpropanoic acid (1.5g). Methyl 
4-(3-hydroxyprop-1-en-2-yl)benzoate (120 mg, 0.60 mmol) was 
hydroformylated with 0.05 mol % p-toluenesulfonic acid (500 L 
of 6.0 × 10-4 M in benzene, 3.0 × 10-4 mmol) at 45 °C  for 12 h. 
Analysis of crude mixture after oxidation by 1H NMR showed a b:l selectivity of > 98:2. 
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Branched product was isolated as a white solid (106 mg, 74%). 1H NMR (acetone d-6, 
400 MHz)  7.96 (d, 2H, J = 8.6), 7.53 (d, 2H, J = 8.6), 4.10 (d, 1H, J = 10.8), 3.86 (s, 
3H), 3.84 (d, 1H, J = 10.8), 1.62 (s, 3H); 13C NMR (Acetone d-6, 100 MHz)  175.2, 
166.1, 147.3, 129.2, 128.7, 126.7, 67.9, 52.5, 51.4, 20.2; IR: 2952, 1719, 1437, 1282, 
1194, 1115, 1018, 707 cm–1; HRMS (DART-TOF) calcd. for C12H15O5 [M+H]
+: 
239.09195, found: 239.09209. 
2-(4-Cyanophenyl)-3-hydroxy-2-methylpropanoic acid (1.5h). 
4-(3-Hydroxy-prop-1-en-2-yl)-benzonitrile (96 mg, 0.60 mmol) was 
hydroformylated with 0.20 mol % p-toluenesulfonic acid (2.0 mL of 
6.0 × 10-4 M in benzene, 1.2 × 10-3 mmol) at 45 °C  for 12 h. Analysis 
of crude mixture after oxidation by 1H NMR showed a b:l selectivity 
of > 98:2. Branched product was isolated as a white solid (82 mg, 67%). 1H NMR 
(CDCl3, 400 MHz)  7.40 (br s, 1H), 7.64 (d, 2H, J = 8.4), 7.48 (d, 2H, J = 8.4), 4.02 (d, 
1H, J = 11.2), 3.76 (d, 1H, J = 11.2), 1.66 (s, 3H); 13C NMR (CDCl3, 100 MHz)  179.5, 
145.0, 132.4, 127.4, 118.3, 111.6, 68.5, 52.6, 20.2; IR: 3362, 2240, 1721, 1220, 1034, 
836, 677, 558 cm–1; HRMS (DART-TOF) calcd. for C11H12NO3 [M+H]
+: 206.08172, 
found: 206.08261. 
3-Hydroxy-2-methyl-2-(naphthalen-2-yl)propanoic acid (1.5i). 
2-(Naphthalen-2-yl)-prop-2-en-1-ol (110 mg, 0.60 mmol) was hydroformylated with 0.05 
mol % p-toluenesulfonic acid (500 L of 6.0 × 10-4 M in benzene, 3.0 × 10-4 mmol) at 
35 °C  for 12 h. Analysis of crude mixture after oxidation by 1H NMR showed a b:l 
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selectivity of 95:5. Branched product was isolated as a white solid 
(117 mg, 85%). 1H NMR (Acetone d-6, 500 MHz)  7.94-7.87 (m, 
4H), 7.61-7.59 (m, 1H), 7.51-7.49 (m, 2H), 5.15-3.23 (br s, 1H), 
4.28 (d, 1H, J = 10.5), 4.19 (br s, 1H), 3.95 (d, 1H, J = 11.0), 2.81 
(s, 1H), 1.77 (s, 3H); 13C NMR (Acetone d-6, 125 MHz)  175.9, 139.4, 133.5, 132.5, 
128.0, 127.8, 127.4, 126.0, 125.9, 125.0, 125.0, 68.2, 52.4, 20.4; IR: 2921, 1697, 1027, 
816, 751, 477 cm–1; HRMS (DART-TOF) calcd. for C14H18NO3 [M+NH4]
+: 248.12867, 
found: 248.12972. 
3-Hydroxy-2-methyl-2-(thiophen-3-yl)propanoic acid (1.5j). 2-(Thiophen-3-yl)- 
prop-2-en-1-ol (84 mg, 0.60 mmol) was hydroformylated with 0.20 
mol % p-toluenesulfonic acid (2.0 mL of 6.0 × 10-4 M in benzene, 1.2 
× 10-3 mmol) at 45 °C  for 12 h. Analysis of crude mixture after 
oxidation by 1H NMR showed a b:l selectivity of 95:5. Branched product was isolated as 
a white solid (78 mg, 70%). 1H NMR (CDCl3, 500 MHz)  7.32-7.31 (m, 1H), 7.24 (d, 
1H, J = 1.5), 7.13-7.12 (m, 1H), 6.87 (br s, 1H), 4.11 (d, 1H, J = 11.2), 3.72 (d, 1H, J = 
11.2), 1.67 (s, 3H); 13C NMR (CDCl3, 125 MHz)  180.3, 140.5, 126.3, 125.9, 121.7, 
68.7, 50.1, 20.6; IR: 2925, 1698, 1222, 1029, 871, 782, 684 cm–1; HRMS (DART-TOF) 
calcd. for C8H10O3S [M+NH4]
+: 204.06944, found: 204.07035. 
2-methyl-2-(pyridin-3-yl)propane-1,3-diol (1.5k). 2-(pyridin-3-yl)-prop-2-en-1-ol 
(20 mg, 0.15 mmol) was hydroformylated with 0.20 mol % p-toluenesulfonic acid (500 
L of 6.0 × 10-4 M in benzene, 0.30 × 10-3 mmol) at 45 °C  for 12 h. Reduction with 
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NaBH4 (17 mg, 0.45 mmol) and MeOH (3.0 mL) at rt for 2h was 
performed instead of oxidation. Analysis of crude mixture after 
reduction by 1H NMR showed a b:l selectivity of 98:2. Branched 
product was isolated as a white solid (17 mg, 68%). 1H NMR (Methanol d-4, 500 MHz) 
 8.65 (d, 1H, J = 1.7), 8.39 (dd, 1H, J = 1.5, 4.9), 7.96-7.94 (m, 1H), 7.43-7.40 (m, 1H), 
3.84 (d, 2H, J = 11.0), 3.75 (d, 2H, J = 11.0), 1.37 (s, 3H); 13C NMR (Methanol d-4, 125 
MHz)  147.7, 146.0, 140.7, 135.9, 123.4, 77.0, 43.8, 18.8; IR: 3346, 2812, 1416, 1020, 
820, 713, 632 cm–1; HRMS (DART-TOF) calcd. for C9H14NO2 [M+H]
+: 168.10245, 
found: 168.10277. 
3-hydroxy-2,2-dimethylpropanoic acid (1.5l). 2-methylprop-2-en-1-ol (43 mg, 0.60 
mmol) was hydroformylated with 0.20 mol % p-toluenesulfonic acid 
(2.0 mL of 6.0 × 10-4 M in benzene, 1.2 × 10-3 mmol) at 45 °C  for 12 h. 
Analysis of crude mixture after oxidation by 1H NMR showed a b:l selectivity of 76:24. 
Branched product was isolated as a white solid (35 mg, 49%). 1H NMR (acetone d-6, 500 
MHz)  3.57 (s, 2H), 1.16 (s, 6H); 13C NMR (Acetone d-6, 125 MHz)  117.8, 68.8, 43.8, 
21.4; IR: 2933, 1692, 1236, 1044 cm–1; HRMS (DART-TOF) calcd. for C5H14NO3 
[M+NH4]
+: 136.09737, found: 136.09743. 
 
Linear Product Syntheses and Characterizations 
General Procedure. The oven dried glass reaction vial was placed in the Endeavor, 
and corresponding alcohol substrates (0.60 mmol) was added.  The Endeavor was sealed 
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and purged with nitrogen (4 × 100 psi).  A solution of dicarbonylacetylacetonato 
rhodium (I) (6.2 mg, 2.4 × 10-2 mmol, 4.0 mol %), triphenylphosphine (13 mg, 4.8 × 10-2 
mmol, 8.0 mol %) and benzene (to total volume of 4 mL) was injected, followed by 
injection of additional benzene (2 mL) to wash the injection port. The Endeavor was 
purged with nitrogen (1 × 100 psi), stirring was started at 250 rpm, and the Endeavor was 
heated to and held at 75 °C  for 10 minutes. Stirring was stopped, the Endeavor was 
charged with 400 psi H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was 
maintained at a constant temperature and pressure of 75 °C  and 400 psi H2/CO for 16 h. 
The Endeavor was vented to ambient pressure and cooled to ambient temperature. The 
sample was removed and concentrated. The crude residue was dissolved in CH2Cl2 (9 mL) 
and pyridinium chlorochromate (390 mg, 1.8 mmol, 3.0 eq.), sodium acetate (25 mg, 0.30 
mmol, 0.50 eq.), and 3Å molecular sieves (1.2 g, 4-8 mesh) were added and the solution 
was agitated on an orbital shaker for 12 hours. Flash column chromatography 
(Hex/EtOAc = 8/1) afforded pure products. 
4-Phenyldihydrofuran-2(3H)-one (1.6a, 83 mg, 85%). 1H NMR (CDCl3, 500 MHz) 
 7.39 (t, 2H, J = 7.6), 7.31 (t, 1H, J = 7.3), 7.25 (d, 2H, J = 7.6), 4.69 (dd, 
1H, J = 7.8, 9.1), 4.28 (dd, 1H, J = 8.1, 9.1), 3.80 (m, 1H), 2.94 (dd, 1H, J 
= 8.8, 17.6), 2.69 (dd, 1H, J = 9.0, 17.4); 13C NMR (CDCl3, 125 MHz)  
176.3, 139.4, 129.2, 127.7, 126.7, 74.0, 41.1, 35.7; IR 1759, 1156, 1007, 760, 702 cm-1; 
HRMS (DART-TOF) calcd. for C10H11O2 [M+H]
+: 163.07590, found 163.07652. 
Chapter 1, page 31 
 
4-(3,5-Bis(trifluoromethyl)phenyl)dihydrofuran-2(3H)-one (1.6b, 130 mg, 72%). 
1H NMR (CDCl3, 500 MHz)  7.86 (s, 1H), 7.28 (s, 2H), 4.77 (dd, 
1H, J = 8.1, 9.0), 4.34 (dd, 1H, J = 8.1, 9.3), 3.98 (m, 1H), 3.06 (dd, 
1H, J = 8.8, 17.6), 2.73 (dd, 1H, J = 8.8, 17.6); 13C NMR (CDCl3, 
125 MHz)  174.9, 142.1, 132.7 (q, J = 34.4), 127.1, 123.0 (q, J  = 
271.1), 121.9, 72.9, 40.8, 35.3; IR 1786, 1374, 1276, 1170, 1110, 1030, 899, 842, 707, 
682 cm-1; HRMS (DART-TOF) calcd. for C12H9F6O2 [M+H]
+: 299.05067, found 
299.05024.  
4-(4-Methoxyphenyl)dihydrofuran-2(3H)-one (1.6c, 74 mg, 64%). 1H NMR 
(CDCl3, 400 MHz)  7.13 (d, 2H, J = 8.8), 6.90 (d, 2H, J = 8.8), 4.62 
(dd, 1H, J = 8.1, 9.1), 4.20 (dd, 1H, J = 8.1, 9.1), 3.79 (s, 3H), 3.72 (m, 
1H), 2.88 (dd, 1H, J = 8.6, 17.4), 2.61 (dd, 1H, J = 9.3, 17.4); 13C 
NMR (CDCl3, 100 MHz)  176.4, 159.0, 131.3, 127.7, 114.5, 74.2, 
55.3, 40.4, 35.9; IR 1765, 1511, 1454, 1254, 1164, 1014, 838, 602, 554 cm-1; HRMS 
(DART-TOF) calcd. for C11H13O3 [M+H]
+: 193.08647, found 193.08682. 
4-(4-Chlorophenyl)dihydrofuran-2(3H)-one (1.6d, 73 mg, 62%). 1H NMR (CDCl3, 
400 MHz)  7.31 (d, 2H, J = 8.6), 7.29 (d, 2H, J = 8.4), 4.63 (dd, 1H, J = 
7.8, 9.2), 4.20 (dd, 1H, J = 7.6, 9.0), 3.79-3.70 (m, 1H), 2.90 (dd, 1H,  J 
= 8.8, 17.6), 2.60 (dd, 1H, J = 8.8, 17.4); 13C NMR (CDCl3, 100 MHz)  
176.0, 138.0, 133.5, 129.3, 128.1, 73.7, 40.5, 35.6; IR 1774, 1485, 1425, 
1161, 1093, 1011, 832, 680, 511, 496 cm-1; HRMS (DART-TOF) calcd. for C10H10ClO2 
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[M+H]+: 197.03693, found 197.03745. 
4-(4-Bromophenyl)dihydrofuran-2(3H)-one (1.6e, 110 mg, 76%). 1H NMR (CDCl3, 
500 MHz)  7.49 (d, 2H, J = 8.6), 7.12 (d, 2H, J = 8.3), 4.66 (dd, 1H, J = 
7.8, 9.0), 4.23 (dd, 1H, J = 7.6, 9.1), 3.76 (m, 1H), 2.92 (dd, 1H, J = 8.6, 
17.4), 2.62 (dd, 1H, J = 8.8, 17.6); 13C NMR (CDCl3, 125 MHz)  175.9, 
138.6, 132.3, 128.4, 121.6, 73.7, 40.6, 35.6; IR 1764, 1486, 1422, 1154, 
1010, 825, 539, 491 cm-1; HRMS (DART-TOF) calcd. for C10H10BrO2 [M+H]
+: 
240.98642, found 240.98681. 
4-(3-Chlorophenyl)dihydrofuran-2(3H)-one (1.6f, 95 mg, 81%). 1H NMR (CDCl3, 
500 MHz)  7.31 (m, 1H), 7.24 (s, 1H), 7.14 (d, 2H, J = 8.3), 4.68 (dd, 
1H, J = 7.8, 9.0), 4.27 (dd, 1H, J = 7.6, 9.0), 3.79 (m, 1H), 2.95 (dd, 
1H, J = 8.5, 17.3), 2.66 (dd, 1H, J = 8.8, 17.6); 13C NMR (CDCl3, 125 
MHz)  175.9, 141.6, 135.0, 127.9, 127.1, 124.9, 73.6, 40.7, 35.5; IR 1773, 1598, 1480, 
1164, 1083, 1019, 907, 785, 729, 693, 441 cm-1; HRMS (DART-TOF) calcd. for 
C10H10ClO2 [M+H]
+: 197.03693, found 197.03729. 
Methyl 4-(5-oxotetrahydrofuran-3-yl)benzoate (1.6g, 63 mg, 48%). 1H NMR 
(CDCl3, 500 MHz)  8.01 (d, 2H, J = 8.5),7.30 (d, 2H, J = 8.5), 4.67 
(dd, 1H, J = 7.8, 9.0), 4.26 (dd, 1H, J = 7.8, 9.3), 3.89 (s, 3H), 
3.86-3.83 (m, 1H), 2.94 (dd, 1H, J = 8.8, 17.6), 2.66 (dd, 1H, J = 8.8, 
17.4); 13C NMR (CDCl3, 125 MHz)  175.9, 166.5, 144.7, 130.4, 
129.6, 126.8, 73.5, 52.2, 41.0, 35.4; IR 1778, 1717, 1280, 1168, 1109, 1019 cm-1; HRMS 
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(DART-TOF) calcd. for C12H13O4 [M+H]
+: 221.08138, found 221.08169. 
4-(5-Oxotetrahydrofuran-3-yl)-benzonitrile (1.6h, 82 mg, 72%). 1H NMR (CDCl3, 
400 MHz)  7.65 (d, 2H, J = 8.2), 7.34 (d, 2H, J = 8.4), 4.67 (dd, 1H, J = 
7.8, 9.2), 4.25 (dd, 1H, J = 7.4, 9.2), 3.84 (m 1H), 2.96 (dd, 1H, J = 8.8, 
17.4), 2.63 (dd, 1H, J = 8.4, 17.6); 13C NMR (CDCl3, 100 MHz)  175.4, 
145.0, 133.0, 127.6, 118.3, 111.8, 73.2, 41.0, 35.4; IR 2225, 1763, 1609, 
1507, 1166, 1013, 832, 729, 561 cm-1; HRMS (DART-TOF) calcd. for C11H10NO2 
[M+H]+: 188.07115, found 188.07101. 
4-(Naphthalen-2-yl)dihydrofuran-2(3H)-one (1.6i, 97 mg, 76%). 1H NMR (CDCl3, 
500 MHz)  7.87 (m, 3H), 7.69 (s, 1H), 7.54 (m, 2H), 7.35 (d, 1H, J = 
8.3), 4.74 (dd, 1H, J = 7.8, 9.0), 4.38 (dd, 1H, J = 7.8, 9.0), 3.95 (m, 
1H), 3.01 (dd, 1H, J = 8.8, 17.6), 2.80 (dd, 1H, J = 9.0, 17.6); 13C 
NMR (CDCl3, 125 MHz)  176.4, 136.8, 133.4, 132.7, 129.1, 127.7, 
126.7, 126.3, 125.5, 124.5, 73.9, 41.2, 35.7; IR 1759, 1158, 1006, 831, 749, 477 cm-1; 
HRMS (DART-TOF) calcd. for C14H13O2 [M+H]
+: 213.09155, found 213.09151. 
4-(Thiophen-3-yl)dihydrofuran-2(3H)-one (1.6j, 50 mg, 50%). 1H NMR (CDCl3, 
500 MHz)  7.38-7.36 (m, 1H), 7.11-7.10 (m, 1H), 7.00-6.99 (m, 1H), 4.64 
(dd, 1H, J = 7.8, 9.0), 4.26 (dd, 1H, J = 7.8, 9.0), 3.90-3.86 (m, 1H), 2.91 
(dd, 1H, J = 8.6, 17.4), 2.64 (dd, 1H, J = 8.6, 17.4); 13C NMR (CDCl3, 125 
MHz)  176.2, 140.1, 127.2, 125.8, 121.0, 73.5, 36.8, 35.6; IR 1770, 1167, 1017, 783 
cm-1; HRMS (DART-TOF) calcd. for C8H9O2S [M+H]
+: 169.03232, found 169.03152. 
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2-(pyridin-3-yl)butane-1,4-diol (1.6k, 19 mg, 75%). 2-(pyridin-3-yl)prop-2-en-1-ol 
(20 mg, 0.15 mmol) was hydroformylated. Reduction with NaBH4 (17 mg, 
0.45 mmol) and MeOH (3.0 mL) at rt for 2h was performed instead of 
oxidation. 1H NMR (Methanol d-4, 500 MHz)  8.46 (s, 1H), 8.41(d, 1H, J 
= 3.7), 7.80-7.78 (m, 1H), 7.43-7.40 (m, 1H), 3.78-3.72 (m, 2H), 3.55-3.51 
(m, 1H), 3.45-3.40 (m, 1H), 3.03-2.99 (m, 1H), 2.10-2.03 (m, 1H), 1.87-1.80 (m, 1H); 
13C NMR (Methanol d-4, 125 MHz)  149.0, 146.7, 139.3, 136.3, 123.8, 65.7, 59.1, 42.3, 
34.3; IR 3260, 2925, 2855, 1427, 1050, 1028, 713 cm-1; HRMS (DART-TOF) calcd. for 
C9H13NO2 [M+H]
+: 168.10245, found 168.10230. 
4-methyldihydrofuran-2(3H)-one (1.6l, 37 mg, 62%). Characterization data of this 
compound was previously reported.23 
 
 
Binding Study of Catalyst 1.1 
 
Catalyst 1.1 (5.7 mg, 2.0 × 10-2 mmol) was dissolved in C6D6 (1 mL) in an NMR 
tube under N2. p-Toluenesulfonic acid (0.10 mL of 5.0 × 10
-4 M in C6D6, 5.0 × 10
-5 mmol) 
was added to the solution, followed by addition of 2-phenylprop-2-en-1-ol (13 mg, 0.10 
mmol) and iPrOH (46 L, 0.60 mmol). The solution was heated at 45 °C  overnight. 
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Analysis of the reaction by 1H NMR showed 1.8:1.1 = 38:62, leading to Keq1= 4.0. 
 
Catalyst 1.1 (5.7 mg, 2.0 × 10-2 mmol) was dissolved in C6D6 (1 mL) in an NMR 
tube under N2. p-Toluenesulfonic acid (0.10 mL of 5.0 × 10
-4 M in C6D6, 5.0 × 10
-5 mmol) 
was added to solution, followed by addition of 3-hydroxy-2-methyl-2-phenylpropanal (16 
mg, 0.10 mmol, isolated from hydroformylation) and i-PrOH (23 L, 0.30 mmol). 
Solution was heated at 45 °C  overnight. Analysis of the reaction by 1H NMR showed 
1.9:1.1 = 41:59. 
Note:  Ignoring minor aldehyde dimerization, Keq2 was calculated to be 2.3.  
 
Catalyst 1.1 (11 mg, 4.0 × 10-2  mmol), 2-phenylprop-2-en-1-ol (13 mg, 0.10 
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mmol) and p-toluenesulfonic acid (0.20 mL of 5.0 × 10-4 M in benzene d-6, 1.0 × 10-4 
mmol) were dissolved in benzene d-6 (1 mL) under N2. The solution was allowed to 
stand at room temperature for 10 min, and then solvent was removed under vacuum. The 
residue was redissolved in benzene d-6 (1 mL), and 1H NMR analysis of solution showed 
1.8 was formed (> 99%). 3-hydroxy-2-methyl-2-phenylpropanal (16 mg, 0.10 mmol, 
isolated from hydroformylation) was added, and mixture was heated at 45 °C  overnight. 
Analysis of the reaction by 1H NMR showed 1.9:1.8 = 39:61. 
Note:  Ignoring minor aldehyde dimerization, Keq3 was calculated to be 0.57. 
This result matches the calculated Keq from binding study experiments 1 and 2 (Keq2 / 
Keq1 = Keq3; 2.3 / 4.0 = 0.58). 
 
Hydroformylation using Catalyst 1.1 and Acetal Protection 
The oven dried glass reaction vial was placed in the Endeavor, and 
2-phenylprop-2-en-1-ol (80 mg, 0.60 mmol) was added.  The Endeavor was sealed and 
purged with nitrogen (4 × 100 psi).  A solution of dicarbonylacetylacetonato rhodium (I) 
(6.2 mg, 2.4 × 10-2 mmol, 4.0 mol %), 1.1 (34 mg, 0.12 mmol, 20 mol %), 
p-toluenesulfonic acid (2.0 mL of 6.0 × 10-4 M, 1.2 × 10-3 mmol, 0.20 mol %) and 
benzene (to a total volume of 4 mL) was injected, followed by injection of additional 
benzene (2 mL) to wash the injection port. The Endeavor was purged with nitrogen (1 × 
100 psi), stirring was started at 250 rpm, and the Endeavor was heated to and held at 
45 °C  for 10 minutes.  Stirring was stopped, the Endeavor was charged with 400 psi 
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H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was maintained at a 
constant temperature and pressure of 45 °C  and 400 psi H2/CO respectively for 12 h. The 
Endeavor was vented to ambient pressure and cooled to ambient temperature. The 
reaction was removed from the Endeavor and concentrated. The residue was redissolved 
in benzene (0.6 mL). Ethylene glycol (74 L, 1.3 mmol) and a few crystals of 
p-toluenesulfonic acid were added. The reaction was refluxed for 3 h. The resulting 
mixture was cooled to room temperature and solvent was removed. Flash column 
chromatography (Hex/EtOAc = 6/1) afforded the pure product as colorless liquid. 
2-(1,3-Dioxolan-2-yl)-2-phenylpropan-1-ol (1.7a, 90.2 mg, 72%). 1H NMR 
(CDCl3, 500 MHz)  7.49-7.47 (m, 2H), 7.38-7.35 (m, 2H), 7.28-7.25 
(m, 1H), 5.16 (s, 1H), 4.03-3.85 (m, 6H), 2.31 (t, 1H, J = 6.2), 1.42 (s, 
3H); 13C NMR (CDCl3, 125 MHz)  141.8, 128.4, 127.0, 126.8, 108.5, 68.2, 65.3, 65.0, 
46.5, 17.1; IR: 3458, 2884, 1107, 1028, 767, 699 cm–1; HRMS (DART-TOF) calcd. for 
C12H17O3 [M+H]
+: 209.11777, found: 209.11798. 
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Chapter 2. Desymmetrization of meso-1,2-Diols 
 
2.1 Selective Silyl Transfers 
Protecting groups serve as a temporary shield for functionalities in a molecule, 
allowing the advance manipulation of sites with less inherent activities1,2 Although in an 
ideal synthesis masking functional groups should be avoided, the strong advantage of 
protecting groups retains them as a practical and critical strategy in current organic 
syntheses.2 
The robust nature and chemical orthogonality of silyl groups make them ideal 
choices for temporarily masking protic functionalities such as alcohols.3 While the 
formation of silyl ether has been traditionally used for protections, new methods merging 
this transformation with enantio- and site-selective processes add significant synthetic 
value to silyl protection by introducing asymmetry and functional group differentiation to 
readily available achiral substrates. 
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Early work by Ishikawa showed modified guanidines can promote asymmetric 
silylation of indanol in moderate enantioselectivities (Scheme 2.1).4 In 2006, Hoveyda 
and Snapper developed an organic catalyst 2.1 for the desymmetrization of 1,2- and 
1,3-diols via silyl transfer (Scheme 2.2).5a This catalyst was also shown to promote the 
resolution of racemic 1,2-diols5b, 5c and desymmetrization of meso-1,2,3-triols5d. Later, 
addition of 5-ethylthiotetrazole as the co-catalyst was demonstrated to dramatically 
increase the efficiency of this catalytic system. Aided by computational study, the 
observation was proposed to occur with a bi-catalyst mechanism; catalyst 2.1 serves as a 
chiral Brønsted base to selectively deprotonate the diol via multiple hydrogen bonds, 
while the deprotonated tetrazole activates the nucleophile for the transfer (Figure 2.1).5e 
Subsequently, several metal6a-d and non-metal catalysts6e have been reported to 
effectively promote enantio- and stereoselective silyl transfer to alcohols. 
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     Previous advances in asymmetric silylation have showed its prominent utility in 
building block preparation and complex molecule synthesis. We thus decided to expand 
scaffolding catalysis and contribute to this valuable field. Different from the prior 
examples, we aimed to design an organic catalyst that takes advantage of an induced 
intramolecularity to enable a selective activation of substrates. 
 
2.2 Induced Intramolecularity in Organocatalysis 
     The development of new catalysts represents a continuing focus of modern organic 
chemistry. As a fundamental understanding of previous catalyst designs, the activation of 
an organic transformation can be summarized as creating reactive pathways with lower 
energetic requirements, therefore allowing previously unfeasible reactions to proceed.7 
This process is widely proven achievable with the formation of intermediates where the 
target site of substrate is electronically activated by the catalyst towards the subsequent 
steps of a reaction (e.g., Lewis acid or base activation, hydrogen bond activation, 
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enamine formation, iminium formation, metal complexation, etc.).8 
 
 
 
An alternative and less explored strategy to enable difficult organic reactions is the 
preorganization of reactants (Figure 2.2).9 This type of acceleration is best represented by  
enzymatic10 and supramolecular catalysis11. By forming an intermediate wherein the 
substrate and reagent are positioned in a reactive arrangement in the substrate binding 
pocket, an enzyme effectively establishes an intramolecular transformation. This mode of 
activation can lead to a rate enhancement of a factor of 104-108 for 1.0 M reactants at 
room temperature. This dramatic acceleration has been demonstrated in a paragon report 
by Kelly,12 in which  a templating catalyst 2.2 accelerates an SN2 reaction solely by 
constraining substrates to the proper orientation in the necessary proximity (Scheme 2.3). 
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Inspired by the successful application of reactant preorganization in other fields, 
small synthetic catalysts have been developed to achieve the same activation mode. In an 
early report of glycine ester hydrolysis with carbon dioxide as a catalyst, Wieland 
proposed the formation of a carbamic acid intermediate from the free amine group and 
CO2, which accelerated the reaction through intramolecular esterification (Scheme 2.4, 
equation 1).13 Subsequently, a number of aldehyde and ketone catalysts were reported by 
several groups to promote hydrolysis and alcoholysis of esters,14 amides,15 and nitriles.16 
Acting in the same manner as the carbon dioxide, these catalysts were able to covalently 
bond to the substrate’s -hydroxyl or amine, and promote an intramolecular hydrolysis 
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(Scheme 2.4, equation 2). 
 
 
 
More recently, Beauchemin has employed alkyl aldehydes as catalysts for a 
traditionally challenging intermolecular hydroamination between hydroxylamines and 
allylic amines (Scheme 2.5).17 In the proposed mechanism, the aldehyde catalyst 
covalently binds to both reactants, enabling the intramolecular addition of the 
hydroxylamine to the olefin. Subsequent development of chiral aldehyde 2.4 enabled this 
reaction to proceed in high enantioselectivity.18 
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Boronic acids and esters are known to both covalently exchange with carboxylic 
acids and intramolecularly activate them via additional hydrogen bonding (Scheme 2.6). 
In 1996, Yamamoto reported the use of aryl boronic acids to activate carboxylic acids in 
amidation reactions.19a, 19b Incorporation of a pyridinium group by Yamamoto and Wang 
further enhanced the practicality of these catalysts by allowing for recycling.19c-e Later, 
Hall founded 2-iodophenyl boronic acid to efficiently catalyze the amidation of 
carboxylic acids at room temperature. The catalytic activity of boronic acids was further 
expanded to site-selective esterification of -hydroxycaboxylic acids, transesterification 
of -keto esters, and other carbon-carbon bond forming reactions.20 More recently, 
borinate catalysts have also been applied by Taylor in the site-selective functionalization 
of carbohydrates and other complex molecules (discussed in Chapter 4).21 
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2.3 Development of a Scaffolding Catalyst for Electrophile Transfer. 
     We sought to develop a new organic catalyst that would desymmetrize 
meso-1,2-diols, and would use induced intramolecularity as the predominant form of 
catalysis.22 We envisioned that binding the substrate to the catalyst with a single rigid 
covalent bond would efficiently transfer asymmetry into the product of this reaction. 
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     In order to design an effective desymmetrization catalyst we drew inspiration from 
our work in hydroformylation as well as the recently reported silyl transfer catalyst 
developed by Hoveyda and Snapper. Using ligand 2.5 as a template we retained the 
substrate-binding site as an oxazolidine ring, but replaced the metal-binding phosphine 
with N-methylimidazole, which could either serve to activate incoming electrophiles or 
act as a general base. Additionally, to increase the synthetic practicality of the catalyst, a 
chiral backbone that derives from commercial available amino alcohols was installed. We 
hypothesized that catalyst 2.6 would bind to one hydroxyl within a meso-1,2-diol, and 
selectively functionalize the other free hydroxyl (Figure 2.4).  
 
Chapter 2, page 50 
 
 
 
2.4 Desymmetrization of meso-1,2-Diols 
The modular design of 2.6 allowed a family of catalysts to be synthesized and 
tested in the desymmetrization of cis-cyclopentane-1,2-diol (Table 2.1). Initial 
experiments with catalyst 2.9a formed the mono-protected product in 17% yield and -9% 
ee (Table 2.1, entry 1). Increasing the steric hindrance of the substituents on the 
oxazolidine backbone led to improved enantioselectivity (Table 2.1, entry 2 and 3). Based 
on the less expensive valinol core, analogues with a substitutent adjacent to the imidazole 
ring were prepared and examined. Addition of a second stereocenter (2.11) dramatically 
increased both the yield and the enantioselectivity of the desymmetrization (Table 2.1, 
entry 5). Interestingly 2.10, a diastereomer of 2.11, promotes the formation opposite 
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enantiomer product in low ee (Table 2.1, entry 4), consistent with a strong matched 
mismatched relationship between the stereocenters.  
 
 
 
     With optimal catalyst 2.11 identified, an investigation of the desymmetrization 
substrate scope revealed a broad tolerance of meso-1,2-diols at mild temperatures (4 °C to 
room temperature, Table 2.2). Introduction of oxygen heterocycle into the five-membered 
ring substrate was successful (Table 2.2, entry 1). Substrates with six-membered rings 
such as cyclohexene, 1,2,3,4-tetrahydro-2,3-napthalene, and cyclohexane are well 
Chapter 2, page 52 
 
tolerated and provide high yields and ee’s (Table 2.2, entry 2-4). Medium-sized ring diols, 
as well as acyclic diols also enantioselectively furnish the desired products (Table 2.2, 
entry 5-7).  
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     Multiple different silyl reagents were also selectively transferred by catalyst 2.11 
(Table 2.3). High yields and ee’s were obtained with the uses of both sterically less 
hindered triethylsilyl chloride and larger tert-butyldiphenylsilyl chloride (Table 2.3, entry 
1 and 2). The transfer of significantly reactive dimethylphenylsilyl chloride led to a 
decrease in enantioselectivity (79% ee), which may due to the acceleration of the 
background reaction (Table 2.3, entry 3). 
 
 
 
     Acyclic meso-1,2-diols had previously been competent substrates in the 
desymmetrization; however, extended reaction time (36 h) is required for transferring 
tert-butyldimethylsilyl chloride (Table 2.2, entry 7). The use of triethylsilyl chloride 
dramatically lowered the reaction time (4 h) for meso-2,3-butanediol, while maintaining 
high enantioselectivity (Table 2.4, entry 1). In addition, we explored challenging 
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substrates that electronically deactivate hydroxyl groups towards tert-butyldimethylsilyl 
chloride, which were previously inaccessible with our catalysts. These substrates were 
also effectively desymmetrized with triethylsilyl chloride in 4-8 hours (Table 2.4, entry 2 
and 3). 
 
 
 
     We then turned to study the mechanism of catalysis in the desymmetrization of 
meso-1,2-diols. A protic solvent tert-butanol was tested in the reaction. The product was 
obtained in high enantioselectivity (92% ee), inconsistent with a possible hydrogen bond 
catalysis (Scheme 2.7, equation 1). Moreover, a control catalyst 2.12 that is unable to 
covalently bind to substrate was synthesized, and does not promote the selective silyl 
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transfer, highlighting the necessity of substrate binding to the catalyst in order to achieve 
the rate acceleration (Scheme 2.7, equation 2). 
 
 
 
     To further understand the mechanistic step that generates the selectivity during this 
reaction, we performed a binding experiment between diol 2.7a and catalyst 2.11 
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(Scheme 2.7 equation 3). 1H NMR analysis of the crude mixture showed that two binding 
products are formed as diastereomers (d.r. = 60:40). This observation suggested that the 
binding event provides minimal discrimination between the two hydroxyl groups. Thus, 
the origin of the reaction selectivity should lie in the silyl transfer step. 
This conclusion directed us to obtain an X-ray structure of catalyst 2.11 binding to 
4-bromobenzyl alcohol (Figure 2.4). The X-ray structure confirmed our assignment of the 
stereocenters in 2.11, and more importantly, showed that the two isopropyl groups 
conformationally arrange the substrate binding site, as well as the substrate backbone, 
which may be responsible for the selectivity during the silyl transfer step. 
 
 
 
2.5 Conclusions 
We have successfully developed an organic catalyst that applies a single reversible 
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covalent bond to bind to substrates. Through the rigid mode of binding, the catalyst is 
able to preorganize the substrate to achieve both a rate enhancement and a high 
selectivity of the reaction. This catalyst has been shown to facilitate a highly 
enantioselective desymmetrization of meso-1,2-diols via silyl transfer. The potential 
applications of this new catalytic system could be further expanded with new catalysts 
selectively functionalizing other diols (trans-1,2-diols, cis-1,3-diols, and trans-1,3-diols), 
as well as catalyzing other electrophile transfers, to be developed. 
 
2.6 Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and 
used without further purification. Lithium reagents were titrated against 2-pentanol using 
1,10-phenanthroline as the indicator. Flash column chromatography was performed using 
EMD Silica Gel 60 (230-400 mesh) and ACS grade solvents as received from Fisher 
Scientific. All experiments were performed in oven or flame dried glassware under an 
atmosphere of nitrogen or argon using standard syringe and cannula techniques, except 
where otherwise noted. All reactions were run with dry, degassed solvents dispensed from 
a Glass Contour Solvent Purification System (SG Water, USA LLC). 1H and 13C NMR 
were performed on a Varian Gemini 400 MHz, Varian Gemini 500 MHz, or a Varian 
Unity Inova 500 MHz spectrometer. Deuterated solvents were purchased from 
Cambridge Isotope Labs and stored over 3Å molecular sieves. C6D6 was degassed by 
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three successive freeze-pump-thaw cycles and stored over 3Å molecular sieves in a dry 
box under a nitrogen atmosphere. All NMR chemical shifts are reported in ppm relative 
to residual solvent for 1H and 13C NMR. Coupling constants are reported in Hz. All IR 
spectra were gathered on a Bruker Alpha FT-IR equipped with a single crystal diamond 
ATR module and values are reported in cm1. All GC analyses were performed on an 
Agilent Technologies 7890A GC System. HRMS and X-ray crystal structure data were 
generated in Boston College facilities. Analytical chiral high-performance liquid 
chromatography (HPLC) was performed on a Shimadzu-LC-2010A HT. 
 
Catalyst Synthesis 
N-methyl-imidazole-2-carboxaldehyde was made following literature procedures23 
and matched reported spectra. 
(S)-2-((1-Methyl-1H-imidazol-2-yl)methylamino)propan-1-ol.24 To a solution of 
N-methyl-imidazole-2-carboxaldehyde (650 mg, 8.7 mmol) in 
methanol (17 mL) was added (S)-alaninol (960 mg, 8.7 mmol) and 
4Å molecular sieves (1.7 g). After heating at reflux for 24 hours, the 
reaction was cooled to room temperature, and NaBH4 (340 mg, 8.7 mmol) was added. 
The reaction was stirred at room temperature for 2 hours, followed by quenching with 
dropwise addition of concentrated HCl (0.44 mL). The resulting mixture was further 
neutralized with Na2CO3 (1.4 g). The precipitated salts were filtered off, and the filtrate 
was concentrated. Flash column chromatography (CH2Cl2:MeOH = 10:1) afforded pure 
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product as a colorless oil (1.0 g, 70%). 1H NMR (CDCl3, 500 MHz) δ 6.86 (d, 1H, J = 
1.2), 6.77 (d, 1H, J = 1.2), 3.91 (d, 1H, J = 14.4), 3.76 (d, 1H, J = 14.4), 3.60 (s, 3H), 
3.53 (dd, 1H, J = 11.0, 3.9), 3.26-3.30 (m, 1H), 2.82 (qt, 1H, J = 10.3, 3.9), 1.04 (d, 3H, J 
= 6.4); 13C NMR (C6D6, 126 MHz) δ 147.0, 126.9, 121.2, 65.5, 54.9, 42.9, 32.7, 17.3; IR: 
3201, 2872, 1636, 1499, 1452, 1283, 1048, 736, 662 cm–1; HRMS (DART-TOF) calcd. 
for C8H16N3O [M+H]
+: 170.1293, found: 170.1292. []D
25 = +33.0 (c = 1.10, CHCl3, l = 
50 mm). 
(4S)-2-Methoxy-4-methyl-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine (2.9a, 
d.r = 66:34). To a solution of 
(S)-2-(((1-methyl-1H-imidazol-2-yl)-methyl)-amino)-propan-1-ol 
(1.0 g, 6.0 mmol) in anhydrous methanol (24 mL) under argon was 
added N,N-dimethylformamide dimethyl acetal (0.80 mL, 6.0 mmol). The reaction was 
stirred at room temperature for 2 hours, and the solvent was removed under vacuum. The 
residue was redissolved in anhydrous methanol (24 mL), and the reaction was stirred at 
room temperature for another 2 hours, at which time, 1H NMR analysis showed that all 
the substrate was consumed and product had formed. The solvent was removed under 
vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, and the 
residue was extracted with degassed pentane. The pentane was removed under vacuum, 
and Kugelrohr distillation (170 °C @ 0.05 mmHg) afforded pure product as a colorless 
oil (330 mg, 26%). 1H NMR (C6D6, 500 MHz) δ 7.15 (s, 0.34H), 7.12 (d, 0.66H, J = 0.1), 
6.37 (s, 0.34H), 6.36 (s, 0.34H), 5.24 (s, 0.66H), 5.17 (s, 0.34H), 3.98 (t, 0.34H, J = 7.3), 
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3.78 (t, 0.66H, J = 6.8), 3.68-3.72 (m, 2H), 3.36-3.43 (m, 0.66H), 3.32-3.34 (m, 0.34H), 
3.28 (s, 0.66H), 3.23 (s, 0.66H), 3.14 (s, 0.34H), 3.07 (s, 0.34H), 2.94-2.96 (m, 1H), 
0.735 (d, 1H, J = 6.1), 0.705 (d, 2H, J = 5.9); 13C NMR (C6D6, 126 MHz) δ 145.7, 145.4, 
121.8, 121.7, 114.7, 111.7, 109.0, 73.1, 72.6, 57.9, 54.9, 53.1, 51.4, 47.1, 43.4, 38.3, 32.7, 
17.5, 16.8; IR: 2928, 1501, 1458, 1284, 1162, 1113, 1066, 1017, 975, 742 cm–1; HRMS 
(DART-TOF) calcd. for C19H14N3O [M-OMe]: 180.1137, found: 180.1142. []D
24 = 
+11.6 (c = 1.09, C6H6, l = 50 mm). 
(S)-3-Methyl-2-((1-methyl-1H-imidazol-2-yl)methylamino)butan-1-ol.24 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (2.1 g, 20 mmol) 
in methanol (40 mL) was added (S)-valinol (2.2 g, 20 mmol) and 4Å 
molecular sieves (4.0 g). After heating at reflux for 24 hours, the 
reaction was cooled to room temperature, and NaBH4 (760 mg, 20 mmol) was added. The 
reaction was stirred at room temperature for 2 hours, followed by quenching with 
dropwise addition of concentrated HCl (1.0 mL). The resulting mixture was further 
neutralized with Na2CO3 (3.3 g). The precipitated salts were filtered off, and the filtrate 
was concentrated. Flash column chromatography (CH2Cl2:MeOH = 10:1) afforded the 
pure product as a colorless oil (2.3 g, 58%). 1H NMR (CDCl3, 500 MHz)  6.86 (d, 1H, J 
= 1.5), 6.77 (d, 1H, J = 1.2), 3.90 (d, 1H, J = 14.7), 3.78 (d, 1H, J = 14.9), 3.62 (dd, 1H, J 
= 11.2, 3.7), 3.58 (s, 3H), 3.39 (dd, 1H, J = 11.0, 7.3), 2.42 (m, 1H), 1.74 (m, 1H), 0.92 (d, 
3H, J = 6.8), 0.87 (d, 3H, J = 6.8); 13C NMR (CDCl3, 125 MHz)  147.4, 126.9, 121.3, 
65.1, 61.6, 44.0, 32.6, 30.0, 19.5, 19.0; IR: 3199, 2955, 2871, 1500, 1465, 1283, 1043, 
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734, 705, 661 cm–1; HRMS (DART-TOF) calcd. for C10H20N3O [M+H]
+: 198.1606, 
found:198.1606. []D
25 = +19.0 (c = 1.0, CH2Cl2, l = 50 mm). 
(4S)-4-Isopropyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine 
(2.9b, d.r. = 70:30). To a solution of 
(S)-3-methyl-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)butan-1-
ol (860 mg, 4.4 mmol) in anhydrous methanol (18 mL) under argon 
was added N,N-dimethylformamide dimethyl acetal (580 L, 4.4 mmol). The reaction 
was stirred at room temperature for 2 hours, and the solvent was removed under vacuum. 
The residue was redissolved in anhydrous methanol (18 mL), and the reaction was further 
stirred at room temperature for 2 more hours until 1H NMR analysis showed that all of 
the substrate was consumed and product had formed. The solvent was removed under 
vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, and the 
residue was extracted with degassed pentane. The pentane was removed under vacuum, 
and Kugelrohr distillation (130 °C @ 0.05 mmHg) afforded pure product as colorless oil 
(490 mg, 47%). 1H NMR (C6D6, 500 MHz) δ 7.15 (d, 0.3H, J = 1.2), 7.12 (d, 0.7H, J = 
1.0), 6.36 (d, 0.3H, J = 1.0), 6.35 (d, 0.7H, J = 1.2), 5.34 (s, 0.3H), 5.21 (s, 0.7H), 4.02 (d, 
0.3H, J = 13.9), 3.895 (t, 0.6H, J = 8.1), 3.84 (d, 0.3H, J = 13.9), 3.79 (t, 0.7H), 3.74 (d, 
0.7H, J = 13.4), 3.67-3.70 (m, 0.7H), 3.65 (d, 0.7H, J = 13.7), 3.17 (s, 0.9H), 3.09 (s, 
2.1H), 3.07 (s, 2.1H), 2.98 (s, 09H), 2.82-2.86 (m, 1H), 1.67 (dt, 0.7H, J = 20.5, 6.8), 
1.58 (ddd, 0.3H, J = 13.9, 6.8, 3.7), 0.715 (d, 0.3H, J = 6.8), 0.685 (d, 0.7H, J = 6.8), 
0.645 (d, 0.7H, J = 6.8), 0.58 (d, 0.3H, J = 7.1); 13C NMR (CDCl3, 126 MHz) δ 145.9, 
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145.5, 128.7, 128.2, 121.6, 121.3, 115.1, 111.9, 68.3, 67.1, 65.6, 64.7, 53.0, 51.8, 49.3, 
43.9, 32.5, 32.4, 30.7, 28.7, 20.1, 19.9, 17.5, 15.4; IR: 2956, 1500, 1466, 1284, 1158, 
1123, 1080, 1062, 986, 741 cm–1; HRMS (DART-TOF) calcd. for C11H18N3O [M-OMe]: 
208.1450, found: 208.1459. []D
25 = -7.09 (c = 0.71, CDCl3, l = 50 mm). 
(S)-3,3-Dimethyl-2-((1-methyl-1H-imidazol-2-yl)methylamino)butan-1-ol.24 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (750 mg, 6.8 
mmol) in methanol (14 mL) was added (S)-tert-leucinol (0.80 g, 6.8 
mmol) and 4Å molecular sieves (1.4 g). After heating at reflux for 
24 hours, the reaction was cooled to room temperature, and NaBH4 (260 mg, 6.8 mmol) 
was added. The reaction was stirred at room temperature for 2 hours, followed by 
quenching with dropwise addition of concentrated HCl (0.34 mL). The resulting mixture 
was further neutralized with Na2CO3 (1.1 g). The precipitated salts were filtered off, and 
the filtrate was concentrated. Flash column chromatography (CH2Cl2:MeOH = 10:1) 
afforded the pure product as a colorless oil (720 mg, 50%). 1H NMR (CDCl3, 500 MHz) 
 6.97 (d, 1H, J = 1.5), 6.88 (d, 1H, J = 1.0), 4.20 (br s, 2H), 4.15 (d, 1H, J = 15.9), 3.97 
(d, 1H, J = 15.6), 3.82 (dd, 1H, J = 11.2, 3.7), 3.45 (s, 3H), 3.51 (dd, 1H, J = 11.2, 8.1), 
2.45 (dd, 1H, J = 8.1, 3.7), 0.94 (s, 9H); 13C NMR (CDCl3, 125 MHz)  147.7, 126.0, 
121.6, 68.7, 62.1, 46.0, 35.1, 32.9, 27.2; IR: 3333, 2950, 2868, 1501, 1476, 1283, 1110, 
1045, 736 cm–1; HRMS (DART-TOF) calcd. for C11H22N3O [M+H]
+: 212.17629, found: 
212.17638. []D
25 = +5.0 (c = 1.0, CH2Cl2, l = 50 mm). 
(4S)-4-tert-Butyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine 
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(2.9c, d.r. = 85:15). To a solution of 
(S)-3,3-dimethyl-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)buta
n-1-ol (0.70 g, 3.3 mmol) in anhydrous methanol (13 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (0.40 mL, 
3.3 mmol). The reaction was stirred at room temperature for 2 hours, and the solvent was 
removed under vacuum. The residue was redissolved in anhydrous methanol (13 mL), 
and the reaction was again stirred at room temperature for 2 hours until 1H NMR analysis 
showed all the substrate was consumed and product had formed. The solvent was 
removed under vacuum. The flask was brought into a dry glove box under nitrogen 
atmosphere, and the residue was extracted with degassed pentane. The pentane was 
removed under vacuum, and Kugelrohr distillation (180 °C @ 0.05 mmHg) afforded the 
pure product as a colorless oil (190 mg, 23%). 1H NMR (C6D6, 500 MHz) δ 7.21 (s, 1H), 
6.38 (s, 1H), 5.55 (s, 0.85H), 5.28 (s, 0.15H), 3.95 (d, 1H, J = 13.4), 3.85-3.89 (m, 1H), 
3.78-3.81 (m, 1H), 3.65 (d, 1H, J = 13.4), 3.15 (s, 0.5H), 3.13 (s, 2.5H), 3.01 (s, 2.5H), 
3.00 (s, 0.5H), 2.65-2.68 (m, 1H), 0.85 (s, 1.4H), 0.83 (s, 7.6H); 13C NMR (CDCl3, 126 
MHz) δ 145.2, 127.3, 121.7, 120.9, 114.9, 111.0, 72.3, 68.8, 66.3, 65.1, 53.2, 52.5, 51.8, 
38.1, 34.6, 33.5, 33.3, 26.7, 26.4; IR: 2955, 2905, 1499, 1477, 1285, 1147, 1132, 1082, 
1066, 993, 740 cm–1; HRMS (DART-TOF) calcd. for C12H20N3O [M-OMe]: 222.1606, 
found: 222.1612. []D
25 = -7.09 (c = 0.71, CDCl3, l = 50 mm). 
(S)-3-Methyl-2-((S)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propylamino)butan-1-
ol.24 N-methyl-2-imidazolecarboxaldehyde (1.62 g, 14.7 mmol) and (S)-valinol (1.52 g, 
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14.7 mmol) were heated at reflux in toluene for 3 hours. The 
solution was concentrated in vacuo. The resulting crude oxazolidine 
was dissolved in tetrahydrofuran (86 mL) and cooled to –78 C. 
Isopropyl magnesium chloride (22.8 mL, 45.6 mmol, 2.0M in THF) 
was added dropwise. After stirring for 16 hours and allowing the solution to warm to 
room temperature, the reaction was quenched by slowly adding H2O (5 mL). The layers 
were separated, and the organic layer was washed with H2O (100 mL) and brine (100 
mL). The organic layers were concentrated. Column chromatography (1% NEt3 and 10% 
MeOH in CH2Cl2) yielded slightly yellow oil (86:14 diastereomer ratio). Rapid stirring of 
the oil with hexanes (3 mL) resulted in the precipitation of a slightly yellow solid that 
was one diastereomer (1.50 g, 43%). 1H NMR (CDCl3, 500 MHz) δ 6.98 (d, 1H, J = 1.0), 
6.76 (d, 1H, J = 1.2), 3.61 (s, 3H), 3.57 (dd, 1H, J = 11.0, 3.9), 3.42 (d, 1H, J = 7.6), 
3.34-3.37 (m, 1H), 3.17-3.21 (bs, 1H), 2.06 (dd, 1H, J = 11.0, 4.2), 1.99 (dt, 1H, J = 21.0, 
6.8), 1.55-1.62 (m, 2H), 1.07 (d, 3H, J = 6.8), 0.86 (d, 3H, J = 6.8), 0.79-0.87 (m, 6H); 
13C NMR (CDCl3, 126 MHz) δ 150.7, 127.5, 120.3, 63.2, 60.3, 58.4, 34.6, 32.8, 29.7, 
19.8, 19.0; IR: 3219, 2958, 2198, 1467, 1281, 1047, 724, 439 cm–1; HRMS (DART-TOF) 
calcd. for C13H26N3O [M+H]
+: 240.2076, found: 240.2079. []D
24 = -27.9 (c = 1.0, CHCl3, 
l = 50 mm).  
(4S)-4-Isopropyl-2-methoxy-3-((S)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)-
oxazolidine (2.10, d.r. = 95:5). (S)-3-methyl-2-((S)-2-methyl-1-(1-methyl-1H-imidazol-2- 
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yl)propylamino)butan-1-ol (1.01g, 4.18 mmol) was dissolved in 
methanol (17 mL) and sparged with nitrogen for 5 minutes. 
N,N-dimethylformamide dimethylacetal (2.79 mL, 20.9 mmol) was 
added in one portion, and the solution was stirred 13 hours at 50 C. 
The solution was concentrated under high vacuum. The yellow residue was dissolved in 
methanol (17 mL) and another portion (2.79 mL, 20.9 mmol) of N,N-dimethylformamide 
dimethylacetal was added. After 3 hours, the solution was concentrated and stored in a 
dry glovebox. The yellow residue was distilled (150 C at 0.25 torr) to yield a slightly 
yellow oil (994 mg, 84%). 1H NMR (C6D6, 500 MHz) δ 7.20 (s, 1H), 6.37 (s, 0.05H), 
6.30 (s, 0.95H), 5.41 (s, 0.05H), 5.35 (s, 0.95H), 3.97 (ddd, 1H, J = 13.2, 5.6, 1.2), 3.79 
(dd, 1H, J = 7.8, 2.2), 3.65 (d, 0.08H, J = 10.8), 3.51 (t, 1H, J = 7.8), 3.43 (d, 0.92H, J = 
10.3), 3.33 (s, 2.83H), 3.10 (s, 0.17H), 3.08 (s, 0.17H), 2.88 (s, 2.83H), 2.58-2.65 (m, 1H), 
2.16-2.22 (m, 1H), 1.32 (d, 2.7H, J = 6.6), 1.24 (d, 0.3H, J = 6.6), 1.08 (d, 0.3H, J = 6.8), 
1.03 (d, 2.7H, J = 6.6), 0.94 (d, 2.7H, J = 6.9), 0.90-0.92 (m, 0.3H), 0.81 (d, 2.7H, J = 
6.6), 0.74 (d, 0.3H, J = 6.4); 13C NMR (C6D6, 126 MHz) δ 147.5, 128.9, 120.4, 114.9, 
66.7, 62.5, 61.6, 51.4, 32.7, 32.3, 31.8, 21.8, 21.0, 20.7, 17.6; IR: 2955, 2871, 1473, 1383, 
1366, 1282, 1168, 1136, 1054, 959, 727 cm–1; HRMS (DART-TOF) calcd. for 
C14H24N3O [M-OMe]: 250.1919, found: 250.1920. []D
26 = -12.5 (c = 1.20, CDCl3, l = 
50 mm). 
(S)-3-Methyl-2-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propylamino)butan-1-
ol.24 To a stirring solution of L-valinol (25.3 g, 250 mmol) in anhydrous THF (188 mL) 
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under nitrogen atmosphere was added a solution of 
isobutyraldehyde (18.1 g, 250 mmol). MgSO4 (15.1 g, 125 mmol) 
was added, and the reaction was stirred at room temperature for 3 
hours (1H NMR analysis showed oxazolidine formed). In another 
oven-dried glass reaction flask, to a solution of N-methylimidazole (45.2 g, 550 mmol) in 
anhydrous THF (250 mL) under nitrogen atmosphere was added butyllithium (55 mL of 
10 M in hexanes, 550 mmol) slowly at -78 °C . The solution was stirred at -78 °C for 30 
minutes, and the formed oxazolidine solution was slowly cannula transferred into the 
N-methylimidazolium lithium solution at -78 °C. The resulting mixture was stirred 
overnight and gradually warmed to room temperature. Aqueous NH4Cl (50 mL) was 
added slowly to quench the reaction at 0 °C. MgSO4 (15 g) was added. The mixture was 
stirred at room temperature for 15 minutes, filtered and concentrated. Excess 
N-methylimidazole was distilled off (150 °C @ 1.0 mmHg). Flash column 
chromatography (Hex/EtOAc = 2:1 to pure EtOAc) afforded the pure product 1a as 
colorless oil (32.8 g, 55%). 1H NMR (CDCl3, 500 MHz)  6.93 (d, 1H, J = 1.2), 6.78 (d, 
1H, J = 1.2), 3.56 (m, 4H), 3.35 (d, 1H, J = 1.2), 3.34 (d, 1H, J = 3.9), 2.15 (m, 1H), 1.90 
(m, 1H), 1.64 (m, 1H), 0.98 (d, 3H, J = 6.8), 0.93 (d, 3H, J = 6.8), 0.88 (d, 3H, J = 2.9), 
0.87 (d, 3H, J = 2.9); 13C NMR (CDCl3, 125 MHz)  151.7, 127.0, 121.3, 64.2, 62.9, 
60.4, 34.0, 32.9, 31.7, 20.2, 19.5, 19.4, 17.7; IR: 2956, 2871, 1488, 1468, 1280, 1045, 
725 cm–1; HRMS (DART-TOF) calcd. for C13H26N3O [M+H]
+: 240.2076, found: 
240.2087. []D
25 = +40.0 (c = 1.0, CH2Cl2, l = 50 mm). 
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(4S)-4-Isopropyl-2-methoxy-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)-propyl
)oxazolidine (2.11). To a solution of 
(S)-3-methyl-2-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyla
mino)butan-1-ol (8.4 g, 35 mmol) in anhydrous methanol (70 mL) 
under nitrogen atmosphere was added N,N-dimethylformamide 
dimethyl acetal (24 mL, 175 mmol). The reaction was stirred at 50 °C overnight (1H 
NMR analysis showed all substrate consumed and product formed). Solvent was removed 
under vacuum, and the residue was redissolved in anhydrous methanol (70 mL). The 
reaction was stirred at 50 °C for 2 hours, and solvent was removed under vacuum. 
Impurities were distilled off (100 °C @ 0.05 mmHg). Kugelrohr distillation (130 °C  @ 
0.05 mmHg), followed by recrystallization with pentane (20 mL, 3 mL/g) at -40 °C  
overnight afforded the pure product 2.11 as white solid (5.6 g, 57 %).1H NMR (CDCl3, 
500 MHz)  7.12 (d, 1H, J = 1.2), 6.80 (s, 1H), 6.20 (d, 1H, J = 1.2), 3.70 (dd, 1H, J = 
9.0, 8.1), 3.52 (dd, 1H, J = 7.8, 7.1), 3.29 (s, 3H), 3.22 (d, 1H, J = 10.8), 2.78 (s, 3H), 
2.60 (m, 2H), 1.68 (m, 1H), 1.34 (d, 3H, J = 6.4), 0.85 (d, 3H, J = 6.8), 0.66 (d, 3H, J = 
6.8), 0.63 (d, 3H, J = 6.6); 13C NMR (CDCl3, 125 MHz)  148.8, 128.7, 120.1, 112.4, 
66.1, 65.8, 60.5, 52.7, 33.7, 32.2, 29.5, 21.6, 21.0, 20.2, 16.9; IR: 2956, 1470, 1281, 1052, 
964 cm–1; HRMS (DART-TOF) calcd. for C14H24N3O [M-OMe]: 250.1919, found: 
250.1926. []D
26 = -57.0 (c = 1.0, CH2Cl2, l = 50 mm). 
(S)-4-isopropyl-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)oxazolidine 
(2.12). To a stirring solution of 
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(S)-3-methyl-2-(((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)
amino)butan-1-ol (720 mg, 3.0 mmol) and paraformaldehyde (90 mg, 
3.0 mmol) in anhydrous toluene (30 mL), p-toluenesulfonic acid 
monohydrate (5.7 mg, 3.0 × 10-2 mmol) was added. After heating at 
reflux overnight, the reaction was cooled to room temperature, and CH2Cl2 (30 mL) was 
added. The resulting solution was concentrated. Flash column chromatography (100% 
EtOAc) afforded the product as colorless oil (520 mg, 68%). 1H NMR (CDCl3, 500 MHz) 
 7.00 (d, 1H, J = 1.2), 6.73 (d, 1H, J =1.2), 5.01 (d, 1H, J = 4.6), 4.34 (d, 1H, J = 4.4), 
3.61 (s, 3H), 3.41 (m, 3H), 2.57 (dd, 1H, J = 12.7, 6.6), 2.22 (m, 1H), 1.70 (m, 1H), 1.12 
(d, 3H, J = 6.6), 0.93 (d, 3H, J = 6.8), 0.86 (d, 3H, 6.6), 0.66 (d, 3H, 6.6); 13C NMR 
(CDCl3, 125 MHz)  147.9, 127.9, 120.3, 81.8, 67.6, 67.2, 62.8, 33.1, 33.0, 31.0, 21.1, 
20.2, 20.0, 18.1; IR: 2955, 2868, 1468, 1279, 1140, 1084, 945, 724 cm–1; HRMS 
(DART-TOF) calcd. for C14H26N3O: [M+H]
+: 252.2076, found: 252.2075. []D
26 = +32.0 
(c = 1.0, CH2Cl2, l = 50 mm). 
 
Crystal Structure of 2.13 
In order to confirm the relative stereochemistry, 2.11 was converted to the more 
crystalline compound 2.13. 
(2R,4S)-2-((4-Bromobenzyl)oxy)-4-isopropyl-3-((R)-2-methyl-1-(1-methyl-1H-imid
azol-2-yl)propyl)oxazolidine (2.13). To an oven-dried reaction vial was added solution of 
(4S)-4-isopropyl-2-methoxy-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)oxaz
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olidine 2.11 (56 mg, 0.20 mmol), 4-bromobenzyl alcohol (41 mg, 
0.22 mmol, 1.1 eq.), and 1,2,2,6,6-pentamethylpiperidine 
hydrochloride (1.2 mg, 6.0 x 10-3 mmol, 3 mol %) in 1.0 mL 
anhydrous THF. After stirring at room temperature for 8 hours, 
solvent was removed under vacuum, and the residue was 
redissolved in 1.0 mL anhydrous THF. Removal and addition of solvent was repeated 
every 8 hours, until 1H NMR showed that reaction was completed. Recrystallization of 
the crude product with Et2O at 4°C afforded pure product 2.13. 
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Catalyst Equilibrium Experiment with Substrate: 
 
In a glovebox, catalyst 2.11 (5.6 mg, 0.020 mmol), 1,2,2,6,6-pentamethylpiperidine 
hydrochloride (0.60 mg, 3.0 x 10-3 mmol), and cis-1,2-cyclopentanediol (10.2 mg, 0.10 
mmol) were dissolved in THF-d8 (0.45 mL) and added to a NMR tube. 
Trimethoxybenzene, as an internal standard, (0.050 mL, 0.010 mmol, 0.20 M solution in 
THF) was added to the NMR tube. The exchange reaction was followed by 1H NMR. The 
reaction reached equilibrium in 3 hours with 40% starting catalyst 2.11 remaining and a 
60:40 ratio of diastereomers. The Keq was determined to be 0.193. This reaction was 
repeated to give a Keq of 0.205. The average Keq is 0.199 ± 0.006. 
 
Catalyst Optimization of Silyl Ttransfer Reaction 
To an oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol (20.0 
mg, 0.20 mmol), catalyst (0.040 mmol, 20 mol %), and 1,2,2,6,6-pentamethylpiperidine 
hydrochloride (1.2 mg, 6.0 x 10-3 mmol, 3 mol %) in anhydrous THF (0.25 mL) was 
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added. The reaction was stirred at room temperature for 10 minutes. 
1,2,2,6,6-pentamethylpiperidine (44 L, 0.24 mmol, 1.2 eq.) was added, followed by 
addition of a solution of tert-butylchlorodimethylsilane (60.0 mg, 0.40 mmol, 2.0 eq.) in 
anhydrous THF (0.25 mL). After stirring at room temperature for 4 hours, the reaction 
was quenched by addition of N,N-diisopropylethylamine (100 L) and methanol (30 L). 
The mixture was stirred at room temperature for 10 minutes and filtered through a 
Pasteur pipette packed with silica gel, followed by flushing with EtOAc (15 mL). To the 
combined filtrate, 1,3,5-trimethoxybenzene (50 μL of 0.40M in EtOAc, 0.020 mmol) was 
added as internal standard. Chiral GLC Analysis (Supelco Beta Dex 120 (30 × 0.15 mm × 
0.25 m film thickness), 78 °C for 100 min, 20 °C/min to 180 °C, 180°C for 20 min, 15 
psi.) of the crude product afforded yields and enantioselectivities. 
 
 
Major Product 
Enantiomer 
Minor Product 
Enantiomer 
Diol Substrate 
Internal 
Standardb 
GLC Ret. Time 91.7 min 94.0 min 103.9 min 109.5 min 
Response 
Factora 
0.62 0.62 1.79 1.00 
a Response factors were calculated against internal standard on GLC. b 
1,3,5-trimethoxybenzene was used as internal standard. 
 
Table 2.1, entry 1. Reaction was performed with 2.9a using the general procedure. 
Chiral GLC analysis afforded yield (17%) and enantioselectivity (-9% ee). 
Table 2.1, entry 2. Reaction was performed with 2.9b using the general procedure. 
Chiral GLC analysis afforded yield (19%) and enantioselectivity (34% ee). 
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Table 2.1, entry 3. Reaction was performed with 2.9c using the general procedure. 
Chiral GLC analysis afforded yield (20%) and enantioselectivity (40% ee). 
Table 2.1, entry 4. Reaction was performed with 2.10 using the general procedure. 
Chiral GLC analysis afforded yield (25%) and enantioselectivity (-16% ee). 
Table 2.1, entry 5. Reaction was performed with 2.11 using the general procedure. 
Chiral GLC analysis afforded yield (84%) and enantioselectivity (97% ee). 
 
Substrate Scope with TBSCl 
To an oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol (41 mg, 
0.40 mmol), catalyst 2.11 (22 mg, 0.080 mmol, 20 mol %), and 
1,2,2,6,6-pentamethylpiperidine hydrochloride (2.3 mg, 0.012 mmol, 3 mol %) in 
anhydrous THF (0.50 mL) was added. The reaction was stirred at room temperature for 
10 minutes. 1,2,2,6,6-pentamethylpiperidine (87 L, 0.48 mmol, 1.2 eq.) was added, 
followed by addition of a solution of tert-butylchlorodimethylsilane (120 mg, 0.80 mmol, 
2.0 eq.) in anhydrous THF (0.50 mL). After stirring at room temperature for 4 hours, the 
reaction was quenched by addition of N,N-diisopropylethylamine (200 L) and methanol 
(60 L). The mixture was stirred at room temperature for 10 minutes and was 
concentrated. Flash column chromatography (Hex/EtOAc = 20/1) afforded pure product 
as a colorless oil (80 mg, 92 %, 94% ee) (Chiral GLC Analysis (Supelco Beta Dex 120 
(30 × 0.15 mm × 0.25 m film thickness), 78 °C for 100 min, 20 °C/min to 180 °C, 
180°C for 20 min, 15 psi.)). 
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(1R,2S)-2-(tert-butyldimethylsilyloxy)cyclopentanol (Table 2.1, entry 5). The 
general procedure was followed to yield a colorless oil (79.5 mg, 92%, 
94% ee). GLC (Supelco Beta Dex 120 (30 x 0.15 mm x 0.25 μm film 
thickness), 78 C for 100 min, 20 C/min to 180 C, 180 C for 20 min, 15 psi., trmajor = 
91.6 min, trminor = 94.4 min);
 1H NMR (CDCl3, 500 MHz) δ 4.02-4.06 (m, 1H), 3.89-3.93 
(m, 1H), 2.605 (d, 1H, J = 3.9), 1.59-1.88 (m, 5H), 1.42-1.51 (m, 1H), 0.91 (s, 9H), 0.10 
(s, 3H), 0.08 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 75.4, 73.7, 31.6, 31.1, 26.0, 20.2, 
18.3, -4.4, -4.8; []D
26 = +18.7 (c = 0.52, CHCl3, l = 50 mm). 
 (3R,4S)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-ol (Table 2, entry 1). 
The general procedure was followed using 4 equivalents of 
tert-butylchlorodimethylsilane at 0.2 M and running 24 hours to yield a 
colorless oil (32 mg, 73%, 92% ee). The reaction was repeated to afford the product in 85% 
yield and 85% ee. GLC (Supelco Beta Dex 120 (30 × 0.15 mm × 0.25 m film thickness), 
75 °C for 260 min, 20 °C/min to 180 °C, 180°C for 20 min, 15 psi., trmajor = 223.3 min, 
trminor = 229.7 min); 
1H NMR (CDCl3, 500 MHz)  4.26 (dd, 1H, J = 11.5, 5.9), 4.08-4.12 
(m, 1H), 3.87-3.92 (m, 2H), 3.71 (dd, 1H, J = 9.5, 3.7), 3.57 (dd, 1H, J = 9.0, 5.6), 2.81 
(d, 1H, J = 4.6), 0.90 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H); 13C NMR (CDCl3, 125 MHz)  
73.6, 72.5, 72.4, 71.2, 26.0, 18.3, -4.5, -4.8; IR: 2953, 2930, 2858, 1254, 1131, 1069, 836, 
779 cm–1; HRMS (DART-TOF) calcd. for C11H23O3Si: [M+H]
+: 219.14165, found: 
219.14213. []D
26 = +21.0 (c = 1.1, CH2Cl2, l = 50 mm). 
(1R,6S)-6-(tert-butyldimethylsilyloxy)cyclohex-3-enol (Table 2.2, entry 2). The 
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general procedure was followed running at 0.2 M in THF for 12 hours 
to yield a colorless oil (80.1 mg, 88%, 90% ee). The reaction was 
repeated to afford the product in 85% yield and 90% ee. GLC (Supelco Beta Dex 120 (30 
x 0.15 mm x 0.25 μm film thickness), 95 C for 70 min, 20 C/min to 180 C, 180 C for 
20 min, 15 psi., trmajor = 73.9 min, trminor = 74.1 min);
 1H NMR (CDCl3, 400 MHz) δ 
5.55-5.55 (m, 2H), 3.86-3.92 (m, 2H), 2.28-2.30 (m, 2H), 2.18-2.22 (m, 3H), 0.90 (s, 9H), 
0.08 (s, 6H); 13C NMR (CDCl3, 100) δ 124.0, 123.7, 70.0, 69.3, 31.5, 30.7, 26.0, 18.3, 
-4.3, -4.6; []D
24 = +24.2 (c = 1.0, CHCl3, l = 50 mm). 
 (2R,3S)-3-((tert-butyldimethylsilyl)oxy)-1,2,3,4-tetrahydronaphthalen-2-ol (Table 
2.2, entry 3). The general procedure was followed with 
(2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diol (99 mg, 0.60 mmol) 
at 0.2 M in THF for 8 hours to yield a colorless oil (142 mg, 85%, 95% ee). The reaction 
was repeated to afford the product in 90% yield and 94% ee. Chiral HPLC Analysis 
(Chiracel AS-H, hexanes/iPrOH = 99/1, 1.0 mL/min, 220 nm, trmajor = 4.9 min and trminor = 
5.4 min); 1H NMR (CDCl3, 500 MHz) δ 7.04-7.26 (m, 4H), 4.08-4.12 (m, 1H), 4.05-4.06 
(m, 1H), 3.02 (t, 2H, J = 4.2), 2.99 (t, 1H, J = 8.3), 2.87 (dd, 1H, J = 16.1, 5.4), 2.24 (d, 
1H, J = 3.4), 0.90 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 
133.8, 133.4, 129.2, 129.0, 126.3, 126.1, 70.5, 69.8, 34.9, 34.5, 26.0, 18.3, -4.2, -4.5; IR: 
2928, 1253, 1083, 980, 918, 831, 775, 742 cm-1; HRMS (DART-TOF) calcd. for 
C16H27O2Si: [M+H]
+: 279.1780, found:279.1781. []D
25 = +27.0 (c = 1.0, MeOH, l = 50 
mm). 
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(1R,2S)-2-(tert-butyldimethylsilyloxy)cyclohexanol (Table 2, entry 4). The general 
procedure was followed at 0.2 M in THF for 12 hours to yield a colorless 
oil (80.0 mg, 87%, 92% ee). The reaction was repeated to afford the 
product in 85% yield and 91% ee. GLC (Supelco Beta Dex 120 (30 x 0.15 mm x 0.25 
μm film thickness), 80 C for 190 min, 20 C/min to 180 C, 180 C for 20 min, 15 psi, 
trmajor = 167.4 min, trminor = 172.7 min);
 1H NMR (CDCl3, 500 MHz) δ 3.73-3.76 (m, 1H), 
3.63-3.65 (m, 1H), 2.18-2.19 (m, 1H), 1.72-1.79 (m, 2H), 1.65-1.72 (m, 2H), 1.56-1.62 
(m, 2H), 1.44-1.51 (m, 1H), 1.21-1.31 (m, 1H), 0.91 (s, 9H), 0.08 (s, 6H); 13C NMR 
(CDCl3, 100 MHz) δ 72.2, 70.9, 30.7, 30.3, 26.0, 22.2, 21.3, 18.3, -4.3, -4.7; []D
26 = 
+12.1 (c = 1.1, MeOH, l = 50 mm). 
(1R,2S)-2-(tert-butyldimethylsilyloxy)cycloheptanol (Table 2, entry 5). The general 
procedure was followed using 4 equivalents of 
tert-butylchlorodimethylsilane and 2 equivalents of 
1,2,2,6,6-pentamethylpiperidine at 4 C for 24 hours to yield a colorless oil (39.2 mg, 
80%, 90% ee). The reaction was repeated to afford the product in 83% yield and 90% ee. 
GLC (Supelco Beta Dex 120 (30 x 0.15 mm x 0.25 μm film thickness), 95 C for 70 min, 
20 C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 63.4 min, trminor = 63.7 min);
 1H 
NMR (CDCl3, 500 MHz) δ 3.80-3.82 (m, 1H), 3.73-3.75 (m, 1H), 2.55 (d, 1H, J = 4.4), 
1.69-1.84 (m, 4H), 1.44-1.62 (m, 4H), 1.26-1.36 (m, 2H), 0.91 (s, 9H), 0.083 (s, 3H), 
0.081 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 75.8, 73.7, 31.2, 31.1, 28.1, 26.0, 22.6, 
21.4, 18.3, -4.3, -4.8; []D
24 = +6.5 (c = 0.87, CHCl3, l = 50 mm). 
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(1R,2S)-2-(tert-butyldimethylsilyloxy)cyclooctanol (Table 2, entry 6). The general 
procedure was followed using 4 equivalents of 
tert-butylchlorodimethylsilane and 2 equivalents of 
1,2,2,6,6-pentamethylpiperidine for 24 hours to yield a colorless oil (48.8 mg, 94%, 87% 
ee). The reaction was repeated to afford the product in 91% yield and 85% ee. GLC 
(Supelco Beta Dex 120 (30 x 0.15 mm x 0.25 μm film thickness), 150 C for 30 min, 20 
C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 23.2 min, trminor = 23.9 min);
 1H 
NMR (CDCl3, 500 MHz) δ 3.92 (dt, 1H, J = 9.0, 3.2), 3.71-3.73 (m, 1H), 2.67-2.68 (m, 
1H), 1.97-2.04 (m, 1H), 1.40-1.80 (m, 11H), 0.90 (s, 9H), 0.093 (s, 3H), 0.087 (s, 3H); 
13C NMR (CDCl3, 100 MHz) δ 74.7, 73.7, 30.9, 29.2, 27.0, 26.0, 25.7, 25.4, 22.8, 18.3, 
-4.3, -4.7; []D
24 = +2.88 (c = 0.83, CHCl3, l = 50 mm).  
(2R,3S)-3-(tert-butyldimethylsilyloxy)butan-2-ol (Table 2, entry 7). The general 
procedure was followed using 4 equivalents of 
tert-butylchlorodimethylsilane and 2 equivalents of 
1,2,2,6,6-pentamethylpiperidine at 4 C for 36 hours to yield a colorless oil (31.7 mg, 
78%, 91% ee). The reaction was repeated to afford the product in 77% yield and 88% ee. 
GLC (Supelco Beta Dex 120 (30 x 0.15 mm x 0.25 μm film thickness), 80 C for 35 min, 
20 C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 28.1 min, trminor = 29.1 min);
 1H 
NMR (CDCl3, 400 MHz) δ 3.68-3.78 (m, 2H), 2.12-2.13 (m, 1H), 1.085 (d, 3H, J = 5.7), 
1.07 (d, 3H, J = 5.7), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (CDCl3, 100 
MHz) δ 72.1, 71.3, 26.0, 18.2, 17.4, 17.2, -4.2, -4.7; []D
26 = +14.7 (c = 0.19, CH2Cl2, l = 
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50 mm). 
 
Silyl Reagent Scope 
(1R,2S)-2-((triethylsilyl)oxy)cyclopentanol (Table 2.3, entry 1). To an oven-dried 
glass reaction vial, a solution of cis-1,2-cyclopentanediol (61 mg, 0.60 
mmol), catalyst 2.11 (34 mg, 0.12 mmol, 20 mol %), and 
1,2,2,6,6-pentamethylpiperidine hydrochloride (3.4 mg, 0.018 mmol, 3 mol %) in 
anhydrous THF (3.0 mL) was added. The reaction was stirred at room temperature for 10 
minutes. 1,2,2,6,6-pentamethylpiperidine (130 L, 0.72 mmol, 1.2 eq.) was added, 
followed by addition of triethylchlorosilane (120 L, 0.72 mmol, 1.2 eq.). After stirring at 
room temperature for 1 hour, the reaction was concentrated. Flash column 
chromatography (Hex/EtOAc = 20/1) afforded pure product as colorless oil (125 mg, 
96%, 90% ee). A duplicate reaction of cis-1,2-cyclopentanediol (20 mg, 0.20 mmol) with 
the same procedure afforded the pure product as colorless oil (40 mg, 92%, 90% ee). 
Chiral GLC Analysis (Supelco Beta Dex 120 (30 × 0.15 mm × 0.25 m film thickness), 
80 °C for 180 min, 20 °C/min to 180 °C, 180°C for 20 min, 15 psi, trmajor = 160.5 min, 
trminor = 164.2 min). 
1H NMR (CDCl3, 500 MHz)  4.01 (dt, 1H, J = 8.3, 4.9), 3.89 (dt, 
1H, J = 8.3, 3.7), 2.65 (d, 1H, J = 3.4), 1.55-1.85 (m, 5H), 1.44 (m, 1H), 0.95 (t, 9H, J = 
8.0), 0.60 (q, 6H, J = 8.0); 13C NMR (CDCl3, 125 MHz)  75.1, 73.7, 31.7, 31.2, 20.2, 
6.9, 5.0; IR: 2955, 2876, 1123, 1096, 1005, 742, 728 cm–1; HRMS (DART-TOF) calcd. 
for C11H25O2Si: [M+H]
+: 217.1624, found: 217.1629. []D
24 = +18.0 (c = 1.0, CH2Cl2, l = 
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50 mm). 
(1R,2S)-2-((tert-butyldiphenylsilyl)oxy)cyclopentanol (Table 2.3, entry 2). To an 
oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol 
(61 mg, 0.60 mmol), catalyst 2.11 (34 mg, 0.12 mmol, 20 mol %), 
and 1,2,2,6,6-pentamethylpiperidine hydrochloride (3.4 mg, 0.018 mmol, 3 mol %) in 
anhydrous THF (1.5 mL) was added. The reaction was stirred at room temperature for 10 
minutes. 1,2,2,6,6-pentamethylpiperidine (130 L, 0.72 mmol, 1.2 eq.) was added, 
followed by addition of tert-butyl(chloro)diphenylsilane (620 L, 2.40 mmol, 4.0 eq.). 
After stirring at room temperature for 48 hours, the reaction was concentrated. Flash 
column chromatography (Hex/EtOAc = 80/1) afforded pure product as colorless oil (146 
mg, 71%, 88% ee). A duplicate reaction of cis-1,2-cyclopentanediol (20 mg, 0.20 mmol) 
with the same procedure afforded the pure product as colorless oil (53 mg, 78%, 92% ee). 
Chiral HPLC Analysis (Chiracel OD-H, hexanes/iPrOH = 99/1, 1.0 mL/min, 220 nm, 
trminor = 4.9 min and trmajor = 5.7 min). 
1H NMR (CDCl3, 500 MHz)  7.67 (m, 4H), 7.44 
(m, 2H), 7.38 (m, 4H), 4.05 (m, 1H), 3.88 (m, 1H), 2.73 (d, 1H, J = 2.9), 1.54-1.83 (m, 
5H), 1.25 (m, 1H), 1.08(s, 9H); 13C NMR (CDCl3, 125 MHz)  136.0, 135.8, 133.9, 
133.6, 130.1, 130.0, 128.0, 127.9, 76.7, 73.6, 31.1, 31.0, 27.2, 20.0 19.4; IR: 2931, 1105, 
821, 740, 700, 611, 504 cm–1; HRMS (DART-TOF) calcd. for C21H27OSi: [M-OH]
+: 
323.1831, found: 323.1822. []D
26 = +12.0 (c = 1.0, CH2Cl2, l = 50 mm). 
(1R,2S)-2-((dimethyl(phenyl)silyl)oxy)cyclopentanol (Table 2.3, entry 3). To an 
oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol (20 mg, 0.20 mmol), 
Chapter 2, page 79 
 
catalyst 2.11 (11 mg, 4.0 × 10-2 mmol, 20 mol %), and 
1,2,2,6,6-pentamethylpiperidine hydrochloride (1.2 mg, 6.0 × 10-3 
mmol, 3 mol %) in anhydrous THF (2.0 mL) was added. The reaction was stirred at room 
temperature for 10 minutes. 1,2,2,6,6-pentamethylpiperidine (44 L, 0.24 mmol, 1.2 eq.) 
was added, followed by dropwise addition of a solution of chloro(dimethyl)phenylsilane 
(40 L, 0.24 mmol, 1.2 eq.) in anhydrous THF (2.0 mL) over 2 hours by syringe pump. 
The reaction was concentrated. Flash column chromatography (Hex/EtOAc = 20/1) 
afforded the pure product as colorless oil (34 mg, 72%, 79% ee). A duplicate reaction of 
cis-1,2-cyclopentanediol (20 mg, 0.20 mmol) with the same procedure afforded pure 
product as colorless oil (33 mg, 70 %, 79 % ee). Chiral HPLC Analysis (Chiracel OD-H, 
hexanes/iPrOH = 99.8/0.2, 0.50 mL/min, 220 nm, trminor = 10.9 min and trmajor = 11.4 min). 
1H NMR (CDCl3, 500 MHz)  7.55-7.57 (m, 2H,), 7.35-7.40 (m, 3H), 3.98-4.02 (m, 1H), 
3.85-3.88 (m, 1H), 2.575 (dd, 1H, J = 3.7, 0.5), 1.44-1.82 (m, 5H), 1.35-1.44 (m, 1H), 
0.40 (s, 3H), 0.39 (s, 3H); 13C NMR (CDCl3, 125 MHz)  137.8, 133.6, 130.0, 128.2, 
75.7, 73.7, 31.3, 31.0, 20.1, -1.0, -1.1; IR: 2961, 1253, 1117, 1093, 891, 830, 787, 741, 
700 cm–1; []D
26 = +14.0 (c = 1.0, CH2Cl2, l = 50 mm). 
 
Desymmetrization with TESCl 
General procedure. To an oven-dried glass reaction vial, a solution of substrate 
(0.20 mmol), catalyst 2.11 (11 mg, 0.040 mmol, 20 mol %), and 
1,2,2,6,6-pentamethylpiperidine hydrochloride (1.2 mg, 0.0060 mmol, 3 mol %) in 
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anhydrous THF (4.0 mL) was added. The reaction was stirred at room temperature for 10 
minutes. 1,2,2,6,6-pentamethylpiperidine (44 L, 0.24 mmol, 1.2 eq.) was added, 
followed by addition of triethylchlorosilane (40 L, 0.24 mmol, 1.2 eq.). After stirring at 
room temperature for 4 hours, the reaction was concentrated. Flash column 
chromatography (Hex/EtOAc = 20/1) afforded pure product. 
(2R,3S)-3-((triethylsilyl)oxy)butan-2-ol (Table 2.4, entry 1). meso-2,3-Butanediol 
(18 mg, 0.20 mmol) was silylated using general procedure. Pure product 
was isolated as colorless oil (34 mg, 83%, 92% ee). A duplicate reaction 
of meso-2,3-butanediol (54 mg, 0.60 mmol) with the same procedure afforded the pure 
product as colorless oil (104 mg, 85%, 92% ee). Chiral GLC Analysis (Supelco Beta 
Dex 120 (30 × 0.15 mm × 0.25 m film thickness), 85 °C for 50 min, 20 °C/min to 
180 °C, 180°C for 20 min, 15 psi, trmajor = 41.4 min, trminor = 42.5 min). 
1H NMR (CDCl3, 
500 MHz)  3.68-3.87 (m, 2H), 2.20 (d, 1H, J = 3.9), 1.08 (d, 6H, J = 6.1), 0.96 (t, 9H, J 
= 7.8), 0.60 (q, 6H, J = 7.8); 13C NMR (CDCl3, 125 MHz)  71.8, 71.3, 17.6, 17.1, 7.0, 
5.1; IR: 2956, 2877, 1239, 1106, 1003, 908, 725 cm-1; HRMS (DART-TOF) calcd. for 
C10H25O2Si: [M+H]
+: 205.1624, found: 205.1626. []D
24 = +12.2 (c = 1.0, CH2Cl2, l = 50 
mm). 
(3R,4S)-4-((triethylsilyl)oxy)hexa-1,5-dien-3-ol (Table 2.4, entry 2). 
meso-1,5-Hexadiene-3,4-diol (23 mg, 0.20 mmol) was silylated using 
general procedure. Pure product was isolated as colorless oil (38 mg, 
83%, 91% ee). A duplicate reaction of meso-1,5-Hexadiene-3,4-diol (69 mg, 0.60 mmol) 
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was silylated using general procedure. Pure product was isolated as colorless oil (110 mg, 
80%, 92% ee). Chiral GLC Analysis (Supelco Beta Dex 120 (30 × 0.15 mm × 0.25 m 
film thickness), 90 °C for 100 min, 20 °C/min to 180 °C, 180°C for 20 min, 15 psi, trmajor 
= 85.4 min, trminor = 87.4 min).
 1H NMR (CDCl3, 500 MHz)  5.77-5.84 (m, 2H), 5.28 (dt, 
1H, J = 17.4, 1.5), 5.23 (dt, 1H, J = 17.4, 1.5), 5.19-5.20 (m, 1H), 5.16-5.18 (m, 1H), 
4.10-4.12 (m, 1H), 4.04-4.08 (m, 1H), 2.32 (d, 1H, J = 4.4), 0.94 (t, 9H, J = 8.1), 0.60 (q, 
6H, J = 8.1); 13C NMR (CDCl3, 125 MHz)  136.9, 136.6, 117.3, 116.8, 77.1, 76.2, 7.0, 
5.1; IR: 2955, 2877, 1459, 1416, 1238, 1003, 922, 829, 725 cm-1; HRMS (DART-TOF) 
calcd. for C12H23OSi: [M-OH]
+: 211.15182, found: 211.15265. []D
24 = +4.1 (c = 1.0, 
CH2Cl2, l = 50 mm). 
(1R,2S)-1,2-diphenyl-2-((triethylsilyl)oxy)ethanol (Table 2.4, entry 3). 
meso-1,2-Diphenylethane-1,2-diol (43 mg, 0.20 mmol) was silylated for 
8 hours using general procedure. Pure product was isolated as colorless 
oil (53 mg, 81%, 92% ee). A duplicate reaction of meso-1,2-Diphenylethane-1,2-diol (129 
mg, 0.60 mmol) was silylated using general procedure. Pure product was isolated as 
colorless oil (163 mg, 83%, 87% ee). Chiral HPLC Analysis (Chiracel OJ-H, 
hexanes/iPrOH = 99/1, 1.0 mL/min, 220 nm, trmajor = 7.3 min and trminor = 8.6 min). 
1H 
NMR (CDCl3, 500 MHz)  7.16-7.27 (m, 10H), 4.75 (dd, 1H, J = 5.9, 2.9), 4.70 (d, 1H, J 
= 5.9), 2.33 (d, 1H, J = 3.2), 0.77 (t, 9H, J = 7.8), 0.39 (q, 6H, J = 7.8); 13C NMR (CDCl3, 
125 MHz)  140.9, 140.7, 127.98, 127.96, 127.90, 127.7, 127.6, 127.4, 79.3, 78.9, 6.8, 
4.8; IR: 2953, 2876, 1097, 1005, 837, 740, 700 cm-1; HRMS (DART-TOF) calcd. for 
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C10H25O2Si: [M+H]
+: 329.1937, found: 329.1926. []D
24 = +6.6 (c = 1.0, CH2Cl2, l = 50 
mm). 
 
Absolute Stereochemical Proof 
The absolute stereochemistry of the products was determined by comparing the 
optical rotations to known values. The optical rotations of the silylated products in this 
paper were determined to be opposite in sign to the optical rotations of the products 
reported by the Hoveyda and Snapper groups5. The absolute stereochemistry of 
(1R,2S)-2-((triethylsilyl)oxy)cyclopentanol, (1R,2S)-2-((tert-butyldiphenylsilyl)-oxy)- 
cyclopentanol, and (1R,2S)-2-((dimethyl(phenyl)silyl)oxy)cyclopentanol was assigned by 
analogy. 
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Chapter 3. Regiodivergent Resolution of Terminal 1,2-Diols 
 
3.1 Synthesis of Secondary Protected Terminal Diols 
With two versatile hydroxyl groups that are inherently differentiated by steric 
hindrance, terminal 1,2-diols serve as important building blocks in organic synthesis.1 
Owing to this importance, multiple methods have been developed to selectively modify 
terminal 1,2-diols. Since there is a large inherent reactivity difference (8 to 50 fold), this 
synthetic challenge is often addressed by employing reaction sequences wherein the 
primary hydroxyl is functionalized prior to the manipulation of the secondary hydroxyl.2 
As a result of this reactivity paradigm, the traditional preparation of secondary 
hydroxyl mono-protected terminal 1,2-diols is usually achieved in a 3 step procedure 
where the primary and secondary hydroxyls are protected sequentially and orthogonally 
followed by deprotection of the primary hydroxyl (Scheme 3.1, route 1).3 This strategy is 
inherently inefficient both in terms of atom and step economy. 
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     To overcome this drawback, multiple methods have been developed with shortened 
synthetic routes. Early discovery by Bailey suggested the protection of the secondary 
hydroxyl in 1,n-diols could be achieved through acetolysis of their cyclic acetal 
derivatives (Scheme 3.2, equation 1).4a Later, Yamamoto demonstrated a reduction of 
cyclic acetals and orthoformates to furnish secondary protected 1,n-diols with free 
primary hydroxyls (Scheme 3.2, equation 2).4b Consequently, several successes using 
cyclic acetal and orthoformate as starting materials have been reported.4c-f This strategy 
was also expanded by methods using organotin complex5 and silyl reagents6 to form 
cyclic intermediates with terminal diols, which then lead to the protection of secondary 
hydroxyls. 
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Certain alternative strategies employ -hydroxy aldehydes or esters as starting 
materials; with the primary hydroxyl temporarily masked in a higher oxidation state, the 
secondary hydroxyl group can be appropriately functionalized in advance of forming the 
final desired diol product (Scheme 3.1, route 3).7 However, this sequence still requires an 
additional reduction step, and the necessary aldehyde and ester substrates can often prove 
less accessible than the equivalent diols. 
An ideal means of achieving this transformation would facilitate direct 
functionalization of the secondary hydroxyl group in the presence of a free primary 
hydroxyl via a reversal of the substrate’s inherent selectivity (Scheme 3.1, route 2). This 
method should also be applicable to inexpensive and easily accessible starting materials. 
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We envisioned that the scaffolding catalyst previously developed in our group would 
meet all the standards, and grant direct access to the secondary protected products. 
 
3.2 Design of Scaffolding Catalysis for Terminal Diols 
     The successful employment of catalyst 3.1 in desymmetrization of meso-1,2-diols 
encouraged us to test it in the selective functionalization of the secondary hydroxyl 
within terminal 1,2-diols. Considering the mechanism of scaffolding catalysis, this 
reaction can be controlled by two distinct steps: the binding of the catalyst to one 
hydroxyl in the substrate and the activation of the non-bound hydroxyl. Such a situation 
can be represented using Curtin–Hammett principle (Figure 3.1); the site-selectivity is 
attributed to both the ratio of 1o-I:2o-I and the difference of energetic requirements in the 
subsequent functionalizations. Therefore, to reverse the substrate’s inherent bias, the 
catalyst must not just prefer the formation of 1 o-I in the binding step, but also efficiently 
promote the secondary functionalization and impede the primary functionalization. 
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Previously, we have studied the binding selectivity of catalyst 3.1 towards different 
alcohols (Scheme 3.3).8 Adding isopropanol to catalyst 3.1 results in an equilibrium with 
Keq = 0.12, while a much higher Keq = 0.92 was observed with 1-butanol under the same 
conditions. These data clearly demonstrated the catalyst’s ability to preferentially bind to 
less hindered primary hydroxyls over secondary hydroxyls. We thus hypothesized that 
this selectivity leveraged with terminal 1,2-diol, the scaffolding catalyst would bind to the 
primary hydroxyl and activate the adjacent secondary hydroxyl towards the transfer of 
electrophiles. 
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     If the rate limiting step was functionalization of the hydroxyl, the site selectivity 
could be further improved by generating a matched stereochemical relationship between 
enantiopure diol substrates and the chiral catalyst (Scheme 3.4). In the previous 
desymmetrization of meso-1,2-diols, catalyst 3.1 was found to functionalize the 
pro-(S)-hydroxyl group. Therefore, we anticipated that the use of terminal (S)-1.2-diol 
would benefit from a synergy of both binding and stereoselectivity, allowing for the 
direct functionalization of the secondary hydroxyl.9 
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3.3 Selective Functionalization of Enantiopure Terminal 1,2-Diols 
     We began by investigating the site-selective silylation of (S)-3.3a. Using 
N-methylimidazole as a background catalyst, the inherent selectivity of the substrate was 
determined to strongly favor the primary hydroxyl functionalization ((S)-3.4a: (S)-3.5a = 
98:2, Table 3.1, entry 1). This selectivity was dramatically reversed by the employment of 
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catalyst 3.1 ((S)-3.4a: (S)-3.5a = 18:82, Table 3.1, entry 2). Optimization of the catalyst 
structure also revealed that replacement of the isopropyl group adjacent to the imidazole 
ring with a cyclopentyl group (catalyst 3.6) further enhanced the selectivity ((S)-3.4a: 
(S)-3.5a = 12:88), with (S)-3.5a isolated in 74% yield (Table 3.1, entry 3). 
 
 
 
     With a successful initial attempt, we then performed experiments to support our 
initial hypothesis. Control catalyst 3.7, which lacks a substrate-binding site, was 
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synthesized and subjected to the same conditions. This reaction afforded a selectivity 
similar to that of the background experiment, which strongly suggested the formation of 
covalent bond between the substrate and the catalyst was necessary to achieve the 
protection of the secondary hydroxyl (Table 3.1, entry 4). To demonstrate the importance 
of stereochemistry of the substrate, the opposite enantiomer diol, (R)-3.3a, was 
functionalized with catalyst 3.6. As expected, silylation of primary hydroxyl was 
exclusively observed, because the stereoselectivity and inherent substrate reactivity are 
matched (Table 3.1, entry 5). 
With the successful initial examination, we have demonstrated the effectiveness of 
scaffolding catalysts in the selective transfer of silyl groups to both enantiomers of 
terminal 1,2-diol, yet towards different constitutional isomers of the products (Table 3.1, 
entry 3 and 5). This observation indicates that by using a racemic mixture of the diol, our 
catalyst system could promote a regiodivergent resolution that leads to two separable 
enantioenriched products. 
 
3.4 Regiodivergent Resolutions 
Kinetic resolutions are widely applied methods for the synthesis of optically pure 
compounds from racemic starting materials (Scheme 3.5, equation 1).10 The efficiency of 
the resolution is determined by the selectivity factor (s = kfast/kslow). Generally, high 
enantiopurity in a kinetic resolution is achieved with high conversion and reisolation of 
starting material. In order for the product to be isolated in high yield and ee, catalysts 
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with exquisite selectivity are necessary. A classic example can be found in the hydrolytic 
kinetic resolution of racemic epoxides; a highly selective (salen)CoIII catalyst has been 
employed in order to obtain both the diol product and the recovered epoxide in practical 
yields and excellent enantiopurities.11 
  
 
 
 An alternative strategy for obtaining the products in high enantiopurity and yield is to 
perform a regiodivergent resolution, wherein the two enantiomers of starting material are 
converted into structurally isomeric products that can usually be separated by 
conventional methods (Scheme 3.5, equation 2).12 Since the conversions of both substrate 
enantiomers have similar rates over the entire reaction time course, the use of divergent 
resolution avoids the requirement of a high selectivity factor. 
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     Early studies have demonstrated that enzymes can be used to resolve racemic 
substrate through regiodivergent oxidations.13 More recently, synthetic catalysts have 
been successfully developed to achieve the same goal. Bolm introduced a chiral copper 
3.11 to convert racemic cyclobutanone into enantioenriched lactone regioisomers via a 
Bayer-Villiger oxidation (Scheme 3.6).14 Hoveyda showed that a zirconium complex 3.15 
perfectly controlled a regiodivergent ring opening of racemic dihydrofurans triggered by 
a Grignard reagent addition (Scheme 3.7).15 Consequently, multiple examples of 
regiodivergent resolutions involving C-O bonding cleavages,16 as well as other types of 
reactions such as Sharpless epoxidations,17 diazo insertions and cyclopropanations,18 and 
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a ynal cyclization19 have been reported. 
 
 
      
Enantioselective electrophile transfer provides an efficient access to enantiopure 
terminal 1,2-diols from inexpensive racemic starting materials.20 The robust nature and 
chemical orthogonality of silyl protecting groups21 has also made asymmetric silyl 
transfer particularly synthetically valuable in the resolution of alcohols. Recently, 
Hoveyda and Snapper disclosed the kinetic resolution of 1,2-diols via silylation with an 
organic catalyst.22 Later, the same catalyst was applied to a highly effective regiodivergent 
resolution of 1,2-diols.23 However, to the best of our knowledge, no successful 
regiodivergent resolution of terminal 1,2-diols has been reported, presumably due to the 
difficulty to control the silylation of one enantiomer substrate on the less reactive 
secondary hydroxyl group. 
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3.5 Regiodivergent Resolution of Racemic Terminal 1,2-Diols 
 
 
 
With our promising results with enantiopure diols, we envisioned if selectivities 
were maintained, the scaffolding catalyst could enable a regiodivergent resolution of a 
racemic diol mixture (Scheme 3.8). Since the (R)-diol would exclusively furnish the 
primary protected product (R)-3.4, the only resource to form secondary silylated diol 3.5 
would be the (S)-substrate, thereby high enantioselectivity in (S)-3.5 could be expected. 
To our delight, the scaffolding catalysts exhibited a broad substrate scope, with high 
yields (>40% yields) and excellent enantioselectivities (>95% ee’s) for the secondary 
silylated products (Table 3.2, (S)-3.5a-j). Sterically hindered alkyl substituents are well 
tolerated, yielding secondary functionalized products in high ee’s (Table 3.2, entry 1-3). 
Small substituents methyl and vinyl lead to decreased yields (Table 3.2, entry 4 and 8), 
which can result from a drop in the binding selectivity of the catalyst that causes more 
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(S)-3.3 converted to (S)-3.4. Similar results were also observed with groups known to 
deactivate the adjacent secondary hydroxyls such as CH2OPh and vinyl (Table 3.2, entry 
7 and 8). However, consistent to our anticipation, in all cases the ee’s of secondary 
protected products (S)-3.5 were still high. Finally, substrates with halogen groups, which 
offer additional synthetic value, provide excellent yields and enantioselectivities (Table 
3.2, entry 9 and 10). 
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3.6 Time Course Study of Reaction Kinetics 
     While the optimal conditions to yield secondary protected products in high yields 
and enantioselectivities have been disclosed, the primary protected products were formed 
in only modest ee’s under these conditions. We thus sought to reevaluate this reaction in 
order to maximize the yields and selectivities in the silylation of the primary hydroxyls.24 
 
Figure 3.2. Time course study at 0 °C with a single addition of TESCl 
 
 
      To improve the divergent resolution, a time course study of the reaction at a 
reduced catalyst loading was carried out (10 mol % 3.6, Figure 3.2). Intriguingly, the ee’s 
of both products increased over time; moreover, their formation also accelerated during 
the course of the reaction. This observation can be rationalized by considering a kinetic 
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model of the reaction (Scheme 3.9). Since the majority of secondary protected product 
3.5c is obtained from (S)-3.3c, the opposite substrate enantiomer (R)-3.3c serves as an 
inhibitor for the formation of (S)-3.5c by majorly binding to the catalyst with the primary 
hydroxyl, thereby forming an inactive intermediate (R)-3.5c-i with a mismatched 
catalyst-substrate relationship. As (R)-3.3c is gradually converted to (R)-3.4c during the 
course, the concentration of catalyst bound to (S)-3.3c consequently increases, leading to 
the accelerating formation of (S)-3.5c. Additionally, the lower ee’s in the early stage of 
the reaction can result from the limited exchange rate between catalyst 3.6 and diol 3.3c, 
which allows the unselective background silylation to be competitive in the presence of 
excess silyl chloride. 
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      To test this hypothesis we performed a slow addition of silyl chloride in order to 
suppress the rate of the silylation step (Figure 3.3). We also raised the reaction 
temperature to facilitate the exchange between catalyst 3.6 and the substrate. This time 
course showed a synchronized conversion with the silyl chloride addition rate, indicating 
only a limited amount of excess electrophile in solution during the process. To our delight, 
the enantioselectivities of both products remained high during the course, presumably due 
to the minimized unselective background silylation. In addition, the regulated TESCl 
addition further allowed the formation of 3.4c in a constant high rate, while the formation 
of 3.5c was effectively inhibited and remained slow during the first 30 minutes. This rate 
difference allowed us to obtain 3.4c with 47% yield and 92% ee at the consumption of 
~0.70 equiv TESCl. 
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Figure 3.3. Time course study at room temperature with a syringe pump addition of 
TESCl 
 
 
     Based on the time course data, we employed 0.7 equiv of electrophile in order to 
obtain the primary protected product in high yield and enantioselectivity. To improve the 
practicality of the reaction we performed it at room temperature with portion-wise 
addition of TESCl. Application of the new conditions to the previous substrate scope of 
divergent resolution allowed the isolation of a variety of primary silylated diol 3.4 in the 
synthetically practical level of yields and ee’s (Table 3.3). Alkyl groups with different 
steric hindrance were well tolerated in the new conditions (Table 3.3, entry 1-3). Primary 
protected products were also obtained in high enantiopurities with benzyl, CH2OBn, and 
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groups containing halogens (Table 3.3, entry 5, 6, 9 and 10). A decrease of yield and ee 
was observed with methyl, CH2OPh, and vinyl substituents, which were known to 
provide more undesired (S)-3.4 from the (S)-diol substrate (Table 3.3, entry 4). 
 
 
 
     Finally, the tolerance of silyl reagent range in this method was also explored 
(Scheme 3.10). Previous tests of bulky silyl chlorides resulted in no functionalization of 
the secondary hydroxyls. However, a traditional kinetic resolution can still be achieved if 
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the scaffolding catalyst provides a high selectivity factor. Using TBSCl in the resolution 
of 1,2-hexanediol provided (R)-3.4ba in 45% yield and 78% ee (s = 15).  Increasing the 
steric bulk of the silyating reagent to TIPSCl afforded the product in 40% yield and 92% 
ee (s = 45).  This level of selectivity provides a practical method for either isolating the 
product or starting diol in high enantioselectivity and yield. 
 
 
 
3.7 Conclusions 
     Through the synergy of the binding selectivity and stereoselectivity of our 
scaffolding catalysis design, we have demonstrated a method to directly functionalize the 
less reactive site of a molecule. Such reversal of substrate’s inherent selectivity has been 
achieved in the context of terminal 1,2-diols, leading to a regiodivergent resolution 
towards the secondary silylated product in high isolated yields and ee’s. With an 
understanding of the reaction kinetics based on time course studies, we have also 
modified conditions to obtain primary protected product in practical yields and 
enantiopurities with a range of silyl reagents. 
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3.8 Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and 
used without further purification. Lithium reagents were titrated against 2-pentanol using 
1,10-phenanthroline as the indicator. Flash column chromatography was performed using 
EMD Silica Gel 60 (230-400 mesh) and ACS grade solvents as received from Fisher 
Scientific. All experiments were performed in oven or flame dried glassware under an 
atmosphere of nitrogen or argon using standard syringe and cannula techniques, except 
where otherwise noted. All reactions were run with dry, degassed solvents dispensed from 
a Glass Contour Solvent Purification System (SG Water, USA LLC). tert-amyl alcohol 
and tert-butanol were distilled over CaH2 and stored over 3Å molecular sieves in a dry 
box under a nitrogen atmosphere. Deuterated solvents were purchased from Cambridge 
Isotope Labs and stored over 3Å molecular sieves. C6D6 was degassed by three 
successive freeze-pump-thaw cycles and stored over 3Å molecular sieves in a dry box 
under a nitrogen atmosphere. Column chromatography was performed using an ISCO 
automatic purification system (model: Combiflash RF 75 PSI) and RediSep Rf Gold 
pre-packed columns. Hydroformylation was performed in an Argonaut Technologies 
Endeavor Catalyst Screening System using 1:1 H2/CO supplied by Airgas, Inc.
 1H and 
13C NMR were performed on either a Varian Gemini 400 MHz, Varian Gemini 500 MHz 
or a Varian Unity Inova 500 MHz spectrometer. All NMR chemical shifts are reported in 
ppm relative to residual solvent for 1H and 13C NMR. Coupling constants are reported in 
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Hz. All IR spectra were gathered on a Bruker Alpha FT-IR equipped with a single crystal 
diamond ATR module and values are reported in cm1. All GC analyses were performed 
on an Agilent Technologies 7890A GC System. HRMS and X-ray crystal structure data 
were generated in Boston College facilities. Analytical chiral high-performance liquid 
chromatography (HPLC) was performed on a Shimadzu-LC-2010A HT. 
 
Catalyst Synthesis 
(4S)-4-isopropyl-2-methoxy-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)-propyl)
oxazolidine (3.1). The catalyst is synthesized following the previous 
reported procedure (Chapter 2, experimental) 
 
(S)-2-(((R)-cyclopentyl(1-methyl-1H-imidazol-2-yl)methyl)amino)-3-methylbutan-1
-ol. Cyclopentene (68.1 g, 1.00 mol), 
tris(2,4-ditert-butyl-phenyl)phosphite (8.41 g, 13.0 mmol), and 
Rh(acac)(CO)2 (903 mg, 3.50 mmol) were dissolved in anhydrous 
benzene (200 mL) in a pressure vessel. The pressure vessel was purged 3 times with 1:1 
H2/CO, pressurized to 150 psi, and heated to 80 °C. The reactions were stirred for 20 
hours maintaining constant temperature and pressure. The concentration of the resulting 
crude cyclopenatanecarboxaldehyde solution was determined by 1H NMR with internal 
standard (1,3,5-trimethoxybenzene) added to aliquot. The crude product solution was 
then used in the next step without purification. To a stirring solution of (S)-valinol (20.6 g, 
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200 mmol) in anhydrous THF (150 mL) under nitrogen atmosphere was added a solution 
of crude cyclopentanecarboxaldehyde (200 mmol) in benzene (100 mL). MgSO4 (12.0 g, 
100 mmol) was added, and the solution was stirred at room temperature for 3 hours to 
form the imine which closes to the oxazolidine in situ. In another oven-dried glass 
reaction flask, to a solution of N-methylimidazole (36.1 g, 440 mmol) in anhydrous THF 
(200 mL) under nitrogen atmosphere was added n-butyllithium (40 mL, 11 M in hexanes, 
440 mmol) slowly at -78 °C. The solution was stirred at -78 °C for 30 minutes, and the 
formed oxazolidine solution was slowly cannula transferred into the 
N-methylimidazolium lithium solution at -78 °C. The resulting mixture was stirred 
overnight and gradually warmed to room temperature. Saturated aqueous NH4Cl (40 mL) 
solution was added slowly to quench the reaction. MgSO4 (12 g) was added. The mixture 
was stirred at room temperature for 15 minutes, filtered and concentrated. Excess 
N-methylimidazole was distilled off (150 °C @ 1.0 mmHg). Flash column 
chromatography (CH2Cl2/MeOH = 100:1 to 10:1) afforded the pure product as colorless 
oil (40.4 g, 76 %, d.r. = 92:8).  1H NMR (CDCl3, 500 MHz)  0.77 (d, 0.18H, J = 6.8), 
0.82 (d, 0.18H, J = 6.8), 0.87 (d, 2.82H, J = 6.8), 0.91 (d, 2.82H, J = 6.8), 1.20-1.32 (m, 
0.54H), 1.33-1.74 (m, 8.46H), 2.13-2.22 (m, 1.88H), 2.24-2.27 (m, 0.12H), 3.26 (d, 
0.06H, J = 7.1), 3.28 (d, 0.94H, J = 5.9), 3.30 (d, 0.94H, J = 2.9), 3.32 (d, 0.06H, J = 4.4), 
3.61 (s, 2.82H), 3.62 (s, 0.18H), 3.72 (d, 1H, J = 7.6), 6.72 (d, 0.06H, J = 1.2), 6.76 (d, 
0.94H, J = 1.2), 6.93 (d, 0.94H, J = 1.2); 13C NMR (CDCl3, 125 MHz)  38.1, 38.3, 38.4, 
38.6, 44.4, 44.5, 44.6, 48.6, 48.7, 48.9, 49.8, 50.1, 52.1, 65.0, 77.7, 78.0, 79.3, 81.6, 82.0, 
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82.7, 139.7, 140.2, 146.1, 146.2, 169.8, 170.6; IR: 3201, 2952, 2868, 1486, 1467, 1280, 
1107, 1047, 835, 724 cm–1; HRMS (ESI+) calcd. for C15H28N3O [M+H]
+: 266.2227, 
found: 266.2247. []D
20 = +46.7 (c = 1.0, CH2Cl2, l = 50 mm). 
(2R,4S)-3-((R)-cyclopentyl(1-methyl-1H-imidazol-2-yl)methyl)-4-isopropyl-2-meth
oxyoxazolidine (3.6). To a solution of 
(S)-2-(((R)-cyclopentyl(1-methyl-1H-imidazol-2-yl)methyl)amino)-
3-methylbutan-1-ol (7.4 g, 28 mmol) in anhydrous MeOH (56 mL) 
under nitrogen atmosphere was added N,N-dimethylformamide dimethyl acetal (19 mL, 
140 mmol). The reaction was stirred at 50 °C overnight. The solvent was removed under 
vacuum, and the residue was redissolved in anhydrous MeOH (56 mL) in order to 
convert the small amount of dimethylamine bound catalyst to methanol bound catalyst. 
The reaction was stirred at 50 °C for 2 hours, and the solvent was removed under vacuum. 
The residue was moved into a dry box and was dissolved in anhydrous pentane (250 mL). 
The solution was cooled to -40 °C overnight, and dark yellow oil formed on the bottom 
of the flask. The top clear organic layer was decanted off and was concentrated to 
approximately 100 mL. The solution was cooled to -40 °C overnight during which the 
product precipitated as a white solid. The solid was filtered and washed with a small 
portion of cold pentane to afford pure product (−)-2 (3.9 g, 46%). 1H NMR (CDCl3, 500 
MHz)  0.69 (d, 3H, J = 7.1), 0.73-0.80 (m, 1H), 0.87 (d, 3H, J = 6.9), 1.46-1.78 (m, 7H), 
2.33-2.40 (m, 1H), 2.75 (ddd, 1H, J = 8.8, 6.9, 5.1), 2.92 (s, 3H), 2.97-3.06 (m, 1H), 3.34 
(s, 3H), 3.48 (d, 1H, J = 11.0), 3.59 (t, 1H, J = 7.8), 3.75 (t, 1H, J = 8.3), 6.27 (d, 1H, J = 
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1.2), 6.72 (s, 1H), 7.16 (d, 1H, J = 1.2); 13C NMR (CDCl3, 125 MHz)  16.8, 20.1, 25.6, 
26.0, 29.5, 31.8, 32.2, 32.3, 45.1, 52.3, 58.8, 65.4, 66.0, 112.6, 120.2, 128.5, 149.1; IR: 
2952, 2870, 1650, 1482, 1192, 1174, 1122, 1074, 1052, 962 cm–1. Elemental Anaylsis: 
C17H29N3O2 requires: C = 66.42%, H = 9.51%, N = 13.67%, found: C = 66.51%, H = 
9.28%, N = 13.82%. []D
20 = -37.3 (c = 1.0, CH2Cl2, l = 50 mm). 
(S)-4-isopropyl-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)oxazolidine 
(3.7). To a stirring solution of 
(S)-2-(((R)-cyclopentyl(1-methyl-1H-imidazol-2-yl)methyl)amino)-3-
methylbutan-1-ol (0.50 g, 1.9 mmol) and paraformaldehyde (57 mg, 
1.9 mmol) in anhydrous toluene (19 mL), p-toluenesulfonic acid monohydrate (3.6 mg, 
1.9 × 10-2 mmol) was added. After refluxing overnight, reaction was cooled to room 
temperature, and CH2Cl2 (30 mL) was added. The resulting solution was concentrated. 
Flash column chromatography (100% EtOAc) afforded the product as colorless oil (280 
mg, 54%). 1H NMR (CDCl3, 500 MHz)  0.88 (d, 3H, J = 6.8), 0.92 (d, 3H, J = 6.6), 
1.51-1.73 (m, 8H), 2.02-2.07 (m, 1H), 2.57-2.60 (m, 1H), 2.70-2.73 (m, 1H), 3.47 (d, 2H, 
J = 6.3), 3.61 (d, 1H, J = 10.5), 3.68 (s, 3H), 4.42 (d, 1H, J = 4.6), 5.06 (d, 1H, J = 4.4), 
6.78 (d, 1H, J = 1.0), 7.02 (d, 1H, J = 1.2); 13C NMR (CDCl3, 126 MHz)  18.1, 19.8, 
25.1, 25.4, 30.9, 31.0, 31.7, 33.1, 44.4, 61.5, 66.5, 67.6, 82.3, 120.3, 127.6, 148.4; IR: 
2953, 2867, 1650, 1479, 1279, 1171, 1133, 1082, 943, 724 cm–1; []D
20 = +24.4 (c = 0.98, 
CH2Cl2, l = 50 mm). 
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Catalyst Equilibrium Experiments 
 
In a glovebox, a solution of catalyst 3.1 (35 mg, 0.13 mmol) and 
N,N-diisopropylethylamine hydrochloride (2.1 mg, 1.3 × 10-2 mmol) in anhydrous C6D6 
(500 μL) was made. 200 μL of the solution was added to a NMR tube. iPrOH (0.25 mmol, 
130 μL, 2M solution in C6D6) and MeOH (5.0 × 10
-2 mmol, 25 μL, 2M solution in C6D6) 
was added to the NMR tube. C6D6 (150 μL) was added to the NMR tube to reach a total 
volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, equilibrium 
was reached. A ratio of 3.1:3.2a = 68:32 gave a Keq of 0.11. Another 200 μL of the 
catalyst and acid solution was added to another NMR tube. iPrOH (5.0 × 10-1 mmol, 250 
μL, 2M solution in C6D6) and MeOH (5.0 × 10
-2 mmol, 25 μL, 2M solution in C6D6) was 
added to the NMR tube. C6D6 (25 μL) was added to the NMR tube to reach a total 
volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, equilibrium 
was reached. A ratio of 3.1:3.2a = 57:43, gave a Keq of 0.12. The average Keq for the two 
runs is 0.12 ± 0.01. 
 
Chapter 3, page 113 
 
 
 
In a glovebox, a solution of catalyst 3.1 (35 mg, 0.13 mmol) and 
N,N-diisopropylethylamine hydrochloride (2.1 mg, 1.3 × 10-2 mmol) in anhydrous C6D6 
(500 μL) was made. 200 μL of the solution was added to a NMR tube. nBuOH (0.15 
mmol, 75 μL, 2M solution in C6D6) and MeOH (5.0 × 10
-2 mmol, 25 μL, 2M solution in 
C6D6) was added to the NMR tube. C6D6 (200 μL) was added to the NMR tube to reach a 
total volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, 
equilibrium was reached. A ratio of 3.1:3.2b = 67:33 gave a Keq of 0.98. Another 200 μL 
of the catalyst and acid solution was added to another NMR tube. nBuOH (5.0 × 10-2 
mmol, 25 μL, 2M solution in C6D6) and MeOH (5.0 x 10
-2 mmol, 25 μL, 2M solution in 
C6D6) was added to the NMR tube. C6D6 (250 μL) was added to the NMR tube to reach a 
total volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, 
equilibrium was reached. A ratio of 3.1:3.2b = 43:57 gave a Keq of 0.86. The average Keq 
for the two runs is 0.92 ± 0.06. 
 
Site-Selective Silylation of (S)-Cyclohexylethane-1,2-Diol (Table 3.1) 
General Procedure. In a dry box, a solution of (S)-1-cyclohexylethane-1,2-diol (29 
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mg, 0.20 mmol), catalyst 3.6 (8.3 mg, 3.0 x 10-2 mmol, 15 mol %), and 
N,N-diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 mol %) in 
anhydrous tert-amyl alcohol (2.9 mL) was prepared in an oven-dried glass reaction vial. 
The reaction was stirred at 0 °C for 10 minutes. N,N-diisopropylethylamine (45 L, 0.26 
mmol, 1.3 equiv) was added, followed by addition of chlorotriethylsilane (44 L, 0.26 
mmol, 1.3 equiv). The reaction was stirred at 0 °C for 30 minutes. MeOH (100 L) was 
added to quench the reaction. The solvent was removed under reduced pressure. Chiral 
GLC analysis of crude mixture with 1,3,5-trimethoxybenzene as internal standard 
afforded yields of products and the selectivity of the reaction (Supelco Gamma Dex 120 
(30 m × 0.25 mm × 0.25 µm film thickness), 115 °C for 180 min, 20 °C/min to 180 °C, 
180°C for 20 min, 15 psi; tsdantard = 18.6 min, t3.3a = 22.6 min, t3.4a = 40.4 min, t3.5a = 44.0 
min; Response factors (standard: 1.0, 3.3a: 1.3, 3.4a: 0.56, 3.5a: 0.65)).  
Table 1, entry 1. Reaction was performed with N-methylimidazole (2.4 µL, 3.0 x 
10-2 mmol) as catalyst using the general procedure. Chiral GLC analysis of the crude 
mixture afforded <2% yield of 3.5a and a selectivity of 3.4a:3.5a = 98:2. 
Table 1, entry 2. Reaction was performed with 3.1 (8.4 mg, 3.0 x 10-2 mmol) as 
catalyst using the general procedure. Chiral GLC analysis of the crude mixture afforded 
58% yield of 3.5a and a selectivity of 3.4a:3.5a = 18:82. 
Table 1, entry 3. Reaction was performed using the general procedure. Chiral GLC 
analysis of the crude mixture afforded 76% yield of 3.5a and a selectivity of 3.4a:3.5a = 
12:88. Column chromatography (0-20% EtOAc in Hexanes) afforded the pure product as 
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colorless oil (38 mg, 74%).  
Table 1, entry 4. Reaction was performed with 7 (8.3 mg, 3.0 x 10-2 mmol) using 
the general procedure. Chiral GLC analysis of the crude mixture afforded <1% yield of 
3.5a and a selectivity of 3.4a:3.5a = 91:9. 
Table 1, entry 5. Reaction was performed with (R)-1-cyclohexylethane-1,2-diol (29 
mg, 0.20 mmol) using the general procedure. Chiral GLC analysis of the crude mixture 
afforded <2% yield of 3.5a and a selectivity of 3.4a:3.5a > 98:2. 
 
Regiodivergent Resolution of Racemic Terminal 1,2-Diols (Table 3.2) 
General Procedure. In a dry box, a solution of 1-cyclohexylethane-1,2-diol (140 
mg, 1.0 mmol), catalyst 3.6 (46 mg, 0.15 mmol, 15 mol %), and 
N,N-diisopropylethylamine hydrochloride (33 mg, 0.20 mmol, 20 mol %) in anhydrous 
tert-amyl alcohol (14 mL) was prepared in an oven-dried glass reaction vial. The reaction 
was stirred at 0 °C for 10 minutes. N,N-diisopropylethylamine (230 L, 1.3 mmol, 1.3 
equiv) was added, followed by addition of chlorotriethylsilane (220 L, 1.3 mmol, 1.3 
equiv). The reaction was stirred at 0 °C for 45 minutes. MeOH (500 L) was added to 
quench the reaction. The solvent was removed under reduced pressure. Column 
chromatography (0-20% EtOAc in Hexanes, using an ISCO automated purification 
system) afforded 3.4a (145 mg, 56%) and 3.5a (105 mg, 41%) as colorless oils. 
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(S)-2-cyclohexyl-2-(triethylsilyloxy)ethanol (Table 3.2, entry 1, 3.5a). The general 
procedure was followed to yield colorless oil (105 mg, 41%). Chiral 
GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 m 
film thickness), 145 °C for 100 min, 10 °C/min to 200 °C, 200°C for 
10 min, 15 psi., trmajor = 44.4 min, trminor = 45.0 min) 97% ee. 
1H NMR (CDCl3, 500 MHz) 
 0.63 (q, 6H, J = 8.1), 0.98 (t, 9H, J = 8.1), 1.10-1.25 (m, 4H), 1.46-1.53 (m, 1H), 
1.65-1.84 (m, 7H), 3.49 (dt, 1H, J = 6.1, 3.7), 3.53-3.59 (m, 2H); 13C NMR (CDCl3, 126 
MHz)  5.3, 7.1, 26.5, 26.6, 26.8, 29.0, 29.3, 41.4, 64.2, 77.4; IR:  3421, 2924, 2876, 
1450, 1238, 1118, 1006, 739 cm–1; HRMS (DART-TOF) calcd. for C14H31O2Si1: [M+H]
+: 
259.2093, found: 259.2099. []D
20 = +8.7 (c = 1.1, CH2Cl2, l = 50 mm). 
(R)-1-cyclohexyl-2-((triethylsilyl)oxy)ethanol (Table 3.2, Entry 1, 3.4a). The general 
procedure was followed to yield the product as a colorless oil 
(123 mg, 47%). Chiral GC Analysis (Supelco Gamma Dex 120 
(30 m × 0.25 mm × 0.25 µm film thickness), 115 °C for 180 min, 
20 °C/min to 180 °C, 180°C for 20 min, 15 psi, trmajor = 172.2 min, trminor = 169.2 min) 81% 
ee. 1H NMR (CDCl3, 500 MHz)  0.59 (q, 6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 0.98-1.06 
(m, 2H), 1.10-1.25 (m, 3H), 1.33-1.40 (m, 1H ), 1.57-1.65 (m, 2H), 1.69-1.75 (m, 2H), 
1.87-1.91 (m, 1H), 2.48 (d, 1H, J = 2.9), 3.34-3.38 (m, 1H), 3.44 (dd, 1H, J = 9.8, 8.3), 
3.67 (dd, 1H, J = 9.8, 3.2); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 26.3, 26.4, 26.7, 29.0, 
29.1, 40.7, 65.2, 76.0; IR: 2921, 2875, 2852, 1450, 1112, 1079, 1004, 817, 726 cm-1; 
HRMS (ESI+) calcd. for C14H30O2NaSi: [M+Na]
+: 281.1907, found: 281.1915. []D
20 = 
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-6.4 (c = 1.3, CH2Cl2, l = 50 mm). 
(S)-2-(triethylsilyloxy)hexan-1-ol (Table 2, entry 2, 3.5b). The general procedure 
was followed using 1.2 equiv chlorotriethylsilane, 1.2 equiv 
N,N-diisopropylethylamine, 10 mol % 3.1, and a reaction time of 
1.5 hours to yield a colorless oil (88 mg, 38%). Chiral GC 
Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 m film thickness), 95 °C for 
120 min, 20 °C/min to 200 °C, 200°C for 20 min, 15 psi., trmajor = 106.1 min, trminor = 
109.4 min) 98% ee. 1H NMR (CDCl3, 500 MHz)  0.63 (q, 6H, J = 7.8), 0.88-0.91 (m, 
3H), 0.98 (t, 9H, J = 7.8), 1.23-1.34 (m, 4H), 1.47-1.52 (m, 2H), 1.91 (t, 1H, J = 6.4), 
3.42-3.46 (m, 1H), 3.54-3.59 (m, 1H), 3.71-3.76 (m, 1H); 13C NMR (CDCl3, 126 MHz)  
5.3, 7.0, 23.0, 23.3, 24.7, 43.5, 66.8, 71.4; IR:  3408, 2955, 2876, 1459, 1239, 1097, 
1007, 727 cm–1; HRMS (DART-TOF) calcd. for C12H29O2Si1: [M+H]
+: 233.1937, found: 
233.1934. []D
20 = +11.4 (c = 1.1, CH2Cl2, l = 50 mm). 
(R)-1-((triethylsilyl)oxy)hexan-2-ol (Table 3.2, entry 2, 3.4b). The general 
procedure was followed using 1.2 equiv of 
chlorotriethylsilane, 1.2 equiv N,N-diisopropylethylamine, 
10 mol % 3.1, and a reaction time of 1.5 hours to yield a 
colorless oil (129 mg, 55%). Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 
mm × 0.25 µm film thickness), 95 °C for 120 min, 20 °C/min to 180 °C, 180°C for 20 
min, 15 psi, trmajor = 103.2 min, trminor = 102.1 min) 78% ee. 
1H NMR (CDCl3, 500 MHz) 
 0.60 (q, 6H, J = 7.8), 0.89 (t, 3H, J = 7.1), 0.94 (t, 9H, J = 7.8), 1.22-1.45 (m, 6H), 2.44 
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(d, 1H, J = 3.2), 3.36 (dt, 1H, J = 2.0, 8.8), 3.59-3.64 (m, 2H); 13C NMR (CDCl3, 125 
MHz)  4.6, 6.9, 14.2, 23.0, 28.0, 32.7, 67.2, 72.1; IR: 2955, 2934, 2913, 2876, 1459, 
1095, 1004, 803, 726 cm–1; HRMS (ESI+) calcd. for C12H28O2NaSi: [M+Na]
+: 255.1751, 
found: 255.1745. []D
20 = -3.6 (c = 1.1, CH2Cl2, l = 50 mm). 
(S)-4-methyl-2-(triethylsilyloxy)pentan-1-ol (Table 3.2, entry 3, 3.5c). The general 
procedure was followed to yield colorless oil (94 mg, 40%). Chiral 
GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 m 
film thickness), 95 °C for 120 min, 20 °C/min to 200 °C, 200°C for 
20 min, 15 psi., trmajor = 80.4 min, trminor = 86.1 min) 98% ee. 
1H NMR (CDCl3, 500 MHz) 
 0.63 (q, 6H, J = 8.1), 0.90 (d, 3H, J = 6.6), 0.91 (d, 3H, J = 6.6) 0.98 (t, 9H, J = 8.1), 
1.38 (t, 2H, J = 6.8), 1.59-1.67 (m, 1H), 1.92 (t, 1H, J = 6.4), 3.39-3.44 (m, 1H), 3.57 
(ddd, 1H, J = 11.0, 6.1, 3.7), 3.82 (ddt, 1H, J = 9.8, 5.4, 1.2); 13C NMR (CDCl3, 126 
MHz)  5.2, 7.0, 14.2, 23.0, 27.7, 40.0, 66.5, 73.1; IR:  3418, 2955, 2876, 1466, 1087, 
1046, 742 cm–1; HRMS (DART-TOF) calcd. for C12H29O2Si1: [M+H]
+: 233.1937, found: 
233.1943. []D
20 = +10.3 (c = 1.1, CH2Cl2, l = 50 mm). 
(R)-4-methyl-1-((triethylsilyl)oxy)pentan-2-ol (Table 3.2, entry 3, 3.4c). The 
general procedure was followed to yield the product as colorless 
oil (125 mg, 54%). Chiral GC Analysis (Supelco Beta Dex 120 
(30 m × 0.25 mm × 0.25 µm film thickness), 95 °C for 90 min, 
20 °C/min to 180 °C, 180°C for 20 min, 15 psi, trmajor = 75.9 min, trminor = 75.1 min) 82% 
ee. 1H NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 7.8), 0.90 (d, 3H, J = 6.6), 0.92 (d, 3H, 
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J = 6.6), 0.95 (t, 9H, J = 7.8), 1.11 (ddd, 1H, J = 13.5, 8.5, 4.2),1.36 (ddd, 1H, J = 14.2, 
8.8, 5.9), 1.74-1.82 (m, 1H), 2.40 (d, 1H, J = 3.2), 3.33 (dd, 1H, J = 9.8, 7.8), 3.58 (dd, 
1H, J = 9.8, 3.2), 3.71 (ddd, 1H, J = 16.4, 7.8, 3.2); 13C NMR (CDCl3, 125 MHz)  4.6, 
6.9, 22.4, 23.6, 24.8, 42.0, 67.6, 70.3; IR: 2954, 2912, 2876, 1096, 1049, 1004, 789, 726 
cm–1; HRMS (ESI+) calcd. for C12H28O2NaSi: [M+Na]
+: 255.1751, found: 255.1763. 
[]D
20 =  +0.94 (c = 1.2, CH2Cl2, l = 50 mm).  
(S)-2-(triethylsilyloxy)propan-1-ol (Table 3.2, entry 4, 3.5d). The general procedure 
was followed using 1.2 equiv chlorotriethylsilane and 1.2 equiv 
N,N-diisopropylethylamine with a reaction time of 25 minutes. 
Column chromatography (3-20% Et2O in Hexanes) yielded colorless 
oil (69 mg, 36%). Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 
m film thickness), 80 °C for 100 min, 20 °C/min to 200 °C, 200°C for 20 min, 15 psi., 
trmajor = 45.2 min, trminor = 46.8 min) 93% ee. 
1H NMR (CDCl3, 500 MHz)  0.63 (q, 6H, 
J = 7.8), 0.97 (t, 9H, J = 7.8), 1.14 (d, 3H, J = 6.4), 1.96 (dd, 1H, J = 7.6, 5.1), 3.37 (ddd, 
1H, J = 11.7, 6.6, 1.5), 3.48-3.53 (m, 1H), 3.89-3.95 (m, 1H); 13C NMR (CDCl3, 126 
MHz)  5.1, 7.0, 20.1, 68.4, 69.1; IR:  3408, 2955, 2877, 1459, 1238, 1005, 741 cm–1; 
HRMS (DART-TOF) calcd. for C12H29O2Si1: [M+H]
+: 233.1937, found: 233.1934. []D
20 
= +18.6 (c = 1.0, CH2Cl2, l = 50 mm).  
(R)-1-((triethylsilyl)oxy)propan-2-ol (Table 3.2, entrty 4, 3.4d). The general 
procedure was followed using 1.2 equiv chlorotriethylsilane and 1.2 equiv 
N,N-diisopropylethylamine with a reaction time of 25 minutes. Column chromatography 
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(3-20% Et2O in Hexanes) yielded a colorless oil (97 mg, 51%). 
Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 
0.25 µm film thickness), 80 °C for 45 min, 20 °C/min to 180 °C, 
180°C for 20 min, 15 psi, trmajor = 36.8 min, trminor = 35.6 min) 70% ee. 
1H NMR (CDCl3, 
500 MHz)  0.60 (q, 6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 1.10 (d, 3H, J = 6.4), 2.48 (d, 1H, 
J = 3.0), 3.32 (dd, 1H, J = 9.8, 7.8), 3.57 (dd, 1H, J = 9.8, 3.4), 3.77-3.84 (m, 1H); 13C 
NMR (CDCl3, 125 MHz)  4.6, 6.9, 18.4, 68.2, 68.4; IR: 2955, 2911, 2877, 1459, 1239, 
1087, 1006, 801, 724 cm–1; HRMS (ESI+) calcd. for C9H22O2NaSi: [M+Na]
+: 213.1281, 
found: 213,1271. []D
20 = -8.2 (c = 1.1, CH2Cl2, l = 50 mm). 
(S)-3-phenyl-2-(triethylsilyloxy)propan-1-ol (Table 3.2, entry 5, 3.5e). The general 
procedure was followed with 1.2 equiv of chlorotriethylsilane, 1.2 
equiv N,N-diisopropylethylamine, and 10 mol % 3.1 to yield a 
colorless oil (116 mg, 44%). Chiral HPLC Analysis (OD-H, 1.0 
mL/min, 10% iPrOH: 90% Hexanes, 220 nm, trmajor = 4.1 and trminor = 
7.8 min) 96% ee. 1H NMR (CDCl3, 500 MHz)  0.53 (dq, 6H, J = 16.1, 3.4), 0.90-0.93 
(m, 9H), 1.91 (dd, 1H, J = 7.0, 5.6), 2.80 (ddd, 2H, J = 19.6, 13.5, 6.1), 3.40-3.45 (m, 1H), 
3.48-3.53 (m, 1H), 3.92 (dddd, 1H, J = 13.7, 7.3, 4.6, 0.98), 7.16-7.20 (m, 3H), 7.24-7.28 
(m, 2H); 13C NMR (CDCl3, 126 MHz)  5.1, 7.0, 40.8, 65.8, 79.2, 126.5, 128.6, 129.8, 
138.4; IR: 2953, 2912, 2876, 1455, 1238, 1103, 1004, 724, 698, 505 cm–1; HRMS 
(DART-TOF) calcd. for C15H27O2Si1: [M+H]
+: 267.1780, found: 267.1777. []D
20 = -12.6 
(c = 1.0, CH2Cl2, l = 50 mm). 
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(R)-1-phenyl-3-((triethylsilyl)oxy)propan-2-ol (Table 3.2, entry 5, 3.4e). The 
general procedure was followed using 1.2 equiv 
chlorotriethylsilane, 1.2 equiv N,N-diisopropylethylamine, and 
10 mol % 3.1 to yield the product as a colorless oil (133 mg, 
50%). Chiral HPLC Analysis (OD-H, 1.0 mL/min, 2% iPrOH: 98% Hexanes, 220 nm, 
trmajor = 5.50 min and trminor = 6.12 min) 80% ee. 
1H NMR (CDCl3, 500 MHz)  0.59 (q, 
6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 2.42 (d, 1H, J = 3.9), 2.74 (dd, 1H, J = 13.7, 6.4), 2.78 
(dd, 1H, J = 13.7, 7.1), 3.46 (dd, 1H, J = 9.8, 6.8), 3.60 (dd, 1H, J = 10.0, 3.7), 3.85-3.90 
(m, 1H), 7.18-7.22 (m, 3H), 7.27-7.30 (m, 2H); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 
39.8, 66.2, 73.0, 126.5, 128.6, 129.5, 138.5; IR: 2953, 2911, 2876, 1239, 1111, 1031, 792, 
727, 698 cm–1; HRMS (ESI+) calcd. for C15H26O2NaSi: [M+Na]
+: 289.1594, found: 
289.1600. []D
20 = +2.6 (c = 1.0, CH2Cl2, l = 50 mm).  
(R)-3-(benzyloxy)-2-(triethylsilyloxy)propan-1-ol (Table 3.2, entry 6, 3.5f). The 
general procedure was followed using 1.2 equiv 
chlorotriethylsilane, 1.2 equiv N,N-diisopropylethylamine, 10 
mol % 3.1, and a reaction time of 1.5 hours to yield a 
colorless oil (118 mg, 40%).Chiral HPLC Analysis (OD-H, 1.0 mL/min, 0.5% iPrOH: 
99.5% Hexanes, 240 nm, trmajor = 23.2 and trminor = 30.5 min) 99% ee. 
1H NMR (CDCl3, 
500 MHz)  0.57-0.63 (q, 6H, J = 8.0), 0.91-0.95 (m, 9H), 2.04-2.08 (m, 1H), 3.44-3.51 
(m, 2H), 3.57-3.68 (m, 2H), 3.88-3.93 (m, 1H), 4.51 (s, 2H), 7.25-7.35 (m, 5H); 13C 
NMR (CDCl3, 126 MHz)  4.8, 6.7, 64.9, 71.0, 71.9, 73.5, 127.6, 127.7, 128.4, 138.0; IR:  
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3439, 2954, 2876, 1455, 1239, 1098, 1005, 739, 698 cm–1; HRMS (DART-TOF) calcd. 
for C16H29O3Si1: [M+H]
+: 297.1886, found: 297.1881. []D
20 = +21.4 (c = 1.1, CH2Cl2, l 
= 50 mm). 
(R)-1-(benzyloxy)-3-((triethylsilyl)oxy)propan-2-ol (Table 3.2, entry 6, 3.4f). The 
general procedure was followed using 1.2 equiv 
chlorotriethylsilane, 1.2 equiv N,N-diisopropylethylamine, 
10 mol % 3.1, and a reaction time of 1.5 hours to yield 
product as a colorless oil (174 mg, 59%). Chiral HPLC Analysis (OD-H, 1.0 mL/min, 5% 
iPrOH: 95% Hexanes, 220 nm, trmajor = 7.87 min and trminor = 6.95 min) 73% ee. 
1H NMR 
(CDCl3, 500 MHz)  0.59 (q, 6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 2.48 (d, 1H, J = 4.9), 
3.49 (dd, 1H, J = 9.5, 5.9), 3.53 (dd, 1H, J = 9.5, 4.9), 3.62 (dd, 1H, J = 10.0, 5.9), 3.66 
(dd, 1H, J = 10.0, 4.9), 3.82-3.87 (m, 1H), 4.54 (s, 2H), 7.26-7.35 (m, 5H); 13C NMR 
(CDCl3, 125 MHz)  4.6, 6.9, 64.0, 71.0, 71.3, 73.7, 127.9, 128.0, 128.6, 138.4; IR: 2953, 
2910, 2875. 1089, 1004, 804, 728, 696 cm–1; HRMS (ESI+) calcd. for C16H28O3NaSi: 
[M+Na]+: 319.1700, found: 319.1697. []D
20 = 0.53 (c = 1.1, CH2Cl2, l = 50 mm).  
(R)-3-phenoxy-2-(triethylsilyloxy)propan-1-ol (Table 3.2, entry 7, 3.5g). The 
general procedure was followed using 1.4 equiv 
chlorotriethylsilane, 1.4 equiv N,N-diisopropylethylamine, and 
15 mol % 3.1 to yield a colorless oil (87 mg, 31%). 1H NMR 
(CDCl3, 500 MHz)  0.68 (q, 6H, J = 7.8), 0.99 (t, 9H, J = 7.8), 2.00 (dd, 1H, J = 7.6, 
5.4), 3.69 (dd, 1H, J = 11.3, 7.3), 3.75 (ddd, 1H, J = 11.2, 5.4, 4.2), 3.94 (dd, 1H, J = 9.3, 
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6.1), 3.99 (dd, 1H, J = 9.3, 5.9), 4.11-4.15 (m, 1H), 6.90 (dt, 2H, J = 8.8, 0.98), 6.96 (tt, 
1H, J = 7.3, 0.98), 7.26-7.30 (m, 2H); 13C NMR (CDCl3, 120 MHz)  5.1, 7.0, 64.6, 69.2, 
71.3, 114.6, 121.1, 129.7, 158.5; IR:  3415, 2954, 2876, 1600, 1497, 1244, 1130, 1048, 
749, 690 cm–1; HRMS (DART-TOF) calcd. for C15H27O2Si1: [M+H]
+: 283.1730, found: 
283.1730. []D
20 = +15.4 (c = 0.99, CH2Cl2, l = 50 mm). 
Derivitization for ee. The product (15 mg, 9.0 x 10-2 mmol) was dissolved in 300 
µL of CH3CN and treated with 100 µL of hydrogen fluoride in pyridine. After 12 hours, 
column chromatography (1-10% MeOH in CH2Cl2) gave the known diol, 
(R)-3-phenoxypropane-1,2-diol. Chiral HPLC Analysis (OD-H, 1.0 mL/min, 15% 
iPrOH: 85% Hexanes, 240 nm) trmajor = 10.5 and trminor = 20.0 min) 96% ee (as diol). 
(R)-1-phenoxy-3-((triethylsilyl)oxy)propan-2-ol (Table 3.2, entry 7, 3.4g). The 
general procedure was followed using 1.4 equiv 
chlorotriethylsilane, 1.4 equiv N,N-diisopropylethylamine, 
and 15 mol % 3.1 to yield product as a colorless oil (131 mg, 
47%). Chiral HPLC Analysis (OD-H, 1.0 mL/min, 10% iPrOH: 90% Hexanes, 220 nm, 
trmajor = 10.5 min and trminor = 5.09 min) 78% ee. 
1H NMR (CDCl3, 500 MHz)   0.61 (q, 
6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 2.55 (d, 1H, J = 5.1), 3.74 (dd, 1H, J = 10.3, 5.1), 3.78 
(dd, 1H, J = 10.3, 4.6), 3.99-4.05 (m, 3H), 6.89-6.91 (m, 2H), 6.92-6.96 (m, 1H), 
7.25-7.28 (m, 2H); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 63.7, 68.7, 70.5, 114.8, 121.2 
129.7, 158.9; IR: 2953, 2876, 1599, 1495, 1458, 1242, 1079, 1043, 1005, 802, 745, 727, 
689 cm–1; HRMS (ESI+) calcd. for C15H26O3NaSi: [M+Na]
+: 305.1543, found: 305.1552. 
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[]D
20 = -0.19 (c = 1.1, CH2Cl2, l = 50 mm).  
(S)-2-(triethylsilyloxy)but-3-en-1-ol (Table 3.2, entry 8, 3.5h). The general 
procedure was followed with 1.2 equiv chlorotriethylsilane, 1.2 equiv 
N,N-diisopropylethylamine, and a reaction time of 25 minutes to yield a 
colorless oil (71 mg, 35%). Chiral GC Analysis (Supelco Beta Dex 
120 (30 m × 0.25 mm × 0.25 m film thickness), 90 °C for 100 min, 20 °C/min to 180 °C, 
180°C for 20 min, 15 psi., trmajor = 41.4 min, trminor = 43.1 min) 93% ee. 
1H NMR (CDCl3, 
500 MHz)  0.63 (q, 6H, J = 7.8), 0.97 (t, 9H, J = 7.8), 1.96-1.99 (m, 1H), 3.43-3.55 (m, 
2H), 4.20-4.24 (m, 1H), 5.17 (ddd, 1H, J = 10.5, 2.9, 1.2), 5.28 (ddd, 1H, J = 17.4, 2.9, 
1.7), 5.81 (dddd, 1H, J = 23.5, 10.5, 6.4, 1.7); 13C NMR (CDCl3, 126 MHz)  5.1, 6.9, 
67.0, 74.6, 116.5, 138.2; IR:  3415, 2955, 2877, 1459, 1098, 1007, 925, 743 cm–1; 
HRMS (DART-TOF) calcd. for C10H23O2Si1: [M+H]
+: 203.1467, found: 203.1475. []D
20 
= +7.4 (c = 0.82, CH2Cl2, l = 50 mm).  
(R)-1-((triethylsilyl)oxy)but-3-en-2-ol (Table 3.2, entry 8, 3.4h). The general 
procedure was followed using 1.2 eq of chlorotriethylsilane, 1.2 
equiv N,N-diisopropylethylamine, and a reaction time of 25 minutes 
to yield product as a colorless oil (115 mg, 57%). Chiral GC 
Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 90 °C for 
50 min, 20 °C/min to 180 °C, 180°C for 20 min, 15 psi, trmajor = 44.7 min, trminor = 43.0 
min) 57% ee. 1H NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 7.8),  0.95 (t, 9H, J = 7.8), 
2.57 (d, 1H, 3.4), 3.42 (dd, 1H, J = 10.0, 7.8), 3.64 (dd, 1H, J = 10.0, 3.7), 4.13-4.18 (m, 
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1H), 5.17 (dt, 1H, J = 10.5, 1.5), 5.33 (dt, 1H, J = 17.4, 1.5), 5.80 (ddd, 1H, J = 17.1, 10.5, 
5.6); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 66.9, 73.3, 116.7, 136.8; IR: 2955, 2912, 
2877, 1238, 1102, 1004, 923, 795, 725 cm–1; HRMS (ESI+) calcd. for C10H22O2NaSi: 
[M+Na]+: 225.1281, found: 225.1285. []D
20 = +0.84 (c = 1.2, CH2Cl2, l = 50 mm). 
(R)-3-chloro-2-(triethylsilyloxy)propan-1-ol (Table 3.2, entry 9, 3.5i). The general 
procedure was followed with a reaction time of 50 minutes to yield 
product as colorless oil (99 mg, 44%). Chiral GC Analysis (Supelco 
Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 110 °C for 
105 min, 20 °C/min to 200 °C, 200°C for 20 min, 15 psi, trmajor = 56.4 min, trminor = 57.9 
min) 97% ee. 1H NMR (CDCl3, 500 MHz)  0.65 (q, 6H, J = 7.8),  0.98 (m, 9H), 1.85 (t, 
1H, J = 6.4), 3.46 (dd, 1H, J = 10.8, 5.1), 3.58 (dd, 1H, J = 11.0, 7.1), 3.68-3.70 (m, 2H), 
3.89-3.93 (m, 1H); 13C NMR (CDCl3, 125 MHz)  5.0, 6.9, 44.7, 64.0, 72.8; IR: 3397, 
2956, 2878, 1459, 1240, 1120, 1046, 1006, 742 cm–1; HRMS (ESI+) calcd. for 
C9H22ClO2Si: [M+H]
+: 225.1078, found: 225.1071. []D
20 = +8.3 (c = 1.1, CH2Cl2, l = 50 
mm).  
(S)-1-chloro-3-(triethylsilyloxy)propan-2-ol (Table 3.2, entry 9, 3.4i). The general 
procedure was followed with a reaction time of 50 minutes to yield 
product as colorless oil (118 mg, 52%). Chiral GC Analysis 
(Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 110 °C for 50 
min, 20 °C/min to 200 °C, 200°C for 20 min, 15 psi, trmajor = 45.1 min, trminor = 44.3 min) 
90% ee. 1H NMR (CDCl3, 500 MHz)  0.61 (q, 6H, J = 8.1), 0.93-0.96 (m, 9H), 2.54 (d, 
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1H, J = 6.4), 3.54-3.61 (m, 2H), 3.66-3.72 (m, 2H), 3.80-3.86 (m, 1H); 13C NMR (CDCl3, 
125 MHz)  4.5, 6.9, 45.6, 63.3, 71.6; IR: 3425, 2955, 2877, 1459, 1240, 1111, 1006, 804, 
740 cm–1; HRMS (ESI+) calcd. for C9H22ClO2Si: [M+H]
+: 225.1070, found:225.1078. 
[]D
20 = -1.5 (c = 1.1, CH2Cl2, l = 50 mm). 
(R)-3-bromo-2-(triethylsilyloxy)propan-1-ol (Table 3.2, entry 10, 3.5j). The general 
procedure was followed to yield product as colorless oil (109 mg, 
41%). Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm 
× 0.25 µm film thickness), 110 °C for 105 min, 20 °C/min to 200 °C, 
200°C for 20 min, 15 psi, trmajor = 94.7 min, trminor = 97.2 min) 98% ee. 
1H NMR (CDCl3, 
500 MHz)  0.65 (q, 6H, J = 8.1),  0.96-0.99 (m, 9H), 1.85 (t, 1H, J = 6.4), 3.30-3.33 (m, 
1H), 3.43-3.64 (m, 1H), 3.71 (dd, 2H, J = 6.1, 4.2), 3.92-3.96 (m, 1H); 13C NMR (CDCl3, 
125 MHz)  4.8, 6.7, 33.0, 64.3, 72.2; IR: 3382, 2955, 2971, 2877, 1459, 1240, 1118, 
1006, 969, 742, 728 cm–1; HRMS (ESI+) calcd. for C9H22BrO2Si: [M+H]
+: 269.0572, 
found: 269.0573. []D
20 = +6.1 (c = 1.1, CH2Cl2, l = 50 mm).  
(S)-1-bromo-3-(triethylsilyloxy)propan-2-ol (Table 3.2, entry 10, 3.4j). The general 
procedure was followed to yield product as colorless oil (135 mg, 
50%). Chiral GC Analysis (Supelco Gamma Dex 120 (30 m × 
0.25 mm × 0.25 µm film thickness), 110 °C for 80 min, 20 °C/min 
to 200 °C, 200°C for 20 min, 15 psi, trmajor = 74.8 min, trminor = 73.6 min) 90% ee. 
1H 
NMR (CDCl3, 500 MHz)  0.61 (q, 6H, J = 7.8), 0.93-0.96 (m, 9H), 2.56 (d, 1H, J = 6.4), 
3.41-3.49 (m, 2H), 3.68 (dd, 1H, J = 10.0, 4.9), 3.72 (dd, 1H, J = 10.0, 4.9), 3.80-3.85 (m, 
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1H); 13C NMR (CDCl3, 126 MHz)  4.5, 6.9, 34.7, 64.0, 71.3; IR: 2955, 2876, 1459, 
1240, 1108, 1006, 799, 727, 671 cm–1; HRMS (ESI+) calcd. for C9H22BrO2Si: [M+H]
+: 
269.0572, found: 269.0576. []D
20 = -0.99 (c = 1.2, CH2Cl2, l = 50 mm). 
 
Time Course at 0 °C with a Single Addition of TESCl (Figure 3.1) 
In a dry box, a solution of diol 3.3c (24 mg, 0.20 mmol), catalyst 3.6 (6.2 mg, 0.02 
mmol, 10 mol %), and N,N-diisopropylethylamine hydrochloride (2.0 mg, 1.2×10-2 mmol, 
6 mol %) in anhydrous tert-butanol (3 mL) was prepared in an oven-dried glass reaction 
vial. A solution of 1,3,5-trimethoxybenzene as internal standard (50 L, 2.0×10-2 mmol, 
10 mol %, 0.40 M in CDCl3, ) was added. The reaction was brought out of the dry box, 
and was stirred at 4 °C for 15 minutes. N,N-diisopropylethylamine (49 L, 0.28 mmol, 
1.4 equiv) was added, followed by addition of chlorotriethylsilane (44 L, 0.26 mmol, 
1.2 equiv). The reaction was stirred at room temperature for 1 hour. Aliquots (0.5 mL) 
were taken at every 10 min. Methanol (5 L) was added to quench the aliquot. The 
solvent was removed under reduced pressure. Chiral GLC analysis of the crude mixture 
afforded the yield and selectivity. Chiral GLC Analysis (Beta Dex 120 (30 m × 0.15 mm 
× 0.25 mm film thickness), 90 °C for 135 min, 20 °C/min to 160 °C, 160 °C for 20min, 
20 °C/min to 180 °C, 180°C for 20 min, 15 psi, t(S)-3.4b = 96.2 min, t(R)-3.4b = 97.4 min, 
t(S)-3.5b = 104.2 min, t(R)-3.5b = 110.9 min, tstandard = 143.7 min), Response Factors ((S)-3.4c: 
0.59, (R)-3.4c: 0.59, (S)-3.5c: 0.66, (R)-3.5c: 0.66, standard: 1.0). 
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Time Course at Room Temperature with a Syringe Pump Addition of TESCl (Figure 3.2) 
In a dry box, a solution of diol 3.3c (240 mg, 2.0 mmol), catalyst 3.6 (61 mg, 0.20 
mmol, 10 mol %), and N,N-diisopropylethylamine hydrochloride (20 mg, 0.12 mmol, 6 
mol %) in anhydrous tert-butanol (30 mL) was prepared in an oven-dried glass reaction 
vial. The solution brought out of the dry box, and a solution of 1,3,5-trimethoxybenzene 
as internal standard (0.50 mL, 0.20 mmol, 10 mol %, 0.40 M in CDCl3, ) was added. The 
reaction was stirred at room temperature for 15 minutes. N,N-diisopropylethylamine (490 
L, 2.8 mmol, 1.4 equiv) was added, followed by addition of chlorotriethylsilane (440 L, 
2.6 mmol, 1.2 equiv) in 2 mL THF via syringe pump over 1.5 hours. The reaction was 
stirred at room temperature for 2 hour. Aliquots (0.5 mL) were taken every at 10 min. 
Methanol (5 L) was added to quench the aliquot. The solvent was removed under 
reduced pressure. Chiral GLC analysis of the crude mixture afforded the yield and 
selectivity. 
 
Regiodivergent Resolution towards Primary Protected Terminal 1,2-Diols 
General Procedure. In a dry box, a solution of diol substrate (1.0 mmol), catalyst 
3.6 (31 mg, 0.10 mmol, 10 mol %), and N,N-diisopropylethylamine hydrochloride (10 mg, 
6.0 × 10-2 mmol, 6 mol %) in anhydrous tert-butanol (15 mL) was prepared in an 
oven-dried glass reaction vial. The reaction was brought out of the dry box, and was 
stirred at room temperature for 15 minutes. N,N-diisopropylethylamine (120 L, 0.70 
mmol, 0.70 equiv) was added, followed by addition of chlorotriethylsilane (100 L, 0.60 
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mmol, 0.60 equiv) in 4 portions every 15 minutes (dropwise addition was performed for 
each portion added). The reaction was stirred at room temperature for 1 hour (starting 
from the first addition of chlorotriethylsilane). Methanol (150 L) was added to quench 
the reaction. The solvent was removed under reduced pressure, and flash column 
chromatography (hexanes:EtOAc = 60:1) afforded pure product. Chiral GLC or HPLC 
analysis of the product afforded the selectivity. 
(R)-1-cyclohexyl-2-((triethylsilyl)oxy)ethanol (Table 3.3, entry 1, 3.4a). The 
general procedure was followed using 10 mol % catalyst 3.6, 0.70 equiv 
N,N-diisopropylethylamine, and 0.60 equiv chlorotriethylsilane to yield product as 
colorless oil (Run 1: 123 mg, 48%, er = 95:5,  Run 2: 46%, er = 96.5:3.5). 
(R)-1-((triethylsilyl)oxy)hexan-2-ol (Table 3.3, entry 2, 3.4b).The general 
procedure was followed using 10 mol % catalyst 3.1, 0.80 equiv 
N,N-diisopropylethylamine, and 0.70 equiv chlorotriethylsilane to yield product as 
colorless oil (Run 1: 108 mg, 46%, er = 96.5:3.5, Run 2: 46%, er = 96:4). 
 (R)-4-methyl-1-((triethylsilyl)oxy)pentan-2-ol (Table 3.3, entry 3, 3.4c). The 
general procedure was followed using 10 mol % catalyst 3.6, 0.70 equiv 
N,N-diisopropylethylamine, and 0.60 equiv chlorotriethylsilane to yield product as 
colorless oil (Run 1: 101 mg, 43%, er = 96:4, Run 2: 44%, er = 95.5:4.5). 
(R)-1-((triethylsilyl)oxy)propan-2-ol (Table 3.3, entry 4, 3.4d). The general 
procedure was followed using 15 mol % catalyst 3.6, 0.90 equiv 
N,N-diisopropylethylamine, and 0.80 equiv chlorotriethylsilane to yield product as 
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colorless oil (Run 1: 72 mg, 36%, er = 94.5:5.5, Run 2: 38%, er = 93.5:6.5). 
(R)-1-phenyl-3-((triethylsilyl)oxy)propan-2-ol (Table 3.3, entry 5, 3.4e). The 
general procedure was followed using 10 mol % catalyst 3.6, 0.80 equiv 
N,N-diisopropylethylamine, and 0.70 equiv chlorotriethylsilane to yield product as a 
colorless oil (Run 1: 107 mg, 41%, er = 96:4, Run 2: 40%, er = 96:4).  
(R)-1-(benzyloxy)-3-((triethylsilyl)oxy)propan-2-ol (Table 3.3, entry 6, 3.4f). The 
general procedure was followed using 15 mol % catalyst 3.1, 0.70 equiv 
N,N-diisopropylethylamine, and 0.60 equiv chlorotriethylsilane to yield product as 
colorless oil (Run 1: 122 mg, 41%, er = 95:5, Run 2: 40%, er = 95:5). 
(R)-1-phenoxy-3-((triethylsilyl)oxy)propan-2-ol (Table 3.3, entry 7, 3.4g). The 
general procedure was followed using 15 mol % catalyst 3.1, 0.80 equiv 
N,N-diisopropylethylamine, and 0.70 equiv chlorotriethylsilane. The reaction was stirred 
for 2 hours to yield product as colorless oil (Run 1: 98 mg, 35%, er = 95:5, Run 2: 37%, 
er = 94:6).  
(R)-1-((triethylsilyl)oxy)but-3-en-2-ol (Table 3.3, entry 8, 3.4h). The general 
procedure was followed using 15 mol % catalyst 3.6, 0.80 equiv 
N,N-diisopropylethylamine, and 0.70 equiv chlorotriethylsilane to yield product as 
colorless oil (Run 1: 84 mg, 42%, er = 89:11, Run 2: 40%, er = 89:11).  
(S)-1-chloro-3-((triethylsilyl)oxy)propan-2-ol (Table 3.3, entry 9, 3.4i). The general 
procedure was followed using 10 mol % catalyst 3.6, 0.80 equiv 
N,N-diisopropylethylamine, and 0.70 equiv chlorotriethylsilane, to yield product as 
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colorless oil (Run 1: 94 mg, 42%, er = 97.5:2.5, Run 2: 40%, er = 97.5:2.5). 
(S)-1-bromo-3-((triethylsilyl)oxy)propan-2-ol (Table 3.3, entry 10, 3.4j). The 
general procedure was followed using 10 mol % catalyst 3.6, 0.80 equiv 
N,N-diisopropylethylamine, and 0.70 equiv chlorotriethylsilane, to yield product as 
colorless oil (Run 1: 110 mg, 41%, er = 97.5:2.5, Run 2: 40%, er = 97.5:2.5). 
 
Kinetic Resolution Using tert-Butyldimethylsilyl Chloride (Scheme 3.7). 
In a dry box, a solution of hexane-1,2-diol (120 mg, 1.0 mmol), catalyst 3.1 (42 mg, 
0.15 mmol, 15 mol %), and N,N-diisopropylethylamine hydrochloride (10 mg, 0.060 
mmol, 6 mol %) in anhydrous tert-butanol (15 mL) was prepared in an oven-dried glass 
reaction vial. The reaction was brought out of the dry box, and was stirred at room 
temperature for 45 minutes. N,N-diisopropylethylamine (140 L, 0.80 mmol) was added, 
followed by addition of tert-butyldimethylsilyl chloride (110 mg, 0.70 mmol). The 
reaction was stirred at 4 C for 24 hours. Methanol (150 L) was added to quench the 
reaction. The solvent was removed under reduced pressure, and flash column 
chromatography (hexanes:EtOAc = 60:1) afforded pure product as colorless oil (Run 1: 
106 mg, 46%, er = 89:11, Run 2: 101 mg, 43%, er = 89:11). Chiral GLC Analysis (Beta 
Dex 120 (30 m × 0.15 mm × 0.25 mm film thickness), 95 °C for 80 min, 20 °C/min to 
180 °C, 180°C for 20 min, 15 psi, trminor = 56.9 min, trmajor = 57.8 min).  
(R)-1-((tert-butyldimethylsilyl)oxy)hexan-2-ol (3.4ba). 1H NMR (CDCl3, 500 
MHz)  3.59-3.63 (m, 2H), 3.37 (dd, 1H, J = 10.5, 8.3), 2.38 (d, 1H, J = 3.4), 1.24-1.43 
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(m, 6H), 0.86-0.90 (m, 12H), 0.05 (s, 6H); 13C NMR (CDCl3, 125 
MHz)  72.1, 67.5, 32.7, 28.0, 26.1, 23.0, 18.5, 14.2, -5.1, -5.2; IR: 
2955, 2929, 2858, 1463, 1254, 1098, 835, 775 cm–1; HRMS (ESI+) calcd. for C12H29O2Si: 
[M+H]+: 233.1937, found: 233.1938. []D
20 = −4.6 (c = 1.0, CH2Cl2, l = 50 mm). 
 
Kinetic Resolution Using Triisopropylsilyl Chloride (Scheme 3.7). 
In a dry box, a solution of hexane-1,2-diol (120 mg, 1.0 mmol), catalyst 3.1 (42 mg, 
0.15 mmol, 15 mol %), and N,N-diisopropylethylamine hydrochloride (10 mg, 0.060 
mmol, 6 mol %) in anhydrous tert-butanol (15 mL) was prepared in an oven-dried glass 
reaction vial. The reaction was brought out of the dry box, and was stirred at room 
temperature for 45 minutes. N,N-diisopropylethylamine (140 L, 0.80 mmol) was added, 
followed by addition of triisopropylsilyl chloride (150 L, 0.70 mmol). The reaction was 
stirred at 4 C for 48 hours. Methanol (150 L) was added to quench the reaction. The 
solvent was removed under reduced pressure, Flash column chromatography 
(hexanes:EtOAc = 60:1) afforded pure product as colorless oil (Run 1: 115 mg, 42%, er = 
95:5, Run 2: 105 mg, 38%, er = 97:3). Chiral GLC Analysis (Gamma Dex 120 (30 m × 
0.15 mm × 0.25 mm film thickness), 110 °C for 150 min, 20 °C/min to 180 °C, 180°C for 
20 min, 15 psi, trminor = 137.4 min, trmajor = 140.7 min).  
(R)-1-((triisopropylsilyl)oxy)hexan-2-ol (3.4bb). 1H NMR (CDCl3, 500 MHz)  
3.64 (dd, 1H, J = 9.5, 3.2), 3.56-3.61 (m, 1H), 3.40 (dd, 1H, J = 9.5, 7.6), 2.47 (d, 1H, 
3.2), 1.25-1.39 (m, 6H), 0.95-1.07 (m, 21H), 0.84 (m, 3H); 13C NMR (CDCl3, 125 MHz) 
Chapter 3, page 133 
 
 72.2, 67.8, 32.7, 28.0, 23.0, 18.2, 14.2, 12.1; IR: 2940, 2865, 1463, 
1103, 882, 797, 681, 660 cm–1; HRMS (ESI+) calcd. for C15H35O2Si: 
[M+H]+: 275.2406, found: 275.2415. []D
20 = −4.2 (c = 1.0, CH2Cl2, l = 50 mm). 
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Chapter 4. Site-Selective Functionalization of Complex Molecules 
 
4.1 Polyhydroxylated Molecules 
     Carbohydrates are commonly found in metabolic pathways and as structural 
building block in complex molecules. Besides their abundance, carbohydrates serve 
essential roles in biology as mediators of intercellular and intracellular processes, 
including cell-cell recognition, cell signaling regulation, cellular differentiation, and 
immune response.1 These diverse functions have long suggested the potential of 
carbohydrates as therapeutics, leading to their increased use as core scaffolds in drug and 
vaccine discovery (Figure 1).2 
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     The significant biological importance of carbohydrates has led to intensive efforts 
focused on their synthesis.3 However, their polyhydroxylated nature generates a large 
degree of complexity, imposing synthetic challenges to their selective functionalization 
and synthesis. Although significant progress has been made in this field, such as the 
development of automated oligosaccharide synthesis,4 current methods to selectively 
modify carbohydrates heavily rely on elaborate protecting group strategies to ensure the 
appropriate spatial and temporal shielding of undesired reactive sites. 
In a broader context, the same synthetic challenge also impedes the derivatization 
of numerous complex molecules containing polyhydroxylated frameworks. A growing 
desire has arisen for new methods that differentiate and selectively functionalize hydroxyl 
groups within a polyol structure. The ability to site-selectively funcationalize complex 
molecules would allow chemists to access new derivatives of natural products in efficient 
synthetic routes, as well as consequently expand the scope of biological studies in this 
area. 
 
4.2 Selective Functionalization of Natural Products. 
      Given the increasing complexity and diversity of synthetic targets in modern 
organic synthesis, research efforts have been intensely focused on the development of 
new strategies to elevate the efficiency of synthetic routes. New methods to functionalize 
complex molecules with high and predictable site-selectivity could allow rapid access to 
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a diverse range of analogues from advanced common precursors, thereby are highly 
desired. 
 
 
 
Such selective functionalization has been achieved with the stoichiometric use of 
directing groups. Early works by Breslow demonstrated that directed by benzophenone, 
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steroids can be selectively oxidized (Scheme 4.1, equation1).5a Later, aryl iodide has also 
been shown to remotely control the halogenation of steroids (Scheme 4.1, equation 2).5b,5c 
More recently, based on a carboxylic acid directed selective C-H functionalization, Yu 
and Baran reported a synthesis of (+)-Hongoquercin A and related analogues via selective 
derivatizations of a common precursor, demonstrating the high efficiency in synthetic 
designs delivered by site-selective functionalization (Scheme 4.2).5d 
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Multiple reagents and catalysts have also been successfully applied in the 
functionalization of a range of natural products.6 In 2005, Wender reported a highly 
selective C-H oxidation enabled by dimethyldioxirane to install a hydroxyl group to the 
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C9 position of bryostatin analogues (Scheme 4.3, equation 1).6a Later, an iron complex 
was demonstrated by White to selectively oxidize aliphatic tertiary C-H bonds in 
complex molecules with high predictability based solely on their electronic and steric 
properties (Scheme 4.3, equation 2).6b In, 2007, a reagent control approach has also been 
used by Snyder in the programmable synthesis of resveratrol oligomers, allowing the 
access to a variety of natural and unnatural analogues.6c More recently, Burke showed 
that modification of C2’-OH in the polyhydroxylated molecule AmB can be achieved 
through proper electronic tuning of the electrophiles employed (Scheme 4.4).6d 
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4.3 Site-Selective Catalysis in Natural Product Derivatizations. 
The use of a catalyst to control selectivitiy in an organic transformation is a widely 
appreciated strategy in synthesis.7 This field has experienced significant progress over the 
last 30 years, especially in the development of new enantioselective reactions.8 
Alternatively, a less developed aspect of synthetic chemistry is site-selective catalysis, 
wherein a precise and selective modification of a complex molecule is enabled by a 
catalyst.9-11 Achieving this goal is often magnified by the substrate’s elevated complexity, 
requiring the catalyst to differentiate multiple accessible sites and to perform a single 
activation of the desired position. An added challenge is the selective modification of a 
site with little or no innate reactivity; the site-selective catalyst must be able to reverse 
the substrate bias, either by decreasing the activation energy for the target site, or by 
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increasing the energetic requirement for the activation of the other undesired sites within 
the molecule. 
Owing to their high density of hydroxyl groups and strong preference for the 
functionalization of equatorial over axial sites, carbohydrates represent one of the most 
challenging substrate classes in site-selective catalysis. Traditionally, enzymes were 
considered as the primary tool to address this challenge.12. However, their strict 
recognition of the full substrate conformation usually led to narrow substrate scope. To 
explore alternative methods without these limitations, particular attention has been 
devoted to the development of new synthetic catalysts.  
 
 
 
In 1998, Miller developed a library of peptide-based catalysts designed to mimic 
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the active site of enzymes.9 These substrate-specific catalysts were proposed to interact 
with carbohydrates and other complex molecules via multiple non-covalent bonds, and 
facilitate site-selective functionalizations, such as the acyl transfer to C3 hydroxyl of 
N-acetylglucosamine derivative controlled by catalyst 4.1 (Scheme 4.5). Later, Kawabata 
reported a catalyst 4.2 containing 4-pyrrolidinopyridine as the active center.  Catalyst 
4.2 is able to form a hydrogen bond with the free primary hydroxyl group in a 
monosaccharide, and direct acylation of the adjacent C4-OH (Scheme 4.6, equation 
1).10a-d This catalyst was also used to selectively acylate cardiac glycoside digitoxin by 
amplifying the intrinsic reactivity for the C4’-OH (Scheme 4.6, equation 2).10e 
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In addition to the use of non-covalent interactions, temporary covalent bonds have 
been recently employed in designing site-selective functionalization of carbohydrates. In 
2011, a borinate catalyst 4.3 was developed by Taylor to covalently bind to a cis-1,2-diol 
unit within a monosaccharide, and selectively activate the equatorial hydroxyl for the 
transfer of a broad range of electrophiles (Scheme 4.7, equation 1 and 2), including acyl 
chlorides11a, alkyl halides11b, sulfonyl chlorides11c, and glycosyl donors11d. This method 
was further expanded to allow the preparation of cardiac glycoside analogs of digitoxin 
through selective glycosylation of C4’-OH (Scheme 4.7, equation 3).11e 
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Despite these notable successes in the selective functionalization of carbohydrates 
and other natural products, the direct modification of the axial hydroxyl group within 
six-membered cyclic polyols had not been demonstrated with synthetic catalysts. Due to 
significant steric effects, axial hydroxyl groups are often rendered among the least 
reactive sites within carbohydrates; their functionalization thus generally requires the 
prior protection of other hydroxyls groups present. A potent catalyst that enables selective 
manipulation of axial hydroxyls within carbohydrates could effectively shorten syntheses, 
and open new avenues to a broad range of synthetic analogues thereby benefiting both 
chemical and biological research.  
 
4.4 Catalyst Concept  
     We decided to design an organic catalyst that enables selective activation of axial 
hydroxyl groups within carbohydrates. In addition, we aimed to develop predictable 
selectivity over a broad substrate scope, maximizing the synthetic potential of this 
method. Previously, direct activation of axial hydroxyl groups has been only achieved 
with enzymes. Studies of active enzymes revealed that proximity effects stand as a 
powerful means of accessing less reactive sites,12 and widely determine the extraordinary 
selectivities in enzymatic catalysis. A demonstrative example has been reported by 
Howell to show the active site of -1,2-mannosyltransferase Kre2p/Mnt1p, which 
catalyzes the mannosylation of the axial C2-hydroxyl of mannose through the application 
of multiple non-covalent interactions binding and orienting the substrate (Figure 4.2).13  
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     We hypothesized that a synthetic catalyst utilizing reversible covalent bonding 
could produce similar site-selectivities for a broad substrate scope and with consistent 
predictability. This alternative mode of catalyst-substrate interaction would rely on 
recognition of a single functional group display in order to activate the desired target 
site.14 Such a catalyst would require much less orienting structural features, thereby 
allowing a reduction of its molecular weight and complexity. Moreover, by recognizing a 
minimal functional group motif rather than the entire structure the catalyst would be 
applicable to any substrate that contained that substructure (Figure 4.3). 
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     A survey of polyhydroxylated molecules revealed that the majority of their axial 
hydroxyl groups exist within a cis-1,2-diol motif. Catalysts recognizing this specific diol 
could serve as valuable candidates towards axial hydroxyl modifications. Previously 
developed by our group, scaffolding catalyst 4.4 employs a single reversible-formed 
covalent bond to bind to hydroxyl substrates,15-17 and shows excellent activity in the 
enantioselective functionalization of cis-1,2-diols. Although the substrate exchange 
mechanism of 4.4 could lead to unselective binding to multiple sites in carbohydrates, we 
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envisioned that only specific sites with proper proximity to the imidazole residue could 
be activated. In addition, the previously demonstrated stereocontrol of catalyst 4.4 
suggested its potential to further differentiate the two sites within the cis-1,2-diol. Thus, 
the selection of correct catalyst enantiomers could enable a switchable and predictable 
modification between the equatorial, and more importantly, axial hydroxyl groups within 
six-membered rings (Scheme 4.8). 
  
 
 
4.5 Site-Selective Functionalization of Monosaccharides 
     To assure the successful transfer of scaffolding catalyst’s ability to distinguish 
cis-1,2-diol in the presence of other functional group motifs, we began by probing this 
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quality using cyclohexanediols as model substrates (Scheme 4.9).15 Catalyst (−)-4.5 has 
been demonstrated to promote the desymmetrization of meso-1,2-cyclohexanediol. 
However, replacing the cis-1,2-diol in the substrate with a trans-1,2-diol led to a dramatic 
drop of the yield (< 5%). Similarly, both cis- and trans-1,3-diols afforded minimal 
amounts of silylated product. Based on these observations, we expected these scaffolding 
catalysts to maintain their selective activation of cis-1,2-diol in polyol structures. 
 
 
 
     We then tested the effectiveness of the scaffolding catalysts in the context of a 
methyl--D mannose derivative 4.7 (Table 4.1). Using N-methylimidazole as the 
background catalyst, the inherent bias was observed in a transfer of triethylsilyl group, 
indicating the C2 axial hydroxyl is significantly less reactive than the other sites 
(C2:C3:C4 = 5:78:17, Table 4.1, entry 1). The use of scaffolding catalyst (+)-4.5 
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dramatically reversed this bias, with the silylation C2 hydroxyl now favored (76% yield, 
C2:C3:C4 = 90:10:<1, Table 4.1, entry 2). Notably, the absence of a cis relationship 
between C3-OH and C4-OH precluded the functionalization C4 hydroxyl, exactly as 
predicted. The lack of cis-1,2-diol in C2 protected product 4.8a also suppressed the 
second silyl transfer, minimizing the amount of bis-silylated product (9%) obtained at 
high conversion (95%). 
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     Since the site-selectivity of the scaffolding catalyst is dependent on its 
stereochemical configuration, replacing catalyst (+)-4.5 with its opposite 
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pseudo-enantiomer (−)-4.6 enabled a switch of the silylation selectivity to exclusively 
afford C3-protected regioisomer (Table 4.1, entry 3). The lower catalyst loading and 
excellent site selectivity are partially ascribed to the C3 hydroxyl being inherently most 
reactive site in mannose.  
     To demonstrate that our scaffolding catalysis was operating as proposed, we 
performed two control experiments with catalysts (+)-4.5a and (−)-4.6a, which lack the 
ability to covalently bind to mannose. Both catalysts favored the protection of C3 
hydroxyl in dramatically diminished yields (<10% yields, Table 4.1, entry 4 and 5). These 
observations were consistent with our proposed mechanism, wherein reversible covalent 
bonding is necessary for both acceleration and selectivity. 
     Following the initial success in silylation, we explored the transfer of acyl and 
sulfonyl groups. To our delight, high yields and site-selectivities were achieved for both 
equatorial and axial hydroxyl functionalization with appropriate choice of catalyst (−)-4.6 
and (+)-4.5, respectively (Table 4.1, entry 6-11). The success of these reactions are of 
particular value as acylation offers both an orthogonal protection and a functionalization 
of carbohydrates, while mesyl groups can serve to activate hydroxyl group towards a 
variety of further chemical manipulations. We thus demonstrated scaffolding catalysis to 
constitute a broad method for electrophile transfer with predictable selectivity. 
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     A proposed advantage of our functional group display recognition strategy is its 
potentially broad substrate scope. To evaluate this feature, selective functionalizations of 
other monosaccharides containing cis-1,2-diol were investigated (Table 4.2). In contrast 
to the previous mannose derivative, Methyl--L-rhamnose 4.11 consist a cis-1,2-diol 
with opposite stereochemistry. Therefore the use of catalyst (−)-4.6 and (+)-4.5 was 
predicted to result in a reversed selectivity in this case. Consistent with this prediction,  
the scaffolding catalysts allowed the toggling of selective manipulation between C2 and 
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C3 hydroxyls with all three electrophiles (Table 4,2, entry 2, 3, 5, 6, 8 and 9). Similarly, a 
switchable functionalization between C3 and C4 hydroxyls of methyl--L-arabinaose 
4.15 was achieved with (+)-4.5 and (−)-4.5, while reaction at the C2 hydroxyl was 
minimized (Table 4.3). 
 
 
     Further expansion of substrate scope to galactose derivative 4.19 enabled a reversal 
of inherent selectivity which favors the C2-OH. Selective electrophile transfers onto C3 
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hydroxyl were achieved with catalyst (+)-4.5 (Table 4.4, entry 2, 4 and 6). However, 
attempts to functionalize the axial C4 hydroxyl were unsuccessful, suggesting a further 
enlarged inherent bias in this substrate that may arise from an elevated steric hindrance of 
C4 position with the presence of the adjacent C6 methylene group. 
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To access the C4 hydroxyl of galactose, we turned to examining its interconvertible 
bicyclic derivative 1,6-anhydro--D-galactose 4.23. The resulted equatorial C4-OH was 
successfully functionalized with catalyst (−)-4.6 (Table 4.5, entry 2, 4 and 7). Notably, 
the selectivity of acyl and mesyl transfers was also switched by catalyst (+)-4.6 to favor 
the functionalization of the axial hydroxyl group in C3 position (Table 4.5, entry 5 and 8). 
Since 1,6-Anhydro-galactose cannot undergo a ring flip given its geometric constraints, 
the efficient transfer of both electrophiles to its axial hydroxyl is consistent with the 
scaffolding catalyst covalently bonding to the equatorial hydroxyl and consequently 
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activating the axial hydroxyl within the cis-1,2-diol motif (Scheme 4.10, equation 1). 
However, this observation cannot rule out the possibility of a ring flip occurring in the 
cases of unconstrained monosaccharides, which converts the targeting axial hydroxyl 
group into more reactive equatorial position prior to its functionalization (Scheme 4.10, 
equation 2). 
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4.6 Site-Selective Functionalization of Complex Molecules 
     To fully demonstrate the potential synthetic utility of our catalytic system, we 
applied it to the functionalizations of other biologically and therapeutically valuable 
molecules containing cis-1,2-diols. Helicid is a monosaccharide bearing a 
cis,cis-1,2,3-triol that has been found to affect neurological activity.18 Catalyst (−)-4.6 
and (+)-4.6 afforded selective silylation of the C2 and C4 hydroxyls within the triol, 
respectively (Table 4.6), showing a good tolerance of the tethered aldehyde on C1 
position. Notably, although the activation of the axial C3-OH could be enabled by the 
catalysts, the equatorial hydroxyls were preferentially functionalized in both cases 
presumably due to their higher intrinsic activities. Moreover, since cis,cis-1,2,3-triol is a 
common motif in multiple important compounds such as myo-inositol, this reaction 
suggested a potential application of scaffolding catalysts towards their selective 
derivatizations. 
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     We further tested our method on ribonucleosides derivatives, which contain a 
cis-1,2-diol in a five-membered ring. These compounds often require protection of the 
C2’-OH for their uses in automated RNA synthesis.19 Traditional methods relied on 
unselective protections of C2’ and C3’ hydroxyls, followed by column separations to 
obtain the desired products. With (−)-4.6, we selectively transferred a TBS group to the 
C2’-OH of uridine (Scheme 4.11), showing the possibility of direct access to this 
category of molecules. The site-selectivity was also switched by our catalysts using more 
reactive TESCl. 
 
Chapter 4, page 164 
 
 
 
     Finally, we demonstrated the power of the scaffolding catalysis by targeting the 
predictable derivatizations of complex molecules. Digoxin, a natural product isolated 
from Digitalis lanta, is a cardiac glycoside used in the treatment of congestive heart 
failure.20 Two acetyl derivatives of digoxin, -acetyldigoxin and -acetyldigoxin, are also 
current cardiac drugs with significant higher costs. With a differentiation of six hydroxyl 
groups required, a single-step site-selective acylation of the target site in digoxin could be 
a highly rewarding synthetic route, facilitating our access to its valuable therapeutic 
derivatives. Gratifying, attempt to acylate the equatorial -OH with catalyst (+)-4.6 
resulted in excellent selectivity and isolated yield (90% yield,  = <2:>98, Scheme 
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4.12). This selectivity was then overturned through the use of catalyst (−)-4.5, allowing a 
transfer of acyl group to the less reactive axial hydroxyl and yielding -acetyldigoxin in 
56 % yield ( = 91:9, Scheme 4.12). The success of this strategy was further 
strengthened by the mesylation of C6-OH and C7-OH of mupirocin methyl ester21, which 
were enabled by catalyst (−)-4.6 and (+)-4.5, respectively (Scheme 4.13). This mesylation 
methodology offers a new route to the rapid and selective derivatize of antibiotics 
containing cis-1,2-diols.. 
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4.7 Future Directions and Conclusions 
     We have demonstrated that functional group motif recognition is a powerful 
approach to enable site-selective functionalization of complex molecules. With a suite of 
chiral scaffolding catalysts targeting cis-1,2-diols via a reversible covalent bonding, high 
and switchable site-selectivities were consistently achieved in the transfer of electrophiles 
to a broad scope of monosaccharides, ribonucleosides, and other complex polyol 
structures. The selectivity offered by this catalytic system has also been proven highly 
predictable, thereby providing additional values for its application towards new 
substrates. 
We envision that this strategy could further benefit from the development of 
catalysts towards other common diol relationship (trans-1,2-diol, cis- and trans-1,3-diols 
etc.), which would enable the activation of other previously inaccessible sites in 
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polyhydroxylated frameworks, therefore further empowering synthetic chemists in the 
rapid derivatization and selective manipulation of these complex molecular architectures. 
 
4.8 Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and 
used without further purification. N,N-Diisopropylethylamine, chlorotriethylsilane, acetyl 
chloride, and methanesulfonyl chloride were purchased from Sigma Aldrich and distilled 
over CaH2 before use. Flash column chromatography was performed using EMD Silica 
Gel 60 (230-400 mesh) and ACS grade solvents as received from Fisher Scientific. All 
experiments were performed in oven or flame dried glassware under an atmosphere of 
nitrogen or argon using standard syringe techniques, except where otherwise noted. All 
reactions were run with dry, degassed solvents dispensed from a Glass Contour Solvent 
Purification System (SG Water, USA LLC).   
1H, 13C, and gCOSY NMR were performed on a Varian Gemini 400 MHz, Varian 
Gemini 500 MHz or a Varian Unity Inova 500 MHz spectrometer. Deuterated solvents 
were purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves. All 
NMR chemical shifts are reported in ppm relative to residual solvent for 1H and 13C 
NMR.  Signals are quoted as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), 
and broad singlet (br s). Coupling constants are reported in Hz. All IR spectra were 
gathered on a Bruker Alpha FT-IR equipped with a single crystal diamond ATR module 
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and values are reported in cm1. All GC analyses were performed on an SHIMADZU 
GC-2014 System. HRMS data were generated in Boston College facilities.  
     Methyl -L-rhamnose, methyl -L-arabinose, and 1,6-anhydro--D-galactose were 
purchased from Carbosynth and used as received. Digoxin was purchased from 
Carbosynth and dried under vacuum at 100 °C overnight before use. The following 
compounds were prepared following the previously reported procedures: 
Methyl-6-(tert-butyldimethylsilyloxy)--D-mannose (4.7)22 , methyl-6-(tert- 
butyldimethylsilyloxy)--D-galactose (4.19)22, 6-(tert-butyldimethylsilyloxy)-helicid 
(4.27)22， 5-dimethoxytrityloxy-uridine23 and mupirocin methyl ester24. 
     All authentic minor products were prepared according to previous procedures.14 
 
Catalyst Synthesis 
     Catalysts (−)-4.5 was prepared according to previous procedures (Chapter 2, 2.11) 
and can be purchased from Strem (Product Number: 07-1222). Catalysts (+)-4.5 was 
prepared with same procedures from D-valinol and can be purchased from Strem 
(Product Number: 07-1223). 
Catalysts (−)-4.6 was prepared according to previous procedures (Chapter 3, 3.6) 
and can be purchased from Strem (Product Number: 07-1226). Catalysts (+)-4.6 was 
prepared with same procedures from D-valinol and can be purchased from Strem 
(Product Number: 07-1227).  
Control catalyst (+)-4.5a was prepared according to previous procedures (Chapter 2, 
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2.12) from D-valinol. 
Control catalyst (−)-4.6a was prepared according to literature procedures (Chapter 
3, 3.7). 
 
Site-Selective Functionalization of Mannose (Table 4.1) 
General procedure A (Table 4.1, entry1). In a dry box, a solution of 4.7 (62 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
tert-amyl alcohol (1.0 mL) was prepared in an oven-dried glass reaction vial. The 
solution was brought out of the dry box, N,N-diisopropylethylamine (42 L, 0.24 mmol, 
1.2 eq) was added to the stirring reaction at room temperature. The reaction was stirred at 
4 °C  for 10 minutes, followed by dropwise addition of chlorotriethylsilane (40 L, 0.24 
mmol, 1.2 eq). The reaction was stirred at 4 °C for 2 hours. MeOH (50 L) was added to 
quench the reaction. The mixture was filtered through a Pasteur pipette packed with silica 
gel, followed by flush with EtOAc (15 mL). The solvent was removed under reduced 
pressure. Column chromatography (Hexane/EtOAc = 20:1 to 5:1) afforded a mixture of 
mono-functionalized products (65 mg, 77%). 1H NMR of the mixture afforded the 
selectivity (C2:C3:C4 = 5:78:17). 
Table 4.1, entry 2. The general procedure A was followed using (+)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. Column chromatography (Hexane/EtOAc = 20:1 
to 1:1) afforded the bis-silylated product (10 mg, 9%), the substrate 4.7 (3 mg, 5%), and a 
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mixture of mono-functionalized products (71 mg, 84%). 1H NMR 
of the mixture afforded the selectivity (C2:C3:C4 = 90:10:-). A 
second column chromatography was performed to isolate the pure 
product 4.8a (64 mg, 76%). 1H NMR (CDCl3, 500 MHz)  4.57 (d, 1H, J = 1.5), 3.90 (dd, 
1H, J = 2.9, 1.7), 3.88 (dd, 1H, J = 10.5, 5.1), 3.85 (dd, 1H, J = 9.0, 3.2), 3.72-3.69 (m, 
2H), 3.53-3.50 (m, 1H), 3.43 (s, 3H), 2.88 (br s, 1H), 2.11 (br s, 1H), 0.96 (t, 9H, J = 8.1), 
0.90 (s, 9H), 0.63 (q, 6H, J = 7.8), 0.089 (s, 3H), 0.086 (s, 3H). 13C NMR (CDCl3, 125 
MHz)  106.9, 83.0, 82.7, 82.4, 75.8, 69.9, 60.4, 31.5, 23.9, 12.4, 10.6, 0.3, 0.2. IR: 3428, 
2953, 2927, 2878, 1251, 1139, 1110, 1048, 1005, 833, 776, 728 cm–1. HRMS 
(DART-TOF) calcd. for C19H42O6Si2: [M+H]
+: 423.2598, found: 423.2591. 
Scale-up experiment. In a dry box, a solution of 3 (1.23 g, 4.0 mmol), (+)-1 (225 
mg, 0.80 mmol, 20 mol %), and N,N-diisopropylethylamine hydrochloride (20 mg, 0.12 
mmol, 3 mol %) in anhydrous tert-amyl alcohol (20 mL) was prepared in an oven-dried 
glass reaction vial. The solution was brought out of the dry box, 
N,N-diisopropylethylamine (836 L, 4.8 mmol, 1.2 eq) was added to the stirring reaction 
at room temperature. The reaction was stirred at 4 °C for 20 minutes, followed by 
dropwise addition of chlorotriethylsilane (806 L, 4.8 mmol, 1.2 eq). The reaction was 
stirred at 4 °C for 2 hours. MeOH (1.0 mL) was added to quench the reaction. The 
mixture was filtered through a column packed with silica gel, followed by flush with 
EtOAc (300 mL). The solvent was removed under reduced pressure. Column 
chromatography (Hexane/EtOAc = 20:1 to 1:1) afforded a mixture of 
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mono-functionalized products (1.39 g, 82%). 1H NMR of the mixture afforded the 
selectivity (C2:C3:C4 = 90:10:-). A second column chromatography was performed to 
isolate the pure product 4.8a (1.25 g, 74%). 
Table 4.1, entry 3. The general procedure A was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded the selectivity (C2:C3:C4 = -:100:-). Column 
chromatography afforded the pure product 4.9a (84 mg, >98%). 
1H NMR (CDCl3, 500 MHz)  4.71 (d, 1H, J = 1.5), 3.87 (d, 1H, J = 1.0), 3.86 (d, 1H, J 
= 0.5), 3.84 (dd, 1H, J = 8.8, 3.7), 3.75-3.73 (m, 1H), 3.70 (td, 1H, J = 9.5, 2.0), 
3.58-3.54 (m, 1H), 3.56 (s, 3H), 2.69 (d, 1H, J = 2.0), 2.57 (d, 1H, J = 1.5), 0.98 (t, 9H, J 
= 8.1), 0.90 (s, 9H), 0.67 (qd, 6H, J = 7.3, 2.5), 0.089 (s, 3H), 0.087 (s, 3H). 13C NMR 
(CDCl3, 125 MHz)  106.7, 83.9, 83.6, 83.2, 79.4, 71.4, 61.3, 32.4, 24.8, 13.3, 11.4, 1.1, 
1.0. IR: 3506, 2953, 2929, 2878, 1252, 1137, 1106, 1054, 977, 834, 778, 742, 729 cm–1. 
HRMS (DART-TOF) calcd. for C19H42O6Si2: [M+NH4]
+: 440.2864, found: 440.2874. 
Scale-up experiment. In a dry box, a solution of 4.7 (1.23 g, 4.0 mmol), (-)-4.6 (62 
mg, 0.20 mmol, 5 mol %), and N,N-diisopropylethylamine hydrochloride (20 mg, 0.12 
mmol, 3 mol %) in anhydrous tert-amyl alcohol (20 mL) was prepared in an oven-dried 
glass reaction vial. The solution was brought out of the dry box, 
N,N-diisopropylethylamine (836 L, 4.8 mmol, 1.2 eq) was added to the stirring reaction 
at room temperature. The reaction was stirred at 4 °C for 20 minutes, followed by 
dropwise addition of chlorotriethylsilane (806 L, 4.8 mmol, 1.2 eq). The reaction was 
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stirred at 4 °C for 2 hours. MeOH (1.0 mL) was added to quench the reaction. The 
mixture was filtered through a column packed with silica gel, followed by flush with 
EtOAc (300 mL). The solvent was removed under reduced pressure. 1H NMR of the 
crude mixture afforded the selectivity (C2:C3:C4 = -:99:1). Column chromatography 
(Hexane/EtOAc = 20:1 to 1:1) afforded the pure product 4.9a (1.69 g, >98%).  
Table 4.1, entry 4. The general procedure A was followed using (+)-4.5a (10 mg, 
0.040 mmol, 20 mol %) as the catalyst. Column chromatography (Hexane/EtOAc = 20:1 
to 5:1) afforded a mixture of mono-functionalized products (6 mg, 7%). 1H NMR of the 
mixture afforded the selectivity (C2:C3:C4 = 3:92:5). 
Table 4.1, entry 5. The general procedure A was followed using (-)-4.6a (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. Column chromatography (Hexane/EtOAc = 20:1 
to 5:1) afforded a mixture of mono-functionalized products (8 mg, 9%). 1H NMR of the 
mixture afforded the selectivity (C2:C3:C4 = 2:92:6). 
General procedure B (Table 4.1, entry 6). In a dry box, a solution of 4.7 (62 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (3.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) was 
added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  for 10 
minutes, followed by dropwise addition of acetyl chloride (17 L, 0.24 mmol, 1.2 eq). 
The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to quench the 
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reaction. The mixture was filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (15 mL). The solvent was removed under reduced pressure. 
1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 mol %) was added 
as standard. 1H NMR of the crude mixture afforded yield (39%) and selectivity 
(C2:C3:C4 = 9:84:7). 
Table 4.1, entry 7. The general procedure B was followed using (+)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded selectivity (C2:C3:C4 = 84:15:1). Column 
chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded the mixture 
of mono-functionalized products with 4.8b as the major product (52 mg, 74%, C2:C3:C4 
= 84:15:1). 1H NMR (CDCl3, 500 MHz)  5.07 (dd, 1H, J = 3.4, 1.5), 4.68 (d, 1H, J = 
1.5), 3.99 (d, 1H, J = 9.0), 3.92 (dd, 1H, J = 10.8, 4.9), 3.85 (dd, 1H, J = 10.5, 5.4), 3.81 
(t, 1H, J = 9.5), 3.60-3.56 (m, 1H), 3.36 (s, 3H), 3.15 (br s, 1H), 2.44 (br s, 1H), 2.11 (s, 
3H), 0.91 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H). 13C NMR (CDCl3, 125 MHz)  171.0, 87.8, 
72.0, 71.0, 70.5, 70.2, 64.5, 55.2, 26.0, 21.1, 18.4, -5.23, -5.25. IR: 3412, 2952, 2929, 
2856, 1748, 1725, 1375, 1251, 1237, 1139, 1078, 1048, 836, 777 cm–1. HRMS 
(DART-TOF) calcd. for C15H30O7Si: [M−OH]
+: 333.1733, found: 333.1743. 
Table 4.1, entry 8. The general procedure B was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude mixture afforded the 
selectivity (C2:C3:C4 = -:100:-). Column chromatography (Hexane/EtOAc = 5:1 to 2:1) 
afforded the pure product 4.9b (67 mg, 96%). 1H NMR (CDCl3, 500 MHz)  5.08 (dd, 
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1H, J = 9.8, 3.2), 4.68 (d, 1H, J = 1.7), 4.00-3.98 (m, 1H), 3.96 (t, 
1H, J = 9.5), 3.91 (dd, 1H, J = 10.5, 4.9), 3.86 (dd, 1H, J = 10.5, 
5.6), 3.67-3.63 (m, 1H), 3.38 (s, 3H), 3.07 (br s, 1H), 2.18 (br s, 
1H), 2.15 (s, 3H), 0.89 (s, 9H), 0.090 (s, 3H), 0.088 (s, 3H). 13C NMR (CDCl3, 125 MHz) 
 171.2, 100.8, 74.6, 71.5, 69.3, 68.2, 64.7, 55.2, 26.0, 21.3, 18.4, -5.3. IR: 3438, 2953, 
2929, 1716, 1369, 1249, 1107, 1048, 969, 833, 776, 732 cm–1. HRMS (DART-TOF) 
calcd. for C15H30O7Si: [M+H]
+: 351.1839, found: 351.1844. 
General procedure C (Table 4.1, entry 9). In a dry box, a solution of 4.7 (62 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (1.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) was 
added to the stirring reaction at room temperature. The reaction was stirred at -15 °C  for 
10 minutes, followed by dropwise addition of methanesulfonyl chloride (19 L, 0.24 
mmol, 1.2 eq). The reaction was stirred at -15 °C for 4 hours. MeOH (50 L) was added 
to quench the reaction. The mixture was filtered through a Pasteur pipette packed with 
silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. Column chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded a 
mixture of mono-functionalized products (53 mg, 68%). GC Analysis (Shimazu 
SHRXI-5MS 15 m, 150 °C for 3 min, 10 °C/min to 200 °C, 200°C for 6 min, 15 psi., tC2 
= 10.50 min, tC3 = 11.04 min, tC4 = 9.50 min) of the mixture afforded selectivity 
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(C2:C3:C4 = 22:56:22). 
Table 4.1, entry 10. The general procedure C was followed using (+)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. GC Analysis of the crude 
mixture afforded selectivity (C2:C3:C4 = 91:8:1). Column 
chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded the pure 
product 4.8c (62 mg, 80%). 1H NMR (CDCl3, 500 MHz)  4.81 (d, 1H, J = 1.7), 4.78 (dd, 
1H, J = 3.2, 1.7), 4.00 (dd, 1H, J = 9.5, 3.2), 3.91 (dd, 1H, J = 10.3, 4.9), 3.83 (dd, 1H, J 
= 10.5, 6.4), 3.78 (t, 1H, 9.3), 3.60-3.56 (m, 1H), 3.38 (s, 3H), 3.13 (s, 3H), 0.90 (s, 9H), 
0.11 (s, 3H), 0.10 (s, 3H). 13C NMR (CDCl3, 125 MHz)  99.2, 7.5, 71.0, 70.6, 69.6, 65.0, 
55.4, 38.6, 26.0, 18.4, -5.3. IR: 3457, 2928, 2856, 1352, 1175, 1138, 1069, 962, 907, 833, 
777, 523 cm–1. HRMS (DART-TOF) calcd. for C14H30O8SSi: [M+H]
+: 387.1509, found: 
387.1510. 
Table 4.1, entry 11. The general procedure C was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. GC Analysis of the crude 
mixture afforded selectivity (C2:C3:C4 = -:100:-). Column 
chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded the pure 
product 4.9c (75 mg, 97%). 1H NMR (CDCl3, 500 MHz)  4.79 (dd, 1H, J = 9.5, 3.2), 
4.72 (d, 1H, J = 1.7), 4.14-4.12 (m, 1H), 4.07 (td, 1H, J = 9.5, 2.0), 3.95 (dd, 1H, J = 10.3, 
4.9), 3.85 (dd, 1H, J = 10.0, 7.1), 3.68-3.63 (m, 1H), 3.49 (d, 1H, J = 2.2), 3.38 (s, 3H), 
3.18 (s, 3H), 2.57 (d, 1H, J = 4.7), 0.90 (s, 9H), 0.111 (s, 3H), 0.107 (s, 3H). 13C NMR 
(CDCl3, 125 MHz)  100.7, 82.7, 70.5, 10.1, 68.9, 65.5, 55.3, 38.6, 26.0, 18.4, -5.3, -5.4. 
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IR: 3497, 2930, 2857, 1350, 1253, 1175, 1135, 1109, 1058, 963, 837, 779 cm–1. HRMS 
(DART-TOF) calcd. for C14H30O8SSi: [M+H]
+: 387.1509, found: 387.1500. 
 
Site-Selective Functionalization of Rhamnose (Table 4.2). 
General procedure D (Table 4.2, entry 1).In a dry box, a solution of 4.11 (36 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
tert-amyl alcohol (1.0 mL) was prepared in an oven-dried glass reaction vial. The 
solution was brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 
mmol, 1.2 eq) was added to the stirring reaction at room temperature. The reaction was 
stirred at 4 °C  for 10 minutes, followed by dropwise addition of chlorotriethylsilane (40 
L, 0.24 mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was 
added to quench the reaction. The mixture was filtered through a Pasteur pipette packed 
with silica gel, followed by flushing with EtOAc (15 mL). The solvent was removed 
under reduced pressure. Column chromatography (Hexane/EtOAc = 10:1 to 3:1) afforded 
a mixture of mono-functionalized products (46 mg, 78%). Selectivity of the mixture was 
determined by 1H NMR (C2:C3:C4 = 7:79:14). 
Table 4.2, entry 2. The general procedure D was followed using (−)-4.6 (12 mg, 
0.040 mmol, 20 mol %) as the catalyst. Column chromatography (Hexane/EtOAc = 10:1 
to 3:1) afforded a mixture of mono-functionalized products with 4.12a as the major 
product (52 mg, 88%). 1H NMR of the mixture afforded the selectivity (C2:C3:C4 = 
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89:11:-). A second column chromatography was performed for 
characterization of the pure product. 1H NMR (CDCl3, 500 MHz) 
 4.54 (d, 1H, J = 1.5), 3.91 (dd, 1H, J = 3.7, 1.7), 3.62-3.58 (m, 
2H), 3.38 (t, 1H, J = 9.3), 3.34 (s, 3H), 2.29 (br s, 1H), 2.03 (d, 1H, J = 10.5), 1.31 (d, 3H, 
J = 6.4), 0.97 (t, 9H, J = 6.0), 0.64 (q, 6H, J = 8.1). 13C NMR (CDCl3, 125 MHz)  101.4, 
74.0, 72.2, 72.1, 67.9, 55.0, 17.8, 6.9, 5.1. IR: 3416, 2953, 2877, 2831, 1458, 1239, 1052, 
1005, 829, 727, 630 cm–1. HRMS (DART-TOF) calcd. for C13H28O5Si: [M+NH4]
+: 
310.2050, found: 310.2049. 
Table 4.2, entry 3. The general procedure D was followed using (+)-4.5 (2.8 mg, 
0.010 mmol, 5 mol %) as the catalyst. The reaction was stirred at 
4 °C for 20 hours. Selectivity was determined by 1H NMR of the 
crude reaction mixture (C2:C3:C4 = -:100:-). Column 
chromatography (Hexane/EtOAc = 10:1 to 3:1) afforded the pure product 4.13a (59 
mg, >98%). 1H NMR (CDCl3, 500 MHz)  4.68 (d, 1H, J = 1.2), 3.80 (dd, 1H, J = 8.8, 
3.7), 3.78 (dd, 1H, J = 3.7, 1.5), 3.65-3.62 (m, 1H), 3.46 (td, 1H, J = 9.1, 2.9), 3.36 (s, 
3H), 2.54 (d, 1H, J = 1.5), 2.04 (d, 1H, J = 3.4), 1.32 (d, 3H, J = 6.4), 0.98 (t, 9H, J = 8.1), 
0.67 (q, 6H, J = 8.1). 13C NMR (CDCl3, 125 MHz)  100.4, 73.4, 73.3, 71.8, 67.5, 55.0, 
17.8, 6.9, 5.1. IR: 3477, 2954, 2911, 2833, 1458, 1238, 1107, 972, 852, 727, 616 cm–1. 
HRMS (DART-TOF) calcd. for C13H28O5Si: [M+ H]
+: 293.1784, found: 293.1780. 
General procedure E (Table 4.2, entry 4). In a dry box, a solution of 4.11 (36 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
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N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (1.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  
for 10 minutes, followed by dropwise addition of acetyl chloride (17 L, 0.24 mmol, 1.2 
eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to quench the 
reaction. The mixture was filtered through a Pasteur pipette packed with silica gel, 
followed by flushing with EtOAc (15 mL). The solvent was removed under reduced 
pressure. Column chromatography (Hexane/EtOAc = 5:1 to 1:1) afforded a mixture of 
mono-functionalized products (37 mg, 83%). Selectivity of the mixture was determined 
by 1H NMR (C2:C3:C4 = 12:79:9). 
     Table 4.2, entry 5. The general procedure E was followed using (−)-4.6 (12 mg, 
0.040 mmol, 20 mol %) as the catalyst in anhydrous THF (3.0 mL). 
Column chromatography (Hexane/EtOAc = 5:1 to 1:1) afforded the 
mixture of mono-functionalized products (32 mg, 73%) with 4.12b 
as the major product. Selectivity was determined by 1H NMR of the isolated mixture 
(C2:C3:C4 = 84:14:2). 1H NMR (CDCl3, 500 MHz)  5.08 (dd, 1H, J = 3.4, 1.5), 4.63 (d, 
1H, J = 1.5), 3.92 (dd, 1H, J = 9.5, 3.4), 3.67-3.63 (m, 1H), 3.45 (t, 1H, J = 9.5), 3.37 (s, 
3H), 3.16 (br s, 2H), 2.14 (s, 3H), 1.34 (d, 3H, J = 6.1). 13C NMR (CDCl3, 125 MHz)  
171.3, 98.7, 73.3, 72.6, 70.3, 68.1, 55.2, 21.2, 17.7. IR: 3409, 2934, 2837, 1747, 1726, 
1376, 1237, 1135, 1076, 1054, 973, 838, 803 cm–1. HRMS (DART-TOF) calcd. for 
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C9H16O6: [M+NH4]
+: 238.1291, found: 238.1294. 
Table 4.2, entry 6. The general procedure E was followed using (+)-4.5 (2.8 mg, 
0.010 mmol, 5 mol %) as the catalyst in anhydrous THF (3.0 mL). 
1H NMR of the crude reaction mixture afforded the selectivity 
(C2:C3:C4 = 1:99:-). Column chromatography (Hexane/EtOAc = 5:1 
to 1:1) afforded the pure product 4.13b (43 mg, 98%). 1H NMR (CDCl3, 500 MHz)  
5.04 (dd, 1H, J = 9.8, 3.2), 4.68 (d, 1H, J = 1.7), 4.05-4.03 (m, 1H), 3.74-3.71 (m, 1H), 
3.64 (td, 1H, J = 9.5, 5.4), 3.41 (s, 3H), 2.21 (d, 1H, J = 5.6), 2.19 (s, 3H), 2.04 (d, 1H, J 
= 5.1), 1.37 (d, 3H, J = 6.1). 13C NMR (CDCl3, 125 MHz)  171.6, 100.6, 75.2, 71.7, 
69.9, 68.6, 55.2, 21.4, 17.8. IR: 3437, 2922, 2837, 1717, 1450, 1372, 1249, 1132, 1056, 
987, 973, 805 cm–1. HRMS (DART-TOF) calcd. for C9H16O6: [M+NH4]
+: 238.1291, 
found: 238.1283. 
General procedure F (Table 4.2, entry 7). In a dry box, a solution of 4.11 (36 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (1.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  
for 10 minutes, followed by dropwise addition of methanesulfonyl chloride (19 L, 0.24 
mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to 
quench the reaction. The mixture was filtered through a Pasteur pipette packed with silica 
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gel, followed by flushing with EtOAc (15 mL). The solvent was removed under reduced 
pressure. Column chromatography (Hexane/EtOAc = 5:1 to 1:1) afforded a mixture of 
mono-functionalized products (37 mg, 72%). Selectivity of the mixture was determined 
by GC analysis (Shimazu SHRXI-5MS 15 m, 120 °C for 2 min, 1 °C/min to 140 °C, 
10 °C/min to 200 °C, 200°C for 2 min, 15 psi., tC2 = 15.07 min, tC3 = 16.30 min, tC4 = 
14.46 min) (C2:C3:C4 = 24:57:19). 
Table 4.2, entry 8. The general procedure F was followed using (−)-4.6 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. The reaction was stirred at 
-15 °C for 4 hours. Selectivity was determined by GC analysis of 
the crude reaction mixture (C2:C3:C4 = 92:8:-). Column 
chromatography (Hexane/EtOAc = 5:1 to 1:1) afforded the pure product 4.12c (42 mg, 
82%). 1H NMR (CDCl3, 500 MHz)  4.82 (dd, 1H, J = 3.2, 1.7), 4.79 (d, 1H, J = 1.7), 
3.93 (d, 1H, J = 9.5), 3.68-3.62 (m, 1H), 3.44 (t, 1H, J = 9.5), 3.38 (s, 3H), 3.15 (s, 3H), 
3.03 (br s, 1H), 2.74 (br s, 1H), 1.33 (d, 3H, J = 6.4). 13C NMR (CDCl3, 125 MHz)  
99.0, 79.0, 73.2, 69.8, 68.3, 55.3, 38.7, 17.6. IR: 3454, 2935, 2842, 1451, 1346, 1173, 
1133, 1051, 963, 907, 855, 637, 529 cm–1. HRMS (DART-TOF) calcd. for C8H16O7S: 
[M+NH4]
+: 274.0961, found: 274.0974. 
Table 4.2, entry 9. The general procedure F was followed using (+)-4.5 (2.8 mg, 
0.010 mmol, 5 mol %) as the catalyst. Selectivity was determined by GC analysis of the 
crude reaction mixture (C2:C3:C4 = 1:99:-). Column chromatography (Hexane/EtOAc = 
5:1 to 1:1) afforded the pure product 4.13c (51 mg, >98%). 1H NMR (CDCl3, 500 MHz) 
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 4.76 (dd, 1H, J = 9.1, 3.2), 4.70 (d, 1H, J = 1.7), 4.19 (br s, 1H), 
3.77-3.70 (m, 2H), 3.40 (s, 3H), 3.18 (s, 3H), 2.73 (br s, 1H), 2.71 
(br s, 1H), 1.38 (d, 3H, J = 5.9). 13C NMR (CDCl3, 125 MHz)  
100.6, 82.8, 70.8, 70.5, 68.4, 55.2, 38.6, 17.8. IR: 3462, 2936, 2839, 1452, 1348, 1198, 
1150, 1055, 959, 860, 799, 530, 513 cm–1. HRMS (DART-TOF) calcd. for C8H16O7S: 
[M+NH4]
+: 274.0961, found: 274.0964. 
 
Site-Selective Functionalization of Arabinose (Table 4.3). 
General procedure G (Table 4.3, entry 1). In a dry box, a solution of 4.15 (33 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
tert-amyl alcohol (1.0 mL) was prepared in an oven-dried glass reaction vial. The 
solution was brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 
mmol, 1.2 eq) was added to the stirring reaction at room temperature. The reaction was 
stirred at 4 °C  for 10 minutes, followed by dropwise addition of chlorotriethylsilane (40 
L, 0.24 mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was 
added to quench the reaction. The mixture was filtered through a Pasteur pipette packed 
with silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. 1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 
mol %) was added as standard. 1H NMR of the crude mixture afforded the yield (39%) 
and selectivity (C2:C3:C4 = 27:14:59). 
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Table 4.3, entry 2. The general procedure G was followed using (−)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. Reaction was performed in 
anhydrous tert-amyl alcohol (3.0 mL). 1H NMR of the crude 
mixture afforded the selectivity (C2:C3:C4 = -:3:97).Column 
chromatography (Hexane/EtOAc = 4:1 to 3:1) afforded the pure product 4.18a (51 mg, 
92%). 1H NMR (CDCl3, 500 MHz)  4.75 (d, 1H, J = 3.2), 4.00 (dd, 1H, J = 5.6, 3.4), 
3.79-3.78 (m, 1H), 3.74-3.72 (m, 2H), 3.57 (dd, 1H, J = 12.2, 3.4), 3.42 (s, 3H), 2.27 (d, 
1H, J = 6.1), 2.23 (br s, 1H), 0.97 (t, 9H, J = 8.1), 0.63 (q, 6H, J = 7.8). 13C NMR 
(CDCl3, 125 MHz)  100.0, 70.8, 70.3, 69.8, 63.6, 55.9, 6.9, 5.1. IR: 3422, 2952, 2911, 
2875, 1070, 1045, 1002, 890, 877, 798, 725 cm–1. HRMS (DART-TOF) calcd. for 
C12H26O5Si: [M+H]
+: 279.1628, found: 279.1625. 
Table 4.3, Entry 3. The general procedure G was followed using (+)-4.5 (2.8 mg, 
0.010 mmol, 5mol %) as the catalyst. 1H NMR of the crude 
mixture afforded the selectivity (C2:C3:C4 = -:98:2).Column 
chromatography (Hexane/EtOAc = 4:1 to 3:1) afforded the pure 
product 4.17a (54 mg, 97%). 1H NMR (CDCl3, 500 MHz)  4.75 (d, 1H, J = 3.7), 3.82 
(dd, 1H, J = 8.8, 3.7), 3.79 (t, 1H, J = 1.5), 3.75 (td, 1H, J = 8.6, 3.4), 3.72 (d, 2H, J = 
1.7), 3.41 (s, 3H), 2.65 (s, 1H), 1.93 (d, 1H, J = 8.3), 0.98-0.95 (m, 9H), 0.68-0.63 (m, 
6H). 13C NMR (CDCl3, 125 MHz)  100.2, 71.9, 70.0, 69.9, 61.7, 55.7, 6.9, 5.1. IR: 
3458, 2952, 2911, 2875, 1062, 998, 848, 742 cm–1. HRMS (DART-TOF) calcd. for 
C12H26O5Si: [M+H]
+: 279.1628, found: 279.1624. 
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General procedure H (Table 4.3, entry 4). In a dry box, a solution of 4.15 (33 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (3.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  
for 10 minutes, followed by dropwise addition of acetyl chloride (17 L, 0.24 mmol, 1.2 
eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to quench the 
reaction. The mixture was filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (15 mL). The solvent was removed under reduced pressure. 
1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 mol %) was added 
as standard. 1H NMR of the crude mixture afforded the yield (6%) and selectivity 
(C2:C3:C4 = 22:72:6). 
     Table 4.3, entry 5. The general procedure H was followed using (−)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. Reaction was stirred for 8 
hours. 1H NMR of the crude mixture afforded the selectivity 
(C2:C3:C4 = 5:9:86).Column chromatography (CH2Cl2/MeOH = 
100:1 to 20:1) afforded the mixture of mono-functionalized products with 4.18b as the 
major product (25 mg, 61%). 1H NMR (acetone-d6, 500 MHz)  5.08-5.07 (m, 1H), 4.69 
(d, 1H, J = 3.4), 3.88 (dd, 1H, J = 9.8, 3.4), 3.80 (dd, 1H, J = 12.7, 1.5), 3.72 (dd, 1H, J = 
9.8, 2.9), 3.57 (dd, 1H, J = 12.7, 2.4), 3.35 (s, 3H), 2.04 (s, 3H). 13C NMR (acetone-d6, 
Chapter 4, page 184 
125 MHz)  170.9, 101.6, 72.7, 70.8, 69.1, 61.4, 55.8, 21.1. IR: 3429, 2937, 1734, 1241, 
1077, 1038, 997 cm–1. HRMS (DART-TOF) calcd. for C8H14O6: [M+H]
+: 207.0869, 
found: 207.0861. 
     Table 4.3, entry 6. The general procedure H was followed using (+)-4.5 (2.8 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded the selectivity (C2:C3:C4 = 3:96:1). Column 
chromatography (Hex/EtOAc = 2:1 to 1:2) afforded the pure 
product 4.17b (34 mg, 83%). 1H NMR (acetone-d6, 500 MHz)  4.96 (dd, 1H, J = 10.3, 
3.4), 4.70 (d, 1H, J = 3.7), 4.12 (d, 1H, J = 3.2), 4.00 (s, 1H), 3.98-3.96 (m, 1H), 3.79 (dd, 
1H, J = 12.5, 1.5), 3.56 (dd, 1H, J = 12.2, 2.4), 3.52 (d, 1H, J = 8.8), 3.37 (s, 3H), 2.02 (s, 
3H). 13C NMR (acetone-d6, 125 MHz)  171.1, 101.8, 74.0, 68.2, 67.6, 63.7, 55.6, 21.1. 
IR: 3436, 2927, 1737, 1716, 1240, 1141, 1057, 997cm–1. HRMS (DART-TOF) calcd. for 
C8H14O6: [M+H]
+: 207.0869, found: 207.0878. 
General procedure I (Table 4.3, entry 7). In a dry box, a solution of 4.15 (33 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (1.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  
for 10 minutes, followed by dropwise addition of methanesulfonyl chloride (19 L, 0.24 
mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to 
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quench the reaction. The mixture was filtered through a Pasteur pipette packed with silica 
gel, followed by flush with EtOAc (15 mL). The solvent was removed under reduced 
pressure. Column chromatography (Hex/EtOAc = 1:1 to 1:3) afforded the mixture of 
mono-functionalized products (13 mg, 27%). 1H NMR of the mixture afforded the 
selectivity (C2:C3:C4 = 68:23:9). 
Table 4.3, entry 8. The general procedure I was followed using (−)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. Column chromatography 
(Hex/EtOAc = 1:1 to 1:3) afforded the mixture of 
mono-functionalized products (45 mg, 93%). 1H NMR of the 
mixture afforded the selectivity (C2:C3:C4 = 3:10:87). A second column chromatography 
(Hex/EtOAc = 1:1 to 1:3) afforded 4.18c for characterizations. 1H NMR (acetone-d6, 
500 MHz)  4.88-4.87 (m, 1H), 4.71 (d, 1H, J = 3.4), 3.96 (dd, 1H, J = 10.0, 3.4), 3.91 
(dd, 1H, J = 13.0, 1.0), 3.74 (dd, 1H, J = 13.0, 2.2), 3.69 (dd, 1H, J = 10.0, 3.7), 3.36 (s, 
3H), 3.15 (s, 3H). 13C NMR (acetone-d6, 125 MHz)  101.5, 81.5, 70.3, 69.0, 62.2, 55.9, 
38.6. IR: 3439, 2939, 1337, 1173, 1076, 975, 925, 895 cm–1. HRMS (DART-TOF) calcd. 
for C7H14O7S: [M+NH4]
+: 260.0804, found: 260.0809. 
     Table 4.3, entry 9. The general procedure I was followed using (+)-4.5 (2.8 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded the selectivity (C2:C3:C4 = 1:92:7). Column 
chromatography (Hex/EtOAc = 1:1 to 1:3) afforded the pure 
product 4.17c (44 mg, 91%). 1H NMR (acetone-d6, 500 MHz)  4.75 (d, 1H, J = 3.2), 
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4.66 (dd, 1H, J = 9.0, 3.2), 4.47 (d, 1H, J = 2.7), 4.13 (s, 1H), 4.04-4.02 (m, 2H), 3.82 (dd, 
1H, J = 12.2, 1.2), 3.61 (dd, 1H, J = 12.5, 2.2), 3.38 (s, 3H), 3.14 (s, 3H). 13C NMR 
(acetone-d6, 125 MHz)  72.1, 52.8, 39.8, 38.0, 34.1, 26.0, 9.0. IR: 3460, 1334, 1171, 
1140, 1061, 1018, 972, 860 cm–1. HRMS (DART-TOF) calcd. for C7H14O7S: [M+NH4]
+: 
260.0804, found: 260.0802. 
 
Site-Selective Functionalization of Galactose (Table 4.4). 
General procedure J (Table 4.4, entry 1). In a dry box, a solution of 4.19 (62 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
tert-amyl alcohol (1.0 mL) was prepared in an oven-dried glass reaction vial. The 
solution was brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 
mmol, 1.2 eq) was added to the stirring reaction at room temperature. The reaction was 
stirred at 4 °C  for 10 minutes, followed by dropwise addition of chlorotriethylsilane (40 
L, 0.24 mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was 
added to quench the reaction. The mixture was filtered through a Pasteur pipette packed 
with silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. 1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 
mol %) was added as standard. 1H NMR of the crude mixture afforded yield (77%) and 
selectivity (C2:C3:C4 = 86:14:-). 
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     Table 4.4, entry 2. The general procedure J was followed using (+)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded selectivity (C2:C3:C4 = 6:94:-). Column 
chromatography (Hexane/EtOAc = 20:1 to 5:1) afforded the pure 
product 4.21a (80 mg, 95%). 1H NMR (CDCl3, 500 MHz)  4.78 (d, 1H, J = 3.2), 
3.88-3.84 (m, 2H), 3.80-3.74 (m, 3H), 3.41 (s, 3H), 2.58 (s, 1H), 1.87 (dd, 1H, J = 5.1, 
3.7), 0.97 (t, 9H, J = 8.1), 0.89 (s, 9H), 0.66 (qd, 6H, J = 7.6, 3.4), 0.08 (s, 6H). 13C NMR 
(CDCl3, 125 MHz)  99.8, 72.7, 70.4, 70.0, 69.9, 62.5, 55.4, 26.0, 18.5, 7.0, 5.1, -5.1, 
-5.3. IR: 3566, 2953, 2930, 2877, 1250, 1086, 1053, 835, 744 cm–1. HRMS (DART-TOF) 
calcd. for C19H42O6Si2: [M+H]
+: 423.2598, found: 423.2612. 
General procedure K (Table 4.4, entry 3. In a dry box, a solution of 4.19 (62 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (3.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  
for 10 minutes, followed by dropwise addition of acetyl chloride (17 L, 0.24 mmol, 1.2 
eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to quench the 
reaction. The mixture was filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (15 mL). The solvent was removed under reduced pressure. 
1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 mol %) was added 
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as standard. 1H NMR of the crude mixture afforded yield (26%) and selectivity 
(C2:C3:C4 = 42:58:-). 
Table 4.4, entry 4. The general procedure K was followed using (+)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded selectivity (C2:C3:C4 = 19:81:-). Column 
chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded the mixture 
of mono-functionalized products with 4.21b as the major product (67 mg, 96%). 1H 
NMR (CDCl3, 500 MHz)  5.03 (dd, 1H, J = 10.0, 2.9), 4.84 (d, 1H, J = 3.9), 4.18 (s, 
1H), 4.06 (td, 1H, J = 10.8, 3.9), 3.91 (dd, 1H, J = 10.8, 4.9), 3.87 (dd, 1H, J = 10.8, 4.2), 
3.76 (t, 1H, J = 4.6), 3.43 (s, 3H), 3.25 (d, 1H, J = 2.0), 2.16 (s, 1H), 1.99 (d, 1H, J = 
11.0), 0.89 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H). 13C NMR (CDCl3, 125 MHz)  171.3, 
100.0, 73.7, 69.6, 69.3, 67.5, 64.0, 55.6, 26.0, 21.4, 18.4, -5.3, -5.4. IR: 3428, 2953, 2929, 
2856, 1739, 1721, 1248, 1146, 1083, 1050, 836, 776 cm–1. HRMS (DART-TOF) calcd. 
for C15H30O7Si: [M−OH]
+: 333.1733, found: 333.1743. 
General procedure L (Table 4.4, entry 5). In a dry box, a solution of 4.19 (62 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (1.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at -15 °C  
for 10 minutes, followed by dropwise addition of methanesulfonyl chloride (19 L, 0.24 
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mmol, 1.2 eq). The reaction was stirred at -15 °C for 4 hours. MeOH (50 L) was added 
to quench the reaction. The mixture was filtered through a Pasteur pipette packed with 
silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. Column chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded the 
mixture of mono-functionalized products (48 mg, 62%). 1H NMR of the mixture afforded 
the selectivity (C2:C3:C4 = 76:24:-). 
     Table 4.4, entry 6. The general procedure L was followed using (+)-4.5 (11 mg, 
0.040 mmol, 20 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded selectivity (C2:C3:C4 = -:100:-). Column 
chromatography (Hexane/EtOAc = 5:1 to 2:1) afforded the pure 
product 4.21c (57 mg, 74%). 1H NMR (CDCl3, 500 MHz)  4.85 (d, 1H, J = 4.2), 4.73 
(dd, 1H, J = 10.0, 2.9), 4.30 (s, 1H), 4.12 (td, 1H, J = 10.0, 4.2), 3.89 (dd, 1H, J = 10.8, 
5.4), 3.85 (dd, 1H, J = 10.8, 4.9), 3.76 (t, 1H, J = 5.1), 3.43 (s, 3H), 3.25 (d, 1H, J = 2.4), 
3.18 (s, 3H), 2.39 (d, 1H, J = 10.3), 0.88 (s, 9H), 0.08 (s, 6H). 13C NMR (CDCl3, 125 
MHz)  99.8, 82.3, 70.0, 69.7, 67.3, 63.3, 55.6, 39.0, 26.0, 18.4, -5.31, -5.32. IR: 3468, 
2952, 2929, 2856, 1350, 1172, 1084, 1047, 961, 834, 776, 731, 526, 489 cm–1. HRMS 
(DART-TOF) calcd. for C14H30O8SSi: [M+H]
+: 387.1509, found: 387.1505. 
 
Site-Selective Functionalization of 1,6-Anhydro-Galactose (Table 4.5). 
General procedure M (Table 4.5, entry 1). In a dry box, a solution of 4.23 (32 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
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N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
tert-amyl alcohol (1.0 mL) was prepared in an oven-dried glass reaction vial. The 
solution was brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 
mmol, 1.2 eq) was added to the stirring reaction at room temperature. The reaction was 
stirred at 4 °C  for 10 minutes, followed by dropwise addition of chlorotriethylsilane (40 
L, 0.24 mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was 
added to quench the reaction. The mixture was filtered through a Pasteur pipette packed 
with silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. 1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 
mol %) was added as standard. 1H NMR of the crude mixture afforded the yield (51%) 
and selectivity (C2:C3:C4 = 91:-:9). 
     Table 4.5, entry 2. The general procedure M was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude 
mixture afforded the selectivity (C2:C3:C4 = 1:-:99). Column 
chromatography (Hexane/EtOAc = 3:1) afforded the pure product 
4.26a (54 mg, 98%). 1H NMR (CDCl3, 500 MHz)  5.36 (t, 1H, J = 1.5), 4.24 (d, 2H, J = 
7.1), 4.06 (t, 1H, J = 4.7), 3.86-3.85 (m, 1H), 3.83 (d, 1H, J = 8.3), 3.63 (dd, 1H, J = 6.4, 
5.9), 2.88 (s, 1H), 2.32 (d, 1H, J = 8.6), 0.96 (t, 9H, J = 8.1), 0.65 (q, 6H, J = 7.7). 13C 
NMR (CDCl3, 125 MHz)  101.6, 74.7, 71.6, 71.2, 65.8, 63.9, 6.8, 4.9. IR: 3430, 2956, 
2878, 1240, 1136, 1099, 1051, 1011, 938, 847, 809, 765, 744, 456 cm–1. HRMS 
(DART-TOF) calcd. for C12H24O5Si: [M+H]
+: 277.1471, found: 277.1474. 
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General procedure N (Table 4.5, entry 3). In a dry box, a solution of 4.23 (32 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (3.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at 4 °C  
for 10 minutes, followed by dropwise addition of acetyl chloride (17 L, 0.24 mmol, 1.2 
eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was added to quench the 
reaction. The mixture was filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (15 mL). The solvent was removed under reduced pressure. 
1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 mol %) was added 
as standard. 1H NMR of the crude mixture afforded the yield (53%) and selectivity 
(C2:C3:C4 = 75:8:17). 
Table 4.5, entry 4. The general procedure N was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude mixture 
afforded the selectivity (C2:C3:C4 = -:3:97). Column 
chromatography (Hexane/EtOAc = 1:1 to 1:2) afforded the pure 
product 4.26b (38 mg, 93%). 1H NMR (acetone-d6, 500 MHz)  5.26 (s, 1H), 5.00 (br s, 
1H), 4.41 (dd, 2H, J = 6.9, 3.2), 4.25 (d, 1H, J = 6.9), 4.07 (t, 2H, J = 1.0), 3.68 (d, 1H, J 
= 6.9), 3.54 (t, 1H, J = 5.9), 2.04 (s, 3H). 13C NMR (acetone-d6, 125 MHz)  170.4, 
103.1, 73.9, 73.1, 70.8, 68.9, 64.8, 20.9. IR: 3432, 2961, 2905, 1727, 1432, 1373, 1238, 
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1132, 1050, 975, 928, 852, 700, 463 cm–1. HRMS (DART-TOF) calcd. for C8H12O6: 
[M+H]+: 205.0712, found: 205.0717. 
Table 4.5, entry 5. The general procedure N was followed using (+)-4.6 (12 mg, 
0.040 mmol, 20 mol %) as the catalyst. 1H NMR of the crude mixture 
afforded the selectivity (C2:C3:C4 = 2:81:17). Column 
chromatography (Hexane/EtOAc = 1:1 to 1:2) afforded the pure 
product 4.25b (30 mg, 73%, C2:C3:C4 = 2:81:7). 1H NMR (CDCl3, 500 MHz)  5.22 (t, 
1H, J = 1.2), 5.03 (dq, 1H, J = 5.1, 1.2), 4.39 (d, 1H, J = 7.1), 4.32 (d, 2H, J = 6.4), 4.24 
(d, 1H, J = 7.1), 4.15-4.12 (m, 1H), 3.56-3.53 (m, 2H), 2.03 (s, 3H). 13C NMR (CDCl3, 
125 MHz)  170.7, 102.2, 75.7, 73.4, 71.5, 64.8, 64.1, 21.1. IR: 3418, 2963, 2904, 1723, 
1435, 1240, 1137, 1066, 1040, 971, 852, 696, 438 cm–1. HRMS (DART-TOF) calcd. for 
C8H12O6: [M+H]
+: 205.0712, found: 205.0721. 
General procedure O (Table 4.5, entry 6). In a dry box, a solution of 4.23 (32 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
THF (3.0 mL) was prepared in an oven-dried glass reaction vial. The solution was 
brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 eq) 
was added to the stirring reaction at room temperature. The reaction was stirred at -15 °C  
for 10 minutes, followed by dropwise addition of methanesulfonyl chloride (19 L, 0.24 
mmol, 1.2 eq). The reaction was stirred at -15 °C for 4 hours. MeOH (50 L) was added 
to quench the reaction. The mixture was filtered through a Pasteur pipette packed with 
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silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. 1,3,5-trimethoxybenzene (50 L of 0.40 M in CDCl3, 0.020 mmol, 10 
mol %) was added as standard. 1H NMR of the crude mixture afforded the yield (50%) 
and selectivity (C2:C3:C4 = 75:6:19). 
Table 4.5, entry 7. The general procedure O was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. 1H NMR of the crude mixture 
afforded the selectivity (C2:C3:C4 = -:1:99). Column 
chromatography (Hexane/EtOAc = 1:1 to 1:2) afforded the pure 
product 4.26c (42 mg, 88%). 1H NMR (acetone-d6, 500 MHz)  5.28 (t, 1H, J = 1.5), 
4.88 (t, 1H, J = 4.4), 4.56 (t, 1H, J = 4.2), 4.44 (d, 1H, J = 7.1), 4.38-4.37 (m, 2H), 4.15 
(br s, 1H), 3.75 (br s, 1H), 3.60 (td, 1H, J = 5.1, 0.5), 3.22 (s, 3H). 13C NMR (acetone-d6, 
125 MHz)  103.3, 75.0, 74.5, 74.0, 71.8, 64.9, 38.8. IR: 3458, 2937, 1340, 1172, 1132, 
1055, 1000, 970, 901, 818, 525, 459 cm–1. HRMS (DART-TOF) calcd. for C7H12O7S: 
[M+NH4]
+: 258.0648, found: 258.0652. 
Table 4.5, entry 8. The general procedure O was followed using (+)-4.6 (12 mg, 
0.040 mmol, 20 mol %) as the catalyst. 1H NMR of the crude mixture 
afforded the selectivity (C2:C3:C4 = -:75:25). Column 
chromatography (Hexane/EtOAc = 1:1 to 1:2) afforded the pure 
product 4.25c (33 mg, 69%). 1H NMR (CDCl3, 500 MHz)  5.26 (s, 1H), 4.74 (dd, 1H, J 
= 2.9, 1.5), 4.62 (d, 1H, J = 6.9), 4.37 (t, 1H, J = 4.4), 4.24 (d, 1H, J = 7.3), 4.22 (dd, 1H, 
J = 6.4, 4.4), 3.83 (d, 1H, J = 6.9), 3.56 (t, 1H, J = 6.4), 3.13 (s, 3H). 13C NMR (CDCl3, 
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125 MHz) 100.9, 81.2, 75.6, 72.2, 64.7, 64.1, 38.3. IR: 3462, 2939, 1333, 1171, 1138, 
1068, 1001, 937, 849, 760, 527, 468 cm–1. HRMS (DART-TOF) calcd. for C7H12O7S: 
[M+NH4]
+: 258.0648, found: 258.0651. 
 
Site-Selective Functionalization of Helicid (Table 4.6). 
General procedure P (Table 4.6, entry 1). In a dry box, a solution of 4.27 (80 mg, 
0.20 mmol), catalyst (N-methylimidazole, 3.2 L, 0.040 mmol, 20 mol %), and 
N,N-diisopropylethylamine hydrochloride (1.0 mg, 0.0060 mmol, 3 mol %) in anhydrous 
tert-amyl alcohol (1.0 mL) was prepared in an oven-dried glass reaction vial. The 
solution was brought out of the dry box, and N,N-diisopropylethylamine (42 L, 0.24 
mmol, 1.2 eq) was added to the stirring reaction at room temperature. The reaction was 
stirred at 4 °C  for 10 minutes, followed by dropwise addition of chlorotriethylsilane (40 
L, 0.24 mmol, 1.2 eq). The reaction was stirred at 4 °C for 4 hours. MeOH (50 L) was 
added to quench the reaction. The mixture was filtered through a Pasteur pipette packed 
with silica gel, followed by flush with EtOAc (15 mL). The solvent was removed under 
reduced pressure. Column chromatography (Hexane/EtOAc = 20:1 to 3:1) afforded a 
mixture of mono-functionalized products (30 mg, 29%). 1H NMR of the mixture afforded 
the selectivity (C2:C3:C4 = 65:3:32). 
Table 4.6, entry 2. The general procedure P was followed using (−)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. Column chromatography (Hexane/EtOAc = 20:1 
to 3:1) afforded a mixture of mono-functionalized products. 1H NMR of the mixture 
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afforded the selectivity (C2:C3:C4 = 95:5:-). A second 
column chromatography (Hexane/EtOAc = 20:1 to 3:1) 
afforded the pure product 4.28 (92 mg, 90%). 1H NMR 
(CDCl3, 500 MHz)  9.90 (s, 1H), 7.82 (d, 2H, J = 8.3), 
7.20 (d, 2H, J = 8.8), 5.28 (d, 1H, J = 7.3), 4.2 (t, 1H, J = 2.9), 3.96-3.90 (m, 2H), 
3.81-3.79 (m, 2H), 3.64 (s, 1H), 2.97 (d, 1H, J = 7.8), 2.89 (s, 1H), 0.96 (t, 9H, J = 7.8), 
0.88 (s, 9H), 0.69 (q, 6H, J = 7.3), 0.04 (s, 3H), 0.02 (s, 3H). 13C NMR (CDCl3, 125 
MHz)  191.1, 162.3, 132.0, 131.3, 116.6, 98.0, 74.5, 71.9, 71.7, 69.2, 64.2, 26.0, 18.5, 
6.9, 5.0, -5.2, -5.3. IR: 3440, 2954, 2929, 2878, 1693, 1601, 1245, 1161, 1066, 834, 745 
cm–1. HRMS (DART-TOF) calcd. for C25H44O7Si2: [M+NH4]
+: 530.2969, found: 
530.3001. 
     Table 4.6, entry 3. The general procedure P was followed using (+)-4.6 (3.1 mg, 
0.010 mmol, 5 mol %) as the catalyst. Column 
chromatography (Hexane/EtOAc = 20:1 to 3:1) 
afforded 4.28 (8 mg, 8%), 4.29 (11 mg, 11%), and 
4.30 (65 mg, 63%), indicating the selectivity (C2:C3:C4 = 10:13:77). 1H NMR (CDCl3, 
500 MHz)  9.89 (s, 1H), 7.81 (d, 2H, J = 8.3), 7.15 (d, 2H, J = 8.3), 5.40 (d, 1H, J = 6.9), 
4.18 (s, 1H), 3.89-3.83 (m, 3H), 3.74 (d, 2H, J = 3.4), 3.66-3.62 (m, 1H), 3.02 (s, 1H), 
2.74 (s, 1H), 0.98 (t, 9H, J = 7.8), 0.85 (s, 9H), 0.67 (q, 6H, J = 8.3), -0.03 (s, 3H), -0.06 
(s, 3H). 13C NMR (CDCl3, 125 MHz)  191.1, 162.3, 131.9, 131.3, 116.9, 98.6, 76.0, 
71.1, 70.2, 68.6, 62.6, 26.0, 18.5, 6.9, 5.0, -5.1, -5.3. IR: 3431, 2953, 2929, 2878, 1687, 
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1601, 1243, 1132, 1058, 861, 832, 778, 744, 729 cm–1. HRMS (DART-TOF) calcd. for 
C25H44O7Si2: [M+NH4]
+: 530.2969, found: 530.2986. 
 
Site-Selective Silylation of Uridine and Characterization of Products: 
2’-O-TBS-’-O-DMTr-uridine (27). In a dry box, a suspension of 
5’-O-DMTr-Uridine 4.31 (168 mg, 0.30 mmol), catalyst (˗)-4.6 (8.4 mg, 0.03 mmol, 10 
mol %), and N,N-diisopropylethylamine hydrochloride (1.5 mg, 0.009 mmol, 3 mol %) in 
anhydrous THF (0.2 mL) was prepared in an oven-dried round-bottom flask. The 
suspension was brought out of the dry box, and N,N-diisopropylethylamine (78 L, 0.45 
mmol, 1.5 eq) was added to the stirring reaction at room temperature, followed by 
dropwise addition of tert-butyldimethylsilyl chloride (90 mg, 0.60 mmol, 2.0 eq) in THF 
(0.1 mL). The reaction was stirred at room temperature for 24 hours. DIPEA (30 L) and 
MeOH (50 L) was added to quench the reaction. The solvent was removed under 
reduced pressure. Column chromatography (Ethyl acetate/Hexane = 1:2 to 1:1) afforded 
the pure product 2’-O-TBS-’-O-DMTr-uridine 4.32 (184 mg, 93%, 2’:3’ = >98:<2 ). 1H 
NMR (CDCl3, 500 MHz)  9.28 (br s, 1H), 7.94 (d, 1H, J = 8.5), 7.38 (d, 1H, J = 7.0), 
7.32-7.23 (m, 7H), 6.85 (d, 1H, J = 9.0), 5.96 (d, 1H, J = 3.0), 5.30 (d, 1H, J = 8.5), 
4.37-4.34 (m, 2H), 4.11-4.10 (m, 1H), 3.80 (s, 6H), 3.54-3.48 (m, 2H), 2.59 (d, 1H, J = 
6.0), 0.93 (s, 9H), 0.19 (s, 3H), 0.16 (s, 3H). 13C NMR (CDCl3, 125 MHz)  163.5, 159.0, 
158.9, 150.5, 144.5, 140.4, 135.4, 135.2, 130.4, 130.3, 128.3 128.2, 127.4, 113.5, 113.5, 
102.5, 88.9, 87.4, 83.7, 76.5, 70.6, 62.5, 55.4, 25.9, 18.2, -4.4, -5.0 IR: 3534, 2951, 2929, 
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1680, 1508, 1460, 1250, 1175, 1115, 1034, 908, 829, 728 cm–1. HRMS (DART-ESI+) 
calcd. for C36H44N2O8Si: [M+H]
+: 661.29452, found: 661.29258. 
 
Site-Selective Acylation of Digoxin and Characterization of Products. 
-Acetyldigoxin (4.34). In a dry box, a suspension of digoxin 4.33 (39 mg, 0.050 
mmol), catalyst (+)-4.6 (4.6 mg, 0.015 mmol, 30 mol %), and N,N-diisopropylethylamine 
hydrochloride (0.3 mg, 0.0015 mmol, 3 mol %) in anhydrous THF (2.5 mL) was prepared 
in an oven-dried round-bottom flask. The suspension was brought out of the dry box, and 
N,N-diisopropylethylamine (11 L, 0.060 mmol, 1.2 eq) was added to the stirring 
reaction at room temperature. The reaction was stirred at 4 °C  for 10 minutes, followed 
by dropwise addition of acetyl chloride (4.3 L, 0.060 mmol, 1.2 eq). The reaction was 
stirred at 4 °C for 16 hours. MeOH (12 L) was added to quench the reaction. The 
solvent was removed under reduced pressure. Column chromatography (CH2Cl2/MeOH = 
50:1 to 30:1) afforded the pure product -acetyldigoxin 4.34 (37 mg, 90%, no 
-acetyldigoxin observed). 1H NMR (CDCl3, 500 MHz)  5.95 (s, 1H), 5.05-5.00 (m, 
2H), 4.98-4.93 (m, 3H), 4.47 (dd, 1H, J = 9.8, 2.9), 4.31-4.28 (m, 3H), 4.24-4.22 (m, 1H), 
4.10-4.05 (m, 2H), 3.91-3.82 (m, 2H), 3.43 (dd, 1H, J = 12.0, 4.2), 3.38 (d, 1H, J = 9.5, 
6.1), 3.31 (dd, 1H, J = 9.5, 2.9), 3.27 (dd, 1H, J = 9.5, 2.9), 2.22-2.14 (m, 1H), 2.13 (s, 
3H), 2.09-1.61 (m, 19H), 1.56-1.48 (m, 4H), 1.27 (d, 3H, J = 6.1), 1.25 (d, 3H, J = 6.4), 
1.21 (d, 3H, J = 6.4), 1.00 (s, 3H), 0.83 (s, 3H). 13C NMR (CDCl3, 125 MHz)  178.6, 
177.4, 172.2, 117.9, 100.8, 100.7, 97.1, 86.9, 83.9, 83.8, 76.8, 75.8, 75.6, 74.6, 69.6, 68.6, 
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68.5, 66.4, 57.4, 47.2, 42.4, 39.4, 39.1, 38.7, 38.1, 36.3, 33.8, 33.7, 31.6, 31.1, 31.0, 28.5, 
27.9, 27.6, 24.4, 22.9, 21.0, 18.63, 18.60, 18.4, 10.0 IR: 3433, 2932, 2880, 1734, 1370, 
1239, 1164, 1084, 1069, 1016, 866 cm–1. HRMS (DART-TOF) calcd. for C43H66O15: 
[M+Na]+: 845.4294, found: 845.4280. 
-Acetyldigoxin (4.35). The same procedure to produce -acetyldigoxin was 
followed using (−)-4.5 (4.2 mg, 0.015 mmol, 30 mol %) as the catalyst. Column 
chromatography (CH2Cl2/MeOH = 50:1 to 30:1) afforded the mixture of mono-acylated 
products with -acetyldigoxin 4.35 as the major product (23 mg, 56%,  = 91:9). 1H 
NMR and 13C NMR spectra of the product matched with the corresponding spectra of 
-acetyldigoxin obtained from Novartis. 1H NMR (CDCl3, 500 MHz)  5.94 (s, 1H), 
5.26 (d, 1H, J = 3.2), 5.03-4.89 (m, 6H), 4.30-4.27 (m, 2H), 4.05 (d, 1H, J = 2.2), 
3.90-3.80 (m, 3H), 3.42 (dd, 1H, J = 11.7, 4.2), 3.37 (dd, 1H, J = 9.0, 5.6), 3.31 (dd, 1H, 
J = 9.5, 2.9), 3.26 (dd, 1H, J = 9.5, 2.9), 2.19-2.15 (m, 1H), 2.12-1.63 (m, 20H), 
1.52-1.50 (m, 3H), 1.34-1.32 (m, 2H), 1.30 (d, 3H, J = 6.4), 1.29-1.27 (m, 2H), 1.24 (d, 
3H, J = 1.7), 1.23 (d, 3H, J = 1.5), 0.99 (s, 3H), 0.82 (s, 3H). 13C NMR (CDCl3, 125 
MHz)  179.2, 178.0, 173.0, 118.4, 101.3, 101.2, 97.6, 87.5, 84.5, 84.2, 76.4, 76.2, 75.2, 
73.4, 72.9, 72.3, 70.2, 69.2, 69.0, 58.0, 47.8, 42.9, 39.6, 39.2, 38.7, 37.8, 36.9, 34.3, 34.2, 
32.1, 31.7, 31.6, 29.1, 28.5, 28.2, 24.9, 23.5, 21.8, 19.3, 19.2, 10.6. IR: 3412, 2931, 2882, 
1736, 1371, 1241, 1163, 1068, 1017m 866 cm–1. HRMS (DART-TOF) calcd. for 
C43H66O15: [M+Na]
+: 845.4294, found: 845.4303. 
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Site-Selective Mesylation of Mupirocin and Characterization of Products. 
6-Mesyl mupirocin methyl ester (4.37). In a dry box, a solution of mupirocin 
methyl ester 4.36 (51 mg, 0.10 mmol), catalyst (−)-4.6 (6.1 mg, 0.020 mmol, 20 mol %), 
and N,N-diisopropylethylamine hydrochloride (0.5 mg, 0.0030 mmol, 3 mol %) in 
anhydrous THF (0.5 mL) was prepared in an oven-dried glass reaction vial. The solution 
was brought out of the dry box, and N,N-diisopropylethylamine (21 L, 0.12 mmol, 1.2 
eq) was added to the stirring reaction at room temperature. The reaction was stirred at 
-15 °C  for 10 minutes, followed by dropwise addition of methanesulfonyl chloride (9.3 
L, 0.12 mmol, 1.2 eq). The reaction was stirred at -15 °C for 20 hours. MeOH (25 L) 
was added to quench the reaction. The mixture was filtered through a Pasteur pipette 
packed with silica gel, followed by flushing with EtOAc (8 mL). The solvent was 
removed under reduced pressure. Selectivity of the reaction was determined by 1H NMR 
in the crude reaction mixture (C6:C7 = >98:<2). Column chromatography 
(Hexane/EtOAc = 1:1 to 1/2) afforded the pure product 4.37 (49 mg, 82%). 1H NMR  
5.73 (s, 1H), 4.53 (dd, 1H, J = 7.8, 2.5), 4.23-4.22 (m, 1H), 4.09-4.03 (m, 3H), 3.92 (dd, 
1H, J = 12, 3.4), 3.84-3.81 (m, 1H), 3.67 (s, 3H), 3.59 (dd, 1H, J = 12, 3.4), 3.11 (s, 3H), 
2.80-2.78 (m, 1H), 2.72 (dd, 1H, J = 7.8, 2.0), 2.56 (d, 1H, J = 3.9), 2.44 (dd, 1H, J = 14, 
3.4), 2.36-2.30 (m, 3H), 2.24 (d, 1H, J = 3.4), 2.20 (d, 3H, J = 1.0), 2.13-2.11 (m, 1H), 
1.85-1.80 (m, 1H), 1.69 (q, 1H, J = 7.4), 1.64-1.60 (m, 4H), 1.36-1.31 (m, 9H), 1.21 (d, 
3H, J = 6.4), 0.95 (d, 3H, J = 7.3). 13C NMR (CDCl3, 125 MHz)  174.5, 166.7, 154.9, 
118.6, 79.2, 72.4, 71.5, 69.3, 65.8, 64.1, 61.5, 55.7, 51.7, 43.1, 42.6, 39.8, 39.1, 34.3, 31.9, 
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29.4, 29.3, 29.2, 28.9, 26.2, 25.1, 20.9, 19.0, 13.0. IR: 3500, 2933, 2858, 1714, 1649, 
1455, 1438, 1353, 1226, 1175, 1152, 1116, 965, 942, 856, 529 cm–1. HRMS (DART-TOF) 
calcd. for C28H48O11S: [M+H]
+: 593.2996, found: 593.2977. 
7-Mesyl mupirocin methyl ester (4.38). In a dry box, a solution of mupirocin 
methyl ester 4.36 (618 mg, 1.2 mmol), catalyst (+)-4.5 (68 mg, 0.24 mmol, 20 mol %), 
and N,N-diisopropylethylamine hydrochloride (6.0 mg, 0.036 mmol, 3 mol %) in 
anhydrous THF (6.0 mL) was prepared in an oven-dried glass reaction vial. The solution 
was brought out of the dry box, and N,N-diisopropylethylamine (251 L, 1.44 mmol, 1.2 
eq) was added to the stirring reaction at room temperature. The reaction was stirred at 
-15 °C  for 10 minutes, followed by dropwise addition of methanesulfonyl chloride (111 
L, 1.44 mmol, 1.2 eq). The reaction was stirred at -15 °C for 20 hours. MeOH (300 L) 
was added to quench the reaction. The mixture was filtered through a Pasteur pipette 
packed with silica gel, followed by flushing with EtOAc (90 mL). The solvent was 
removed under reduced pressure. Selectivity of the reaction was determined by 1H NMR 
in the crude reaction mixture (C6:C7 = 18:82). Column chromatography (Hexane/EtOAc 
= 1:1 to 2/5) afforded the pure product 4.38 (403 mg, 57%). 1H NMR (CDCl3, 500 MHz) 
 5.75 (s, 1H), 5.04 (br s, 1H), 4.07 (t, 2H, J = 6.9), 3.86-3.82 (m, 2H), 3.70-3.3.65 (m, 
5H), 3.61-3.59 (m, 1H), 3.15 (s, 3H), 2.81 (td, 1H, J = 5.9, 2.0), 2.78 (dd, 1H, J = 7.3, 
2.5), 2.65 (d, 1H, J = 14), 2.36 (d, 1H, J = 6.8), 2.32-2.26 (m, 4H), 2.21 (s, 3H), 1.85-1.81 
(m, 1H), 1.79-1.74 (m, 1H), 1.65-1.60 (m, 4H), 1.45 (q, 1H, J = 6.8), 1.38-1.28 (m, 9H), 
1.24 (d, 3H, J = 6.4), 0.93 (d, 3H, J = 6.9). 13C NMR (CDCl3, 125 MHz)  174.5, 166.8, 
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156.1, 118.1, 81.4, 75.4, 71.6, 67.6, 65.8, 64.1, 61.0, 54.8, 51.7, 42.9, 42.6, 39.6, 38.8, 
34.3, 32.0, 29.3, 29.2, 29.1, 29.0, 26.2, 25.1, 21.3, 19.5, 12.6. IR: 3496, 2401, 2930, 2861, 
1736, 1714, 1649, 1457, 1352, 1225, 1174, 1151, 1112, 968, 874, 548 cm–1. HRMS 
(DART-TOF) calcd. for C28H48O11S: [M+H]
+: 593.2996, found: 593.2980. 
 
4.10 References 
1) (a) van Kooyk, Y.; Rabinovich, Nat. Immunol. 2008, 9, 593-601. (b) Helenius, A.; 
Aebi, M. Science 2001, 291, 2364-2369. (c) WeymouthWilson, A. C. Nat. Prod. Rep. 
1997, 14, 99-110. 
2) (a) Butler, M. S. Nat. Prod. Rep. 2008, 25, 475-516. (b) Ernst, B.; Magnani, J. L. Nat. 
Rev. Drug Discov. 2009, 8, 661-677. (c) La Ferla, B.; Airoldi, C.; Zona, C.; Orsato, 
A.; Cardona, F.; Merlo, S.; Sironi, E.; D’Orazio G.; Nicotra, F. Nat. Prod. Rep. 2011, 
28, 630-648. 
3) (a) Ouerfelli, O.; Warren, J. D.; Wilson, R. M.; Danishefsky, S. J. Expert Rev. 
Vaccines 2005, 4, 677-685. (b) Boltje, T. J.; Buskas, T.; Boons, G. J. Nat. Chem. 
2009, 1, 611-622. 
4) (a) Seeberger, P. H.; Werz, D. B. Nat. Rev. Drug Discov. 2005, 4, 751-763. (b) Wang, 
C.; Lee, J.; Luo, S.; Kulkarni. S.; Huang, Y.; Lee, C.; Chang, K.; Hung, S. Nature 
2007, 446, 896-899. (c) Zhu, X.; Schmidt, R. R. Angew. Chem. Int. Ed. 2009, 48, 
1900-1934. (d) Hsu, C.; Hung, S.; Wu, C.; Wong, C. Angew. Chem. Int. Ed. 2011, 50, 
11872-11923. (e) Walczak, M. A.; Danishefsky, S. J. J. Am. Chem. Soc. 2012, 134, 
Chapter 4, page 202 
16430-16433. 
5) (a) Breslow, R.; Baldwin, S.; Flechtner, T.; Kalicky, P.; Liu, S.; Washburn, W. J. Am. 
Chem. Soc. 1973, 95, 3251-3262. (b) Breslow, R.; Corcoran, R. J.; Snider, B. B.; 
Doll, R. J.; Khanna, P. L.; Kaleya, R. J. Am. Chem. Soc. 1977, 99, 905-915. (c) 
Breslow, R.; Heyer, D. J. Am. Chem. Soc. 1982, 104, 2045-2046. (d) Rosen, B. R.; 
Simke, L. R.; Thuy-Boun, P. S.; Doxon, D. D.; Yu, J.; Baran, P. S. Angew. Chem. 
Int. Ed. 2013, 52, 7317-7320. 
6) (a) Wender, P. A.; Hilinski, M. K.; Mayweg, A. V. W. Org. Lett. 2005, 7, 79-82. (b) 
Chen, M. S.; White, M. C. Science 2007, 318, 783-787. (c) Snyder, S. A.; Gollner, A.; 
Chiriac, M. I. Nature 2011, 474, 461-466. (d) Wilcock, B. C.; Uno, B. E.; Bromann, 
G. L.; Clark, M. J.; Anderson, T. M.; Burke, M. D. Nat. Chem. 2012, 4, 996-1003. 
7) Mahatthananchai, J.; Dumas, A. M.; Bode, J. W. Angew. Chem. Int. Ed. 2012, 51, 
10954-10990. 
8) For reviews on enantioselective catalysis, see the special issue in: Chem. Rev. 2003, 
103, 2761-3400. 
9) (a) Miller, S. J.; Copeland, G. T.; Papaioannou, N.; Horstmann, T. E.; Ruel, E. M. J. 
Am. Chem. Soc. 1998, 120, 1629-1630. (b) Griswold, K. S.; Miller, S. J. Tetrahedron 
2003, 59, 8869-8875. (c) Morgan, A. J.; Komiya, S.; Xu, Y.; Miller, S. J. J. Org. 
Chem. 2006, 71, 6923-6931. (d) Lewis, C. A.; Miller, S. J. Angew. Chem. Int. Ed. 
2006, 45, 5616-5619. (e) Sánchez-Roselló, M.; Puchlopek, A. L. A.; Morgan, A. J.; 
Miller, S. J. J. Org. Chem. 2008, 73, 1774-1782. (f) Lewis, C. A.; Merkel, J.; Miller, 
Chapter 4, page 203 
S. J. Bioorg. Med. Chem. Lett. 2008, 18, 6007-6011. (g) Lewis, C. A.; Longcore, K. 
E.; Miller, S. J.; Wender, P. A. J. Nat. Prod. 2009, 72, 1864-1869. (h) Jordan, P. A.; 
Miller, S. J. Angew. Chem. Int. Ed. 2012, 51, 2907-2911. (i) Pathak, T. P.; Miller, S. J. 
J. Am. Chem. Soc. 2012, 134, 6120-6123. (j) Lichtor, P. A.; Miller, S. J. Nature Chem. 
2012, 4, 990-995. ba 
10) (a) Kawabata, T.; Muramatsu, W.; Nishio, T.; Shibata, T.; Schedel, H. J. Am. Chem. 
Soc. 2007, 129, 12890-12895. (b) Kawabata, T.; Furuta, T. Chem. Lett. 2009, 38, 
640-647. (c) Ueda, Y.; Muramatsu, W.; Mishiro, K.; Furuta, T.; Kawabata, T. J. Org. 
Chem. 2009, 74, 8802-8805. (d) Muramatsu, W.; Mishiro, K.; Ueda, Y.; Furuta, T.; 
Kawabata, T. Eur. J. Org. Chem. 2010, 2010, 827-831. (e) Yoshida, K.; Furuta, T.; 
Kawabata, T. Tet. Lett. 2010, 51, 4830-4832. 
11) (a) Lee, D.; Taylor, M. S. J. Am. Chem. Soc. 2011, 133, 3724-3727. (b) Chan, L.; 
Taylor, M. S. Org. Lett. 2011, 13, 3090-3093. (c) Lee, D.; Williamson, C. L.; Chan, 
L.; Taylor, M. S. J. Am. Chem. Soc. 2012, 134, 8260-8267. (d) Gouliaras, C.; Lee, D.; 
Chan, L.; Taylor, M. S. J. Am. Chem. Soc. 2011, 133, 13926-13929. (e) Beale, T. M.; 
Taylor, M. S. Org. Lett. 2013, 15, 1358-1361. 
12) Page, M. I.; Jencks, W. P. Proc. Natl. Acad. Sci. 1971, 68, 1678-1683. 
13) Lobsanov, Y. D.; Romero, P. A.; Sleno, B.; Yu, B.; Yip, P.; Heroscovics, A.; Howell, 
P. L. J. Bio. Chem. 3002, 279, 17921-17931. 
14) Sun, X.; Lee, H.; Lee, S.; Tan, K. L. Nat. Chem. 2013, 5, ASAP. 
15) Sun, X.; Worthy, A. D.; Tan, K. L. Angew. Chem. Int. Ed. 2011, 50, 8167-8171. 
Chapter 4, page 204 
16) Worthy, A.D.; Sun, X., Tan, K. L. J. Am. Chem. Soc. 2012, 134, 7321-7324. 
17) Giustra, Z. X.; Tan, K. L. Chem. Comm. 2013, 49, 4370-4372. 
18) Zheng, L.; Yin, X. J.; Yang, C. L.; Li, Y.; Yin, S. F. Chem. Nat. Comp.2011, 47, 
170-175. 
19) Somoza, A. Chem. Soc, Rev. 2008, 37, 2668-2675. 
20) Repke, K. R. H.; Megges, R. Expert Opin. Ther. Pat. 1997, 7, 1297-1306. 
21) (a) Thomas, C. M.; Hothersall, J.; Willis, C. L.; Simpson, T. J. Nat. Rev. Microbiol. 
2010, 8, 281-189. (b) Silvian, L. F.; Wang, J.; Steitz, T. A. Science 1999, 285, 
1074-1077. 
22) Lee, D. & Taylor, M. S. J. Am. Chem. Soc. 2011, 133, 3724-3727. 
23) Xu, Y., Ishizuka, T., Kimura, T. & Komiyama, M. A J. Am. Chem. Soc. 2010, 132, 
7231-7233. 
24) Scott, R. W.; Murphy, A. C.; Wu, J.; Hothersall, J.; Cox, R. J.; Simpson, T. J.; 
Thomas, C. M.; Willis, C. L. Tetrahedron 2011, 67, 5098-5106. 
  
 
 
 
 
 
 
 
Appendix 1 
 
Spectras for Compound Characterizations. 














































































































































































































































































